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ABSTRACT

THE ETHICAL ANALYSIS OF THE CONNECTION
BETWEEN HOPE AND FERTILITY PRESERVATION

By
Leah Jeunnette
December 2016

Dissertation supervised by Dr. Henk ten Have
Fertility preservation has many different indications and covers a wide variety of
demographics. One major motivation for the use of fertility preservation is hope. When
discussing fertility preservation, healthcare professionals present several options, but
choosing which type of fertility preservation to pursue is a difficult decision. This
dissertation will argue not only that hope is one of the basic drivers for making a decision
regarding fertility preservation, but also the current methods for fertility preservation
create a reliance on hope. Hope can determine if a patient chooses the safest option or
seeks out more radical experimentation or whether to delay cancer treatment in order to
seek fertility preservation. The role of hope in medicine has been researched for a long
time. Although there have been studies aiming to understand the relation between hope,
survival and recovery, the role of hope in fertility preservation is not well explored. This
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dissertation will argue that fertility preservation can benefit from better appreciating the
role of hope. Fertility preservation should take the dependence on hope seriously, but
still be concerned that while promoting hope it does not create a false expectation. The
aim of the dissertation is to ethically examine the connection between fertility
preservation and hope.
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Chapter One: Introduction
I.

Introduction

Fertility preservation places hope in a future outcome for patients. While patients
would not want to be at risk of infertility on purpose, sometimes it is unavoidable when
patients are diagnosed with cancer and other serious diseases. The advancements in
medicine including new techniques and technology, allows patients to not just survive
disease for a short time, but to potentially live long, healthy lives. In order to seek a
better outcome, aggressive treatments are pursued, but they also bring serious side effects
including the risk for infertility or sterility. Precautions are taken, but not all risk for
infertility or sterility can be eliminated. Many patients turn to fertility preservation to
prevent this.
By having access to aggressive treatments, hope is fostered not only to beat
serious diseases like cancer; but also the potential for a future pregnancy through the
cryopreservation of gametes and tissues. By providing these possible cryopreservation
options, hope is fostered not just in these specific treatments, but also for medicine in
general. When patients experience successful treatments for difficult cases, patients may
have a greater expectation for medicine to perform miracles in the future. It is important
that patients are not looking for a medical miracle in the far off distant future, but
understand the current state of medicine and research. Patients need to maintain a
realistic and authentic view of their current circumstances; otherwise, they are bordering
on a false hope that could lead to disappointment.
In trying to maintain this realistic view, there is a multilayered list of concepts and
considerations for fertility preservation. Bioethics should be present to ensure patients'
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rights, and to critically examine the hope that patients have towards fertility preservation
prior to any procedures. This dissertation seeks to ethically analyze the relationship
between hope and fertility preservation by understanding the basic science of fertility
preservation, examining the basic definition of hope, considering all the different factors
that fertility preservation brings about including a short discussion on research and its
impact on medicine. Additionally, this dissertation will discuss the fundamental ethical
concepts of autonomy, beneficence, nonmaleficence, truth-telling, informed consent, and
decision making. It will demonstrate that by addressing the ethical considerations prior
to any procedures, authentic hope can be fostered in fertility preservation.
II.

State of the Problem

Fertility preservation has many different indications and covers a wide variety of
demographics. However, what specifically drives someone to choose to preserve
fertility? One major motivation for the use of fertility preservation is hope. When
discussing fertility preservation, healthcare professionals present several options, but
choosing which type of fertility preservation to pursue is a difficult and complex
decision. This dissertation will argue not only that hope is one of the basic drivers for
making a decision regarding fertility preservation, but also the current methods for
fertility preservation create a reliance on hope, and that reliance needs to be addressed in
a manner that does not exploit the vulnerable or miscommunication of hope.
Over the years, the different types of fertility preservation available have
increased including the availability and access for both standard of care and new research
protocols. This may be due to the more open discussion of fertility, more transparency in
healthcare, or even the marketing and advertisement of options. Many of these new
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research protocols seek for new ways to provide the means to preserve fertility with
minimal risks, time, and effort. The range of options for fertility preservation is from
standard protocols like sperm freezing to experimental research like ovarian
transplantation. Fertility preservation is available for males and females, and from young
children through adults. It is critical not to categorize all fertility preservation into a
singular discussion because of the myriad of factors and possible scenarios and decisions
that have to be made. For instance, fertility preservation should be addressed differently
when dealing with prepubescent patients as opposed to adult patients. While
prepubescent children have access to a few research protocols, adults have standard of
care options available. One must be concerned not only from a general view on fertility
preservation, but also from specific details dealing with the different types of availability,
demographics, ages, or methods.
The problem is that communication and understanding can be difficult between
healthcare professional and patients. Patients have a certain level of expectation for
medicine and research, and sometimes, it is challenging for patients to grasp that research
is not standard of care. While patients may benefit from the research, it is not a guarantee
or to be expected. Patients have a base level of hope in what medicine and research can
do. It is the job of the healthcare professionals to communicate all the available options,
but patients may not understand the nuanced difference between standard of care and
research, the different levels of risk, or even the success rate of specific options.
Additionally, it is also important for patients to understand the difference between current
research studies and the potential future research studies.
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III.

Methodology

This dissertation will argue that fertility preservation can benefit from better
appreciating the role of hope. In other words, fertility preservation should take the
dependence on hope seriously, but still be concerned that promoting hope does not create
a false expectation. The aim of the dissertation is to ethically examine the connection
between fertility preservation and hope.
The basis for hope pulls from philosophy and theology, and the field of
psychology has spent significant time explaining and expressing hope. Hope can
determine if a patient chooses the safest option or seeks out more radical
experimentation. Hope can determine whether to delay cancer treatment in order to seek
fertility preservation or to focus on only the disease. Hope can also force a patient to face
mortality and consider the future. The role of hope in medicine has been discussed a
great deal.1,2,3,4 Although there have been studies aiming to understand the relation
between hope, survival and recovery or hope and cancer, the role of hope in fertility
preservation is not well explored.
By looking at fertility preservation not only from a general description, but also
from through application, it allows hope to take a very specific part in the discussion of
fertility preservation. Because fertility preservation includes both standards of care and
research protocols, the analysis of hope and fertility preservation needs to consider both
standard of care and research.
In order to make the decision of pursuing fertility preservation, patients much
consider their own lives and those around them. This consideration includes how the
patients envisioned their lives regarding their diagnosis and for the future of the lives in
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general. Patients have to decide what future goals and values are most important while at
the same time balancing the options for treatment for a diagnosis or delaying parenthood.
This hope in the future makes the decision much more complex. It is critical to ethically
analyze the advantages and disadvantages of the reliance on hope in fertility preservation.
By doing so, it can prevent the creation of false hope and give patients a more realistic
understanding of their future, rather than the hope of an ideal future.
For the current methods of fertility preservation, many ethical principles are
invoked- such as informed consent, protection of the vulnerable and best interest in
surrogate decision making. Therefore, it is important to review these elements in light of
the understanding of the reliance of hope in fertility preservation. By doing so, one can
better review the current approaches to fertility preservation and provide a better process
and understanding for patients as they make decisions that are complex and difficult.
IV.

Chapter Summaries

In order to analyze the connection between hope and fertility preservation, it is
critical to look at all the different aspects and pieces contained. The history and science
of reproductive technology leading to fertility preservation will be discussed, specifically
how ethics has sought to address the many difficult changes in medicine. The concept of
hope specifically pulling from philosophy and theology, but also has been discussed
specifically in relation to healthcare and research and as such can be discussed with
fertility preservation. By examining the ethical role of hope in its relation to fertility
preservation, this dissertation will discuss why hope is different in this context as
opposed to other areas of healthcare. An ethical analysis of the reliance on hope in
fertility preservation will discuss what specific ethical concepts need to be considered in
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relation to hope and will also develop a critical ethical analysis of the advantages and
disadvantages of the reliance on hope in fertility preservation. Finally, there will be
discussion for improving the current practice of addressing fertility preservation on the
basis of the ethical assessment developed in the various chapters (e.g. in connection to
informed consent, protection of the vulnerable, and research ethics.)
Chapter Two will focus on fertility preservation. The history and science of
fertility preservation will be analyzed, specifically the historical advancements of science
and its contribution to medicine. Whether preventing pregnancy or combating infertility,
reproductive technology has progressed quickly. Medical research has proven that it
continues to find innovative ways to push the expectations and the applications of
technologies. Even though the technology has progressed, law and ethics often is playing
catch up. 5,6,7 Bioethics has struggled to address the advancement of science in a timely
manner.8,9,10 Cryopreservation technology has expanded beyond sperm, embryo, and
oocyte into research of cryopreservation of ovarian and testicular tissues.11,12,13,14,15 This
expansion of innovative cryopreservation has widen the ethical discussion to include new
research protocols.16 While fertility preservation is recommended for those who are at
risk for infertility, either due to delaying pregnancy/ parenthood 17,18 or side effects of
medical treatments like chemotherapy, there is no fool proof way to predict the risks of
infertility. 19,20,21,22,23,24,25 Fertility preservation for delaying parenthood does not
guarantee a successful pregnancy any more than infertility due to medical treatment or
illness. Differences in gender, age, and socioeconomics of the patient population
automatically limit the methods that patients have access to before the first conversation
with a healthcare professional. This division highlights the bioethical issues of decision
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making, procreative liberty, invasiveness of procedures including risk, affordability of
cryopreservation, and even disparities for referral patterns in addition to other bioethical
issues of moral status of embryos, viability, value of life, federal funding, and cost and
insurance coverage. The healthcare professional needs to be open and honest to discuss
what best fit the specific patient. 26,27,28,29 Understanding the standard of care and
experimental options are just as important as understanding the possible demographic
issues that a patient may be facing as they move forward with their highly personal
decision.
Chapter Three seeks to analyze the concept of hope specifically pulling from
philosophy and theology both describing the nature and characteristics.30 In addition, it
will detail the specifics of hope in relation to healthcare and research. 31 Hope can be
discussed in two separate ways, first in existential terms and second in a personal
narrative.32 It is important to consider the effect of the personal narrative (biographical
understanding) in any decision making. By finding key descriptions from the existential
discussion, such as realistic possibility and the future, one can better dictate how hope is
used within a personal narrative like fertility preservation. One of the biggest concerns
regarding hope is ensuring authenticity and preventing false hope.33 Authentic hope has
been connected to trustworthiness and honesty.34 False hope sets up an individual for
disappointment so hope must be based in reality. 35 Within healthcare, hope is part of the
patient-healthcare professional relationship and can demonstrate respect for autonomy
and the prevention of exploitation of the vulnerable.36,37 Without understanding how the
individual is using the word hope, it is difficult to manage and to foster such a concept.
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Chapter Four will examine the ethical role of hope in its relation to fertility
preservation. It will discuss why hope is different in this context as opposed to other
areas of healthcare. Though discussed in the abstract to start, both hope and fertility
preservation are part of a personal narrative for patients. There are two keys players
involved when it comes to understanding the possibility of fertility preservation: the
healthcare professional and patient and families. It is important to consider how hope is
communicated in fertility preservation and what role hope plays in the interactions
between patients and healthcare professionals in the decision making process. For
patients, they are facing two separate decisions: the initial cryopreservation and the
attempt to get pregnant in the future.38 There is a responsibility of both the healthcare
professional to thoroughly explain the truth and the realistic expectations of fertility
preservation and the patient to maintain hope in a realistic, possible way in attempting to
get pregnant. 39 There are specific aspects to the future including genetic offspring,
grandparenthood, and research protocols that are a part of discussion for the future of
patients. Since hope and fertility preservation both involve the discussion of realistic
possibility and the future, it is tough to adequately maintain realistic hope.
Chapter Five will present an ethical analysis of the reliance on hope in fertility
preservation. It will discuss what specific ethical concepts need to be considered in
relation to hope. Ethical principles such as autonomy, beneficence, nonmaleficence, and
justice are extensively discussed in ethical considerations of fertility preservation. Hope
allows patients to look to the future, and because of the principle of autonomy seek out
medicine to attempt a successful pregnancy after fertility preservation.40 Beneficence and
nonmaleficence are not just part of the short term decision, but also a part of the long-
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term future decision.41,42,43 Standard of care and research protocols for fertility
preservation should be made more readily available to promote justice.44 Informed
consent, truth-telling and decision making directly connects to how hope is fostered in
fertility preservation. Because fertility preservation affects many different demographics
and offer different methods to each, informed consent needs to be adequately addressed.
Truth-telling can potentially promote or dampen hope depending on the information and
how it is presented.45,46 By fostering hope in fertility preservation, patients have sense of
control to direct their own care, provides optimism which can effect outcomes, and build
into the survivorship approach to disease. Patients can exert their autonomy, and work
with a trust-worthy healthcare professional throughout the entire process.47,48 While there
are advantages to fostering hope in fertility preservation, there are also disadvantages.
This can include false expectations and projection of the future of science, and trying to
manage the involvement of parents and partners of the patients. By better understanding
the ethical principles and concepts at play, hope is better managed.
Chapter Six will provide elements for improving the current practice on the basis
of the ethical assessment developed in the previous chapter. There are several programs
and advocacy groups that address fertility preservation, but most are aimed at providing
information, not processing decisions or the role that hope has over these decision plays.
These programs and guidelines should encourage the advantages and discouraging the
disadvantages in fostering hope in fertility preservation. These groups provide expertise
for the science, but must also take into consideration the expectations and hope that is
established because of that science. By identifying commonality in fertility preservation
programs and advocacy group guidelines, recommendations can be made on how to
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approach fertility preservation while fostering authentic hope. Seeking fertility
preservation does not necessarily make an individual vulnerable simply because of the
future possibility of infertility. By trying to protect the potentially vulnerable, trust,
honesty, and open communication can be established in all circumstances.49 Clear, wellmanaged communication takes the routine information from a brochure or website into
the practical, real life application of fertility preservation to a specific patient and applies
their specific values and goals.50 Bringing in an ethics consultation may provide an
objective, non-threatening voice where a patient can be heard and respected while it
provides an added layer to ensure understanding. Many oncofertility programs and
guidelines focus on creating a multidisciplinary teams.51,52 Including ethics to the table is
crucial. An ethics consultation can help to eliminate conflict of interest concerns among
healthcare professionals, and allows the patient to identify values and goal, not just for
the disease, but also beyond into survivorship. The connection between hope and fertility
preservation is present whether one acknowledges it or not. In order to protect patients,
ethics can play a much larger role in communication with patients regarding fertility
preservation.
Chapter Seven will be the conclusion of ethically examining the connection
between fertility preservation and hope. The hope that fertility preservation fosters is
based on the possibility to have children and on the realistic future of science in addition
to the authentic relationship between the patient and healthcare professional involved.
Fertility preservation covers a wide range of demographics creating a unique personal
narrative for each person. Healthcare professionals need to refer patients to reproductive
specialists in order to provide the best medical information, which will allow for truth-
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telling and to manage the hope that fertility preservation may foster. Key discussions
need to take place to address the common bioethical scenarios that a patient will face if
and when they undergo fertility preservation. Fertility preservation will continue to
foster hope as long as patients are at risk for infertility either by disease or delay in
parenthood and even if current research protocols become standard of care, new research
studies will be created. By fostering hope, patients are able to see beyond their
circumstances and into the future for a realistic positive outcome.
1
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Chapter Two: Fertility Preservation
I.

Introduction

In order to better understand the connection between hope and fertility
preservation, it is important to understand what fertility preservation is and who it affects.
Fertility preservation is a medical breakthrough category that has taken it cue from other
reproductive technologies some of which are no longer used, while others that still
remain in use today. Many developments in reproductive technology have greatly
influenced the approaches for fertility preservation. For instance, the medical
breakthrough of in vitro fertilization eventually leads to the ability to cryopreserve
embryos. This influence of developing technology has led to many different types of
fertility preservation and the continued push to develop new research protocols and better
understanding of the human body and its development. The types of fertility preservation
vary from standard of care including sperm, embryo, and oocyte cryopreservation to
research protocols, including ovarian and testicular tissue cryopreservation, and ovarian
transposition.1,2 While there are differing options for the types of fertility preservation,
the availability relies heavily on the demographic information of the patient including
gender and age. These nuanced differences of the methods and patient demographics can
affect the connection of fertility preservation to hope.
The struggle for bioethics with any type of technology is trying to keep the
conversation current with the technology. For many, reproductive technology creates an
even greater need for bioethics, because reproductive technology can be quite
controversial. Ethical discussions including defining the beginning and intrinsic value of
life, 3 moral status of embryos, the right to reproduce4,5, issues of access to reproductive
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technology, federal funding of research involving controversial materials like embryos or
fetal materials from abortion,6 the cost for reproductive technology, 7 and the discussion
of insurance coverage for reproductive technology.8 While fertility preservation has its
own unique spin on each of the major ethical issues, it takes its cue from past discussions
and variety of the demographics of patients also affects the ethical discussion.
The demographics of patients heavily affect the discussion of fertility
preservation. Demographic differences including gender, age, and socioeconomic affect
the type of fertility preservation available. Therefore, fertility preservation cannot be a
one size fits all discussion. The discussion must consider the specifics of the context
including gender, age, and socioeconomics of the patients as well as the availability of
standard of care and research protocols.
II.

General History of Reproductive Technology

Whether it is preventing pregnancy via birth control or restoring fertility through
artificial reproductive technology, history is filled with old wives tales, research studies,
experimental medicine, and proven scientific methodologies dealing with reproduction.
The idea of trying to procreate or preventing procreation has long been a focus of medical
research. Even the standard of care for reproductive technology has drastically changed.
Each of these new technologies influences other methods of reproductive technology. As
reproductive technology has developed, new protocols and uses for those technologies
are continuing to be introduced. Major breakthroughs in the attempts to get pregnant
include in vitro fertilization, cryopreservation of gametes, and most recently uterine
transplants. In addition, responses to the reproductive technology have changed. In the
last 50 years, fertility preservation has been pushing reproductive technology forward and
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because of that push, ethics often has to play catch up.9 Ethical issues such as the
intrinsic value of life, moral status of embryos and viability, procreative liberty (including
bodily self-determination), access to reproductive technology, federal funding for
controversial materials, and the cost and insurance coverage for reproductive technology
all affect not only fertility preservation, but also other reproductive technologies.
A.

Major Breakthroughs
Reproductive technology has progressed quickly in recent decades. Because of

these major breakthroughs like in vitro fertilization and cryopreservation, science and
medicine has proven that it continues to find new technologies and push the boundaries
expectations and the applications of such technologies have also widened.10 In vitro
fertilization started as a procedure in order to immediately attempt to get pregnant, but
combined with cryopreservation, women can attempt to get pregnant at a later date.
Sperm, embryos, oocyte, and now ovarian and testicular tissue are all being
cryopreserved to aid in fertility at a later date.11,12,13 However, ovarian and testicular
cryopreservation remains experimental and are being improved with research studies.
The eventual goal is transplanting these tissues back into the patients at a later date to
allow for natural pregnancy.14
1.

Infertility
Infertility has long been an issue in many cultures. There are legends and stories

all through history that focus on the inability to conceive. In both Christianity and
Judaism, the story of Abraham and Sarah focused on their inability to have a son until
they were well past child bearing age.15 For many years, infertility was solely blamed on
the women. Infertility has long been incorrectly associated with a women's inability to
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fulfill her wifely duties and the social opinion that she was somehow less of a women. In
fact, infertility affects men just as often as women.16 For men, infertility is most often
based on sperm (semen) quality including size, motility, and morphology. For women, it
includes both the quality of the oocytes as well as the health of the uterus. In some cases,
infertility can be a result of both partners having issues. It may take some time in order
to fully diagnosis a cause of infertility especially if there appears to be healthy people
involved.
There are many different ways that infertility has been approached. Old wives
tales detail the many different methods and techniques. Today, intrauterine insemination,
in vitro fertilization, medication, and medical procedures like the removal of fibroids and
endometrial tissue are all used to address various infertility issues. Fertility preservation
however, addresses the potential of infertility (or sterility) ahead of time. Essentially,
fertility preservation is a back-up in case someone does end up with infertility or sterility
due to any number of causes.
2.

In Vitro Fertilization
While Louise Brown may be known for being the first successful birth from in

vitro fertilization in 1978, there are many years of research that went into this
announcement. In vitro fertilization is a great example of how and why the purpose of
medical research has added to the body of knowledge. Barry D. Bavister in his article,
"Early history of in vitro fertilization", writes that the earliest development of in vitro
fertilization can be traces by to 1878 with studies focusing on sperm capacitation.17 As
studies progressed, knowledge was gained about how to properly acquire and store
sperm, hyperstimulate and retrieve oocytes, and how to properly introduce sperm and
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oocyte together in a petri dish. It took decades of studies on animals before it was
attempted in humans and even the first attempts were unsuccessful.
In the case of Louise Brown, this was not the first attempt at in vitro fertilization
in a human; however, it was the first documented, successful attempt. For the Browns,
having a child was a dream, but it also created vulnerability in their relationship.18 Drs.
Patrick Steptoe and Robert G. Edwards had never performed a successful in vitro
fertilization before, but did not inform either Lesley or John Brown of this. In fact, it was
10 years between the first successful embryo fertilization until the first successful birth.19
Because it was such a new procedure and newly successful, there were many concerns
over the ethics of this procedure. Discussion from religious perspectives focused on the
concept of souls and the use of artificial reproductive technology. Issues of informed
consent were questioned especially knowing that the Browns were not informed of the
risky nature of the procedure. Based upon earlier issues of informed consent due to
studies like the Tuskegee Syphilis Study, there was a right to be skeptical and concerned
about the importance of informed consent. Finally, there were discussions that focused
on patient safety and the long-term survival and health of the baby. People wanted a
guarantee that the baby would be healthy and normal as compared to spontaneous
pregnancies. Guarantees like this can never be given in research, and to do so is
irresponsible. Even today, while studies have shown that in vitro fertilization is safe and
possess no additional risks compared to spontaneous pregnancies, there is not guarantee
the health and safety of any pregnancy, live birth, and baby.20
At the time of the procedure, Lesley Brown was not informed that Drs. Steptoe
and Edwards had never been successful with in vitro fertilization resulting in a live birth.
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In fact, Lesley Brown admitted that she was unaware of the controversy of the procedure
and even read news articles about herself during her pregnancy highlighting the
controversies.21 It is impossible to speculate as to what decisions would have been made
if the Browns had known that the procedure had never been successful. However, history
has demonstrated over and over the importance of informed consent for any and all
participants- from the case of the Tuskegee Syphilis Study22 to issues surrounding
Henrietta Lacks Case.23
Because in vitro fertilization was new technology, many did not understand the
nuances of what in vitro fertilization meant. There was speculation regarding the
procedure, the safety to the mother and the fetus during pregnancy, and the long-term
health effect of both. Today, in vitro fertilization has been shown to be an effective and
safe procedure for both mother and fetus. The most successful in vitro fertilization rates
are as high as 43% for those under age 35 and as low as 18% for those over age 41.24
Long-term health of Louise Brown and her younger sister, Natalie (also produced via in
vitro fertilization), has been long been established and both sisters have even given birth
to children via natural means.25 However at the time, no one knew exactly what risks of
health the baby would have or if there were any long-term health effects- it was all purely
speculative.
There were also concerns from a religious perspective. Some questions whether
this baby produced would have a soul or whether this had the same value of life as those
conceived naturally. It asked questions about whether or not it was acceptable to
interfere with natural conception and God's will. Though the first case of in vitro
fertilization took place in England, in the United States, right to life and discussions over
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the start of human life were at an all-time high since Roe v Wade was ruled in 1973.26
Even today, the Ethical and Religious Directives for Catholic Health Care Services
clarifies that procreation should not be attempted outside of sexual intercourse.27 This
means that artificial methods to conceive are not allowed by the Catholic Church.
According to Directive 4 medical research must also adhere to the other directives.28
While the Catholic Church is very specific on its stance, other religious groups leave
more room for interpretation up to the individuals.
3.

Cryopreservation
Cryopreservation has been a slow process with interest that depends on the need

by society. The theory of cryopreservation has been discussion since as early as 1683.
Robert Boyle wrote about the observations regarding death as a result of freezing and
how meat is frozen as a means of preservation.29 The major push for having successful
cryopreservation for sperm was led by the farmers needing this technology for bull
sperm. More specifically the first theory of cryopreservation was formulated in the 1930s
by B.J. Luyet30 and by 1949; Polge accidentally conducted a successful cryopreservation
for sperm.31 By 1954, the first live birth was reported using cryopreserved sperm.32,33
While all this focus on sperm was rather quick in its overall success, embryo and
eventually oocyte preservation took much longer. The first live birth for embryos that
were cryopreserved was in 1980s.34,35 The problem was found in the speed of cooling.
Sperm was found to be best preserved in a slow-cooling process, while embryos and
oocytes do better in fast-cooling process. The difference is in water content of the
gametes, and the expansion of water as it cools became a recurring issue that saw damage
initially during cooling, but even later during warming.36 While sperm cryopreservation
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took approximately twenty years, oocyte cryopreservation was not successful for
decades. The first reported successful live birth following a successful oocyte
cryopreservation was not until 1999.37 On top of that, it was not until 2013 that oocyte
cryopreservation became standard of care as recognized by the American Society for
Reproductive Medicine.38
For many years, the use of cryopreservation was for the short term for example to
preserve embryos that are not implanted during the first round of in vitro fertilization.
Today, cryopreservation is used in preventative medicine for potentially long-term
solutions. Fertility preservation continues to push the bounds of what can be
cryopreserved. Currently, studies are being conducted to find ways to safely and
effectively cryopreserve testicular and ovarian tissue. This is just the first step in what
scientists are attempting to do. The idea is a complicated multi-step process which
includes transplanting tissue back into the patient, maturing the tissue, and allowing for
natural conception and pregnancy sometimes 20 years after the cryopreservation was
done.
4.

Uterine Transplants
The most recent area of new and innovative reproductive technology is the focus

on uterine transplants. Currently only successful in Sweden, uterine transplants seek to
address infertility issues that are directly affecting women with uterine factor infertility. 39
Early studies with uterine transplants focused on the success of transplants in animals
before any attempts were made on humans. As a way to learn from issues in previous
studies, many of uterine transplant studies including those conducted on animals and
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humans have made it a priority to discuss the ethical issues that are associated with the
research and even include bioethicist on the uterine transplant team.
The first studies regarding uterine transplants were conducted in Sweden. In
September of 2012, the first transplant was performed by a team that included ten
gynecologists and transplant surgeons from the United States, Australia, and Spain.40
The transplant was done using live donors from family members and all of those involved
were voluntary participants with a clear understanding that this was a research project.
Since the first transplant, a handful of live births have taken place through in vitro
fertilization. These studies are still in the early stages of research. In early 2016, the
Cleveland Clinic in Cleveland, Ohio announced their new research project focusing on
uterine transplants specifically involving deceased donors.
Uterine transplants studies, while taking much care and consideration of the
patients involved, are not conducted without risks and failures. In the case of Cleveland
Clinic less than a month after the healthcare facility announced the success of the
transplants and the details of the study, there was an infection which resulted in the
transplanted uterus being removed. They took care to ensure the patient's well-being was
priority before announcing that the transplanted uterus was removed.41 The Cleveland
Clinic has said it will continue its research study, but with each either successful or failed
transplant, it will adjust its research accordingly.42 Currently, this uterine transplant
studies are for women who have uterine factor infertility, but as the research progresses,
the application of the knowledge gained can be applied for other future research studies.
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B.

Major Ethical Discussions
Because of increasing technology and major breakthroughs, ethics has had its

hand full trying to balance the push of science with bioethical considerations of medicine
and research.43,44,45,46 Ethical discussions including defining the beginning of life, moral
status, the right to reproductive, issues of access to reproductive technology, cost and
insurance coverage for reproductive technology, or federal funding of research involving
controversial materials (embryos, fetal materials from abortion).47,48,49 These ethical
issues are not exclusive to fertility preservation. They are a constant discussion in the
area of reproductive technology, and every time a new study is reported or a new
standard of care is announced, these ethical issues are brought to the surface again.
These ethical issues have been in discussion since before the legalization of birth control
in Griswold v. Connecticut50 and Eisenstadt v. Baird 51 or the legalization of abortion in
Roe v Wade52, or other legal cases and acts involving abortion, Doe v Bolton, Planned
Parenthood v. Casey53, Partial Birth Abortion Ban Act of 200354, and Gonzales v.
Carhart.55 Legal cases are what tend to bring the ethical cases to the public discussion,
but within healthcare, these ethical issues have long been discussed.
1.

Intrinsic Value of Life
There are some that argue that life has an intrinsic value and because of that

should be protected at any and all costs. This intrinsic value of life begins with
conception for many, although various stages throughout gestation have been identified
as the beginning of life. Some even argue that gametes have potentiality for life and
should be protected just as much an embryos or fetuses. The idea stems from the concept
that life is sacred from the beginning. The idea of sanctity of life is often based in
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religious concepts, with the Catholic Church being a good example56. The Catholic
Church believes that all life has value and therefore should be protected.57 This is
because each human life is created by God and therefore if that life is destroyed, it
disrespects the intrinsic value of life that God created. Those who support this position,
often opposed abortion, destruction of embryos, and sometimes the use of contraception.
The idea of intrinsic value of life can also be described as having human dignity. Each
and every human has dignity by virtue of being a human from the point of conception to
the moment of death. No one is able to remove that dignity and it should be respected in
each person.
2.

Moral Status of Embryos/Fetuses (Viability)
One of the ethical issues that has not been explicitly addressed by the laws in the

United States is the moral status of an embryo or fetus. The idea of moral status is that
something has interests that should be considered and possibly protected.58 The
discussion of moral status in reproductive medicine typically centers on embryos and
fetuses. For some, since life begins at conception, embryos and subsequently fetuses
have a moral status and their interests and rights should be protected to the fullest extent
like a grown adult. The argument is that since the embryo has its own unique genetic
material, it is a separate being from the mother; therefore, the embryo/fetus has a moral
status and should be protected. For others, embryos/fetuses have the potential for human
life and therefore have some moral status. They are not at the same level as an adult, but
are not protected at the same level as a fully grown adult. The problem is where to draw
the line with potentiality. For beginning of life issues, the potential life cannot express its
wishes/desires and for a period of time cannot survive on its own. The issue here though
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is that this same argument could be applied to a fully grown adult who is unconscious and
dependent on others for care. It creates a slippery slope of whom and what falls under
potential life.
In Roe v Wade, viability was defined as the time when a fetus can independently
live outside the womb.59 45CFR 46.203(d) defines viability as "able to survive, (given
the benefit of available medical therapy) to the point where it can independently
maintaining heartbeat and respiration."60 For others, moral status may not start until as
late as at birth. In these cases, the embryo/fetus does not have a moral status and
therefore has no rights or a moral interest that needs to be protected.
As pointed out in Principles of Biomedical Ethics, there are many different
theories as what determines moral status.61 One of the difficulties in trying to define
moral status is that often by creating a definition, a specific group may be added or left
out unintentionally. For instance, saying that anything that is life has a moral status,
leaves the question of what defines life. For some they interpret this to mean human life,
but others may want to include high functioning animals. Sometimes by trying to create
a definitive definition, it creates more questions than answers. For Beauchamp and
Childress, they identify five different theories as how to determine moral status: human
properties, cognitive properties, moral agency, sentience, and relationships.62 For each of
these theories, a different trait of something that deserve protection is identified. Even
within each theory there are pitfalls.
3.

Procreative Liberty (Bodily Self-Determination)
Autonomy is often seen as one of the most important aspects in ethical

discussions. Autonomy is thought to be the right or freedom to make choices. It gives
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the individual the right to make decisions regarding their life and is acceptable as long as
no one else is harmed in the process. Those who are dealing with reproductive issues,
specifically those who are attempting to become pregnant, may be categorized as
vulnerable, and need to secure their autonomy and dignity.63 These individuals have
rights based on the principle of autonomy to refuse or seek out treatments. Autonomy
has both positive liberty and negative liberty included within it. Ultimately one must
“balance autonomy and protection of the vulnerable."64
Liberty is a fundamental value65 that is often used to justify health care, but it can
also be used to examine the implications for those seeking reproductive medicine. It is
seen in values and ideas such as privacy, choice, civil rights, dignity, respect, and
individuality.66 At the same time, it provides a way for vulnerable populations to have
protection. Liberty must be then taken into consideration such as equity. If those
struggling with infertility or sterility are categorized as vulnerable then equity says that
we must close the health disparity gap for those who are seeking reproductive medical
treatment.67
Liberty can be divided into two parts – positive and negative liberty.68 “One is to
say that negative liberty is freedom from something and positive liberty is freedom to
something.”69 In reproductive medicine, negative liberty means that someone cannot
force anything upon them. Individuals do not have to use certain medications or try
certain procedures. Provided the individual is competent and has capacity, than they can
even refuse lifesaving treatment. At the same time thought, these individuals need to
understand the consequences of their actions and thus make an informed decision not one
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based in fear or anger. While health professionals must respect that decision, they must
also make sure that the patients are not taking that stance because of being vulnerable.
For instance, in the case of women with breast cancer, there is a recommendation
to pursue fertility preservation in case of sterility due to the chemotherapy and radiation
exposure. However, women cannot be forced to seek fertility preservation. She has the
right to choose not to do anything. This could be based on her belief that her family is
already complete, or she may not have any desire to be mother. The women does not
have to provide a reason for refusing fertility preservation so long as she is competent
and has capacity to make her own decisions. Other demonstrations of negative liberty
can include refusing to abort a fetus or refused to be sterilization.
Positive liberty means that in addition to making choices, others have a duty to
help that person achieve their request.70 Those who are struggling with fertility should
have a positive liberty to seek out healthcare professionals. This positive liberty can be a
little more difficult to access because requesting specific medical interventions is much
harder than refusing. So what should be done? There should be places and opportunities
for the people to seek reproductive medicine. For many, there is access to good
medicine, teaching hospitals, research studies, but in reproductive medicine often it
comes down to the issues of cost and lack of insurance coverage.
4.

Access to Reproductive Technology
As part of positive liberty, patients have the right to seek our medical treatment.

The problem is that accessing reproductive technology is not easy and may be costly.
According to the principle of justice, to be just is to be fair and more specifically
distributive justice is to be equal and fair in the distribution of goods or services.71 In the
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case of healthcare, the principle of justice says that access to medical treatment should be
available to all- no matter of geographic location, gender, age, race, or any other
demographic factor. The goal should be to provide the most healthcare for the most
people. Necessary medicine should be distributed first, followed by elective medicine.
The trouble is how to distribute it and what is considered necessary versus elective.
Essentially, is creates a complex system of those who benefit more than others despite the
attempt to be fair and equal.72 In addition there is a question as to who makes the
decisions and what should, if any, be done for those who still cannot access medical care.
In the case of reproductive technology, some may argue that parts of reproductive
technology do not qualify as necessary medical care. The idea of necessary care or
decent minimum care refers to the need for medicine in order to sustain life or the idea of
catastrophic care, while elective medicine may be important but is not a life or death
situation but focuses more on health wants as opposed to needs.73 In the case of
reproductive technology, there is some necessary care- care during pregnancy, ovarian or
uterine cancer. In more recent years, the Affordability Care Act also added preventative
reproductive technology- contraception- to the list of necessary care.74 While still
controversial regarding coverage, contraception is to be available and covered by all
insurance plans unless the employer has religious objectives.75 It gets trickier when
discussing those are seeking medical treatment to get pregnant. Infertility or sterility is
not life threatening and therefore is not viewed in the same as dealing with a life
threatening disease.
For reproductive technology the idea of access also depends on other factors like
age, gender, and location. One of the biggest issues is the concept of disparities. Under
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the fair-opportunity rule, it says that no one should benefit or be denied anything based
their social or biological properties.76 This becomes problematic for those who do not fit
into the normal category. Disparities such as gender or location can create such a
disadvantage that it becomes burdensome, problematic, and cause harm just by having
those social or biological properties. Going back to the example of cancer, if a woman
has uterine cancer, but has no access to transportation to get to health care, her location
has created a disparity that actually puts her at risk for death. Those who face those types
of disparities are often found to have worse health as well.77 It creates a difficult hurdle
to overcome if they cannot access medical care and tend to have worse health. In
reproductive medicine, accessing healthcare is complicated because it is not a guarantee
for insurance coverage. In fact, most reproductive technology is not covered and is very
expensive.
5.

Cost and Insurance Coverage for Reproductive Technology
The cost for reproductive technology is expensive, and most often not covered by

insurance. As discussed before, reproductive technology is a broad category of medical
advancements. It ranges from small things like Pap smears to experimental procedures
like ovarian tissue cryopreservation. While the most routine and basic medical
treatments are often covered by insurance, more invasive things like in vitro fertilization
is typically not. It makes for a very frustrating process. The cost for these procedures
can be high and can create a burden on those seeking to get pregnancy. So why the high
cost for reproductive technology? The issue is a combination of the type of procedure,
the expertise required for the procedures, the equipment and supplies needed for the
procedure, and sometimes the number of steps involved and the invasiveness of
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procedures. For example, let's compare the procedures of extracting sperm from
extracting oocytes. For men, there are two main ways of getting sperm. One is through
ejaculation through masturbation, the other is to have a healthcare professional extract it
with a needle.78 Either option is fairly simple, is an outpatient procedure and does not
require a lot of equipment or prep time. In a single event, many sperm are provided at
once time, making an effective one time procedure. For women, oocyte extraction is not
as simple. Oocyte extraction is done through hyperstimulation of ovaries to encourage
the body to release more than one matured oocytes during ovulation. The goal is to
collect 14-16 oocytes at the time.79 The procedure requires hormone injections,
ultrasounds, and blood tests. It can only be done when the body is ready to releases the
oocytes. In rare cases, too many oocytes are released and it can cause hyperstimulation
ovarian syndrome.80 Just by understanding the nature of the procedures for oocyte
extraction, one can understand why it is more expensive to retrieve oocytes over sperm.
Because of this, when facing infertility, often the cheaper options are tried first, before
the most expensive treatments. Artificial insemination is more likely to be attempted
before in vitro fertilization because artificial insemination only requires sperm to be
retrieved instead of also retrieving oocytes. However, if a few tries of artificial
insemination does not work, then the more invasive in vitro fertilization is attempted.
Add to that the potential for looking for a surrogate or an egg donor, the cost can quickly
escalate. And none of these procedures for reproductive technology is 100% successful.
Insurance companies and those providing it, like employers, make decisions
whether to cover procedures for infertility or not. Often tests that can diagnosis infertility
are covered, but the procedures and treatments to address the issues of infertility are not
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covered. It does not distinguish the reason for infertility like age (like being over 40) or
biological condition (born without a uterus). All cases of infertility or sterility are
lumped together. Insurance coverage for reproductive technology is even controversial
for smaller procedures like contraception. In some cases, there are controversies as to
what should be covered and what is unnecessary to cover. This leads to a discussion of
the coverage, not just by insurance, but federal funding of reproductive technology that
some may consider immoral.
More recently, some companies have started to take public stances in covering
infertility treatments. Both Apple and Facebook have made public statements that claim
that their benefits for employees will include infertility treatments.81 Both of these
companies will now cover egg freezing for employees. It relieves the financial burden
off the employees. While it is impressive that these companies are leading the charge to
encourage coverage for infertility, it does not mean other companies will follow suit.
Smaller companies find even the most basic healthcare insurance to be expensive, but
adding infertility coverage can create an even more expensive coverage. Those increased
costs may then be passed onto the employees to pay for in some cases.
6.

Funding for Controversial Procedures and Materials
There are some that opposed the use of public money for controversial procedures

and/or materials in health care. Procedures like abortion or the use of fetal material or
embryonic stem cells in research may be viewed an immoral and therefore should not
take place. Further, public funds should not be used to financially support these
procedures or organizations that conduct such procedures or research. The ethical
objection is that these controversial procedures and/or materials destroy human life.82
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They believe that life begins are conception and any action that harms or destroys like is
immoral.
a.

Abortion and research with fetal material
With the passing of Roe v Wade, federal funds, specifically Medicaid, was being

used to fund abortions for those who could not afford it.83 This did not go over well with
those who opposed abortion. People were upset that their tax dollars were supporting a
procedure that they considered to be destruction of human life. Organizations like
Planned Parenthood were receiving federal funding which help offset the cost of
abortions. In 1976 the Hyde Amendment was passed to ensure that federal funds were
not used to fund abortions unless it threatened the life of the mother.84 However,
organizations like Planned Parenthood still receive federal funding for other aspects of
their organizations and some believe that this still frees up other funds that can go
towards abortions. The stance of some is that no federal funds should be provided to any
organization that participates in abortion. Many on the other side of the issue object to
the removal of federal funds. They believe that all women should have access to abortion
especially those who cannot afford an abortion and even more, the cost of raising a child
if they do not have an abortion.85 They believe that women's right to choose should not
only be upheld but supported financially. While many choose to object or support federal
funds, the same issue also can be found with state funds or local funds. The argument is
the same, there are some who object to any public money of the government used to
support procedures that are deemed immoral.
In addition to the objection to federal funds being used for abortions, there is also
the objection to the used of the terminated fetuses in research. Within the argument
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against the destruction of life, are those who object to using that destroyed life to further
the causes of research.86 Even if this developed technology does not use fetal material in
is modern day development or use, it was based upon knowledge gained from fetal
material. There are some who object to even the association with an immoral act and can
cause unease moving forward.87 This can create a similar objection to that of the
knowledge gained from the Nazi experiments during World War II.88 While the
knowledge gained may be useful to some, it was at the risk and harm of those who were
not given a choice to participate.
b.

Contraception
In 2010, with the passing of the Affordable Care Act, there were some that

objected to the requirement that insurance plans were required to cover the cost of
contraception, despite any moral or religious objection.89 The argument in favor of this
decision was that contraception is a preventative medication and should therefore be
covered by healthcare insurance.90 However, there were some who objected to the
requirement of having to pay for this. The exception was those who identify as a
religious institution that have an objection to the use of contraception. The Catholic
Church is just one example. The lack of clarity for this part of the Affordable Care Act,
was how it applied to organizations or businesses that although may not be an official
religious organization, may have missions, values, or ethics that are associated with a
religious belief.91 For example colleges and universities that are religious may not want
to pay for insurance plans that cover the cost of contraception. The objection to paying
for contraception, again stems from the idea that all life has value and that the destruction
of it is immoral. The Catholic Church has an official church position and their Ethical
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and Religious Directives that forbids the use of contraception. The Catholic Church
holds the position that the use of contraception is to interfere with God's plan of
procreation and should not be used.92 Businesses like Hobby Lobby also objected to this
requirement and successfully sued in order to not be forced to pay for coverage for
contraception.93 This ruling confirmed the concept that business, although, not religious
in nature, can have a religious viewpoint and conduct their business in ways that support
that belief. There are some that object to businesses being allowed to refuse coverage for
preventative medication like contraception. They argue that people have religious
beliefs, not businesses.
c.

Embryonic stem cell research
Embryonic stem cell research is considered a controversial way that federal funds

are used. For some, the reason that embryonic stem cells is controversial is that the
embryo is destroyed in order to use for research. If the embryo would have been
implanted into a uterus, the fertilized egg would become a fetus and could be brought to
term to be a baby. The moral status debate is similar to that in abortion. There are
people who argue that life begins are conception and that the destruction of the embryos
is the destruction of human life which has intrinsic value.94 The moral debate here has
impacted politics, legislation, and federal funding of stem cell research. The moral
debate is often associated with religion, but those who opposed are not exclusively
religious. The theory to this type of research is that these embryonic stem cells can be
used to regenerate cells in the body that have been permanently damaged by disease or
accident. Examples include heart disease, Parkinson’s disease, spinal cord injuries,
diabetes, muscular dystrophy, and vision and hearing loss.95 For those who object to
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embryonic stem cell research, they typically object to federal funding of such research.
They do not want their tax dollars to support science that they believe to be immoral.
Legally, the ways federal funds are used to support research for embryonic stem cell has
changed.
In 1995, the Dickey-Wicker Amendment was established by Congress to prohibit
federal funds from being used in research that involved the harm or destruction of
embryonic stem cells. However, in 2001 President Bush gave an executive order to limit
federal funding for embryonic stem cell research.96 President George W. Bush limited
federal funds being given to only those who conducted stem cell research with embryos
created before August 9, 2001. This meant that any embryonic stem cell research done
on new embryonic stem cell lines was to be funded privately. The purpose of all of these
changes from the Dickey-Wicker Amendment was because of the progression of the
science of stem cells. When embryonic stem cells were discovered, there was a push to
allow federal funding to increase the research results. There was also a push by those
opposed to the federal funding being used at all for embryonic stem cell research.
Executive Order Number 13435 was created in 2007 as a follow up to the statement from
2001 as a point of clarification. This 2001 statement, 2007 Executive Order and the
White Paper were established to satisfy both sides of the argument. However, neither
side was happy with the compromise. In March of 2009, President Barak Obama issued
Executive Order Number 13505 which removed the federal barriers to receiving federal
funds for embryonic stem cell research.97 Most recently on August 23, 2010 Federal
Judge Royce C. Lambert struck down Executive Order Number 13505. This means that
the Dickey-Wicker Amendment would have to be struck down in order to provide federal
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funds for embryonic stem cell research. Meaning that at the current time, the federal
laws are the same as what they were during the Bush Administration. This does not
however, restrict private funding of embryonic stem cell research.
III.

Science of Fertility Preservation

Fertility preservation is recommended for those who are at risk for
infertility.98,99,100,101 This could be due to the side effects of medical treatments like
chemotherapy for cancer or lupus or delaying pregnancy/ parenthood.102,103,104 It is hard
to predict infertility or sterility for anyone, but side effects from treatment are difficult to
predict because each person reacts differently to treatments like chemotherapy and
radiation. For those who delay parenthood, infertility can be discussed in general terms
based on what is known regarding decrease fertility with age for both men and women,
but specifics are difficult to predict. Either way, the purpose of fertility preservation is to
prevent infertility risks.
There are both standard of care and research protocols available for fertility
preservation. As more knowledge is gained, more research protocols will become
standard of care as is typical in healthcare. Before a specific type of fertility preservation
is chosen, it is important to consider the gender, age, severity of disease, treatment type
and dosage, and geographic location amongst other demographics for the patient to find
what is suggested best for the situation. For many healthcare professionals, it is vital to
stay up to date on the different techniques or at least have access to a reproductive
specialist as a resource.
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A.

Reasons for Fertility Preservation
Fertility preservation is recommended for those who are at risk for infertility or

sterility. It is meant to be a preventative treatment option in order to address infertility or
sterility if it happens. Infertility or sterility could be caused by various things including
disease like cancer, lupus, kidney disease, Turner syndrome, or even delaying in having
children. The causes and rate differ for every person so predicting infertility or sterility
can be difficult, which creates the importance of fertility preservation. While infertility
and sterility are different, preventing either through fertility preservation is the same.
Essentially fertility preservation is meant to prevent the effects of infertility or sterility.
With fertility preservation, those suffering from infertility or sterility are able to attempt
to get pregnant anyways. Side effects from treatment for disease is one of the biggest
causes of infertility/sterility. The other reason that people pursue fertility preservation is
aging, which is often the major issue when delaying having children. The terminologies
may vary- delay in child bearing, postponing having children, social egg freezing, age
related fertility decline. All that it means is there is no diagnosed disease that has side
effects due to the disease itself or its treatment that may affect fertility. Fertility will
decline with age and by freezing oocytes or embryos at a younger age, there is a better
chance for those materials to be healthy. No matter the cause of infertility or sterility, the
end result is the same- the inability to get spontaneously pregnant through sexual
intercourse.
1.

Side Effects of Disease and Treatment
Once a patient is diagnosed with a disease, the healthcare professional makes a

recommendation of treatment. They are to make recommendation based upon the best
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practice according to the diagnosis and the most up to date information and research.
Once the healthcare professional determines the treatment options and what his or her
recommendations will be, it must be presented to the patient. During this discussion, side
effects of either the disease or treatment are disclosed and patients have to consider what
the side effects mean for them both long term and short term. Most commonly for
diseases such as cancer, kidney diseases, or autoimmune disease, there is a risk of
infertility or sterility either due directly to the disease or the treatment of the disease.
Patients should be concerned about the effects on possible anatomic problems (like
irregularly functioning ovaries) or hormone issues (like a drop in testosterone) all which
can contribute to infertility and/or sterility. There is no fool proof way to predict the
exact risk of infertility, but fertility preservation is done for the just-in-case scenarios.
Essentially, fertility preservation is a type of preventive medicine for
infertility.105,106,107,108,109,110 According to the American Cancer Society the risk of
infertility varies on the gender, age, severity, and location of the disease in the body.111
Women with uterine cancer are at a higher risk for infertility or sterility compared to
women with cancers that do not involved reproductive organs simply because of where
the cancer is located. There is the risk of the uterus no longer being function or even
need to be removed. In order to understand fertility preservation, it is important to
understand what creates the need and interest for it.
a.

Infertility versus sterility
Infertility is defined as the inability to get pregnant over the course of twelve

months after having unprotected sexual intercourse at the correct time each month.112
According to the Centers for Disease Control, infertility affects around 7.5 million
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women (12.3%) age 15-44.113 Both infertility and sterility have multiple causes and is
different for each person though age and family history can play a factor. For women,
fertility is affected by ovulation, fallopian tubes, age, cervix, uterus, partner, and
hormones.114 While only one indicator is needed to cause the issue of infertility, a
combination of factors can cause issues as well. While infertility is not a chosen
condition, sterility can be chosen and purposeful by some, while, for others sterility is not
chosen. Infertility can only be known by those who are trying to get pregnant and thus by
being diagnosed with it, it means that the couple is purposefully trying to get pregnant.
In some cases, sterility is chosen intentionally with the sincere desire to never get
pregnant- either through a vasectomy or tubal ligation, or unintentionally due to side
effects of a disease/treatment. In the case of fertility preservation, this is done just in case
infertility or sterility happens. However, there is no guarantee that infertility or sterility
will happen and so in some cases, despite taking precautions with fertility preservation, it
is unnecessary. For instance, a young man in his twenties may be diagnosed with
Ewing’s sarcoma, freeze his sperm, undergo chemotherapy and radiation and is able to
get his wife pregnant without any issues. In those cases where fertility preservation is
proven unnecessary, patients have to decide what to do with the gametes and/or tissues
that have been cryopreserved.
b.

Cancer
According to the American Cancer Society men have a 1 in 4 and women have a

1 in 5 risk of some type of invasive cancer.115 And while the types of cancers vary, there
are some similarities in the initial approach in how to deal with cancer. The seriousness
of cancer, forces patients to take stock of their lives including what their goals and quality
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of life looks like. Before a patient can make a decision regarding fertility preservation,
some of the things to consider are age, diagnosis, type of treatment, relation of cancer to
reproductive organs, time frame for treatment delay, and any partners that may be
involved, and cost.116,117 All of these factors can be overwhelming to a patient that is still
adjusting to being diagnosed with cancer. The information being provided to a patient
can be intimating and healthcare professionals need to be well-versed in the discussion of
fertility or be willing to refer that patient to someone who is well-versed.
Chemotherapy and radiation are two of the most common treatments for cancer.
The type of chemotherapy and the amount of radiation vary patient to patient. Since
these treatments have been around the longest, the risk of infertility is best understood in
these circumstances. In other treatments like immunotherapy, because they are still
newer, there is not a longer term understanding of the risk for infertility. For male
patients, since sperm is a cell that divides quickly, certain types of chemotherapy may
wrongly kill sperm cells. It may take years for sperm production to return to normal, if it
ever does.118 For female patients, chemotherapy creates a different risk than men.
Chemotherapy may reduce the number of years that women are fertile. Since women are
born with their total number of eggs and chemotherapy may cause damage to those eggs.
The other issue is dealing with pregnancy during and after chemotherapy. Pregnancy
during chemotherapy will harm the fetus and cause serious birth defects so patients are
encouraged to use very effective birth control and take multiple precautions. Attempting
to get pregnant after chemotherapy needs to be done with the supervision of a healthcare
professional ensuring that enough time has passed and to know what if any damage to
eggs remains.119 There are certain types of chemotherapy that are less of a risk for
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infertility, more than others, but both male and female patients need to weigh the
effectiveness of the chemotherapy against the risk of infertility. The American Cancer
Society provides resources that allows patients to easily understand their risks and
concerns. It encourages patients to ask questions and to seek healthcare professionals
that are well versed in fertility preservation.
c.

Other diseases
There are other diseases and conditions that can affect fertility. Disease like

lupus, bone marrow disease, rheumatoid arthritis, multiple sclerosis can be treated with
chemotherapy drugs which comes with a risk of infertility similar to that of
chemotherapy for cancer treatment. According to review of ovarian cryopreservation
studies, ovarian failure can be a result of other issues besides cancer including bone
marrow transplantation, autoimmune diseases requiring chemotherapy, ovarian
pathologies, and endocrine or genetic diseases.120 In these cases, infertility is a risk due
to premature ovarian failure. For example, girls with Turner syndrome are at an
extremely high risk of ovarian failure. In most cases, there is not puberty development
whatsoever.121 In 2016, Kutluk Oktay and his team created practical guidelines for
fertility preservation in women with Turner Syndrome. In their decision-making guide,
the path follows the similar framework for others considering fertility preservation. It is
broken into prepubescent and postpubescent options. The recommendation is to identify
the best option for the patient's situation, but also take into consideration that Turner
Syndrome has an extremely high infertility rate. The best way to go about this is to refer
the patient to a fertility specialist.122
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2.

Delay of Childbearing
There are men and women who purposefully choose to delay having children. It

could be due to not finding the right partner, choosing to focus on career first, or not
feeling mature enough to handle children yet. The reasons vary, but the discussion of
delay is similar. By delaying having children, there is the risk of infertility being a
problem. Since the average age of a women having her first pregnancy has increased,
fertility preservation has become a more go to option for some. The average age for a
first time pregnancy is 26.3 years as of 2014 as compared to 24.9 in 2000.123 The
availability of birth control, sex education, contraception, and abortion may be reasons
women delay having children.124 By delaying the decision to have children, there are
biological concerns that women and men should be aware of before they decide to delay
pregnancy.
The biological affect for delaying having children affects women more severely
than it affects men. Women are born with a finite number of eggs and as they release one
each month, their number decreases. At the same time, the quality of the eggs decreases.
Women who are over the age of 35 are considered to be at high risk for infertility. For
men, the increase in age can correspond to the decrease in sperm count, motility, and
morphology. However, while the health of the sperm does decrease over time, men's
fertility does not start to decrease until late sixties.125 With increase age, there is also the
risk of defects to the fetus and other pregnancy complications. Chromosomal
abnormalities like Down syndrome appear in a greater rate as age increases. 126 Freezing
oocytes, sperm, and embryos when the gametes are younger and healthier, can help to
avoid the potential problems that generally come with older and lower quality oocytes
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and sperm. However, cryopreservation does not guarantee the health and safety of a
pregnancy or fetus any more than a natural pregnancy.
Recently, there have been vocal support from celebrities, specifically women,
who talk about freezing their eggs. Celebrities like Maria Menunos,127 and Kim
Kardashian128 have gone public about their personal decision to freeze their eggs because
they know that they will not have children until they are older. By freezing eggs now,
they are able to keep the health of the eggs frozen and this will give them a better chance
for fertility at a later date. The problem with celebrity endorsements, is that the referrals
are from non-experts. Testimonies are not a bad thing, but a person seeing the celebrity
endorsement should not assume that their situation is the same of the celebrity.
Celebrities have the luxury of being able to travel for care options, may be in a better
financial situation, and may even receive a kickback for advertising the service they
received. While celebrity endorsements raise the profile of fertility preservation, it also
can communicate false information or at the least, misleading information.
One of the newer trends to encourage women to participate in fertility
preservation are egg freezing parties.129 Companies like Egg Banxx host "Let's Chill"
cocktail parties.130 The idea is rather simple, a healthcare professional, usually a
reproductive endocrinologist or obstetrician, provides information to encourage both
singles and couples to consider egg freezing. The typical consumer for this party is those
who are seeking fertility preservation due to delay in having children.131 This type of
direct to consumer advertising is new and the ramifications (and the legality) of it still be
considered. Some may criticize this type of party because healthcare professionals are
crossing the line from professional relationship to more personal due to the nature of the
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party being in people's home. It creates a business strategy aimed for vulnerable women
that are being marketed to by a company aimed to make money. It also takes a private
issue and makes it a social, fashionable trend that needs extra care and consideration.132
The purpose of the party though is just one part of the informed consent processinformation. Healthcare professionals do not perform procedures or hand out medication.
They only present the information about egg freezing and then schedule follow-up
appointments for those who are interested. The follow up appointments should be much
more thorough to ensure full informed consent for those who choose fertility
preservation. Women should not feel pressure to make decisions in these situation, and
they need to fully appreciate and comprehend the benefits, risks, and limitations of
fertility preservation.133 Egg freezing is not just a procedure, but a vital decisions that
can affect the future for women.
B.

Methods of Fertility Preservation
Fertility preservation methodologies range from standard of care interventions to

experimental procedures, to methods that are in the mist of transitioning from experiment
to standard of care. Each procedure comes with its own set of issues. Anytime that
gametes, embryos, or tissues are cryopreserved it is vital that the owner of the material is
in regular communication with the cryopreservation bank. It is necessary to consider the
financial investment that is needed in order to have the procedures done, and to maintain
the cryopreserved material for the necessary length of time before the person is ready to
use their material. In the case of standard of care, those involved need to have a thorough
understanding of what is going to take place not just in terms of the medical procedures,
but also in terms of the psychological and emotional impact it may have on a person.
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Additionally, any time that the cryopreservation involves a partner, it immediately
becomes more complicated. Ownership of the cryopreserved material is not just the
property of the sick patient or the person who initiated the process and in the case of
disagreement or death, what happens to the cryopreserved material. It is equally owned
by both people involved unless there is an anonymous gamete donor. In the case of
research, it is important to understand the purpose of research and what participation the
person will have in the future and what, if any, financial responsibility the person may
have in the future. Additionally, it is important to know what happens with the
cryopreserved material once the study has been completed.
1.

Standard of Care
Standard of care in fertility preservation is only available for those who have

undergone puberty. The standard of care for fertility preservation for women is embryo
freezing, but this requires access to sperm either through a partner or sperm
donation.134,135 Through the technique of in vitro fertilization, embryo freezing is
accomplished. This is considered the most common and successful method for fertility
preservation for women.136 While this is considered standard protocol, this does not
mean there are not difficult factors to consider like delaying medical treatment for the
disease, introduction of high levels of hormones, or lack of a partner for sperm. For men,
sperm freezing is a standard protocol.137,138,139 It is cheaper, easier, and more reasonable
to freeze their sperm and does not require a partner. In its simplest protocol, it is not
invasive or a surgical procedure, only masturbation is necessary.140 If need be, a
physician can retrieve the sperm by aspiration. Sperm banking has proven to be effective
and safe for many years with thousands of live births.141
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a.

Sperm
Sperm cryopreservation has been available since 1953.142 It was initially

introduced as a way to freeze bull sperm for cattle farmers. It was eventually adapted for
use in humans. Sperm is more easily extracted that eggs and freezes quickly and easily.
Either through a patient masturbating or a physician's aspiration, sperm is easy to access
and is not invasive or considered a surgical procedure. Sperm can only be frozen
provided that patient has gone through puberty. There is little to no delay in being able to
access sperm and does not require a partner. It makes it the ideal option for men looking
into fertility preservation. The sample can even be inspected for sperm count, motility,
and morphology.143 If needed, a second sample can be provided after 24-48 hours. Some
of the problems that are often associated with sperm donation is the inability of a man to
provide a sample through self-stimulation. There are a few methods for assisted
stimulation that may help men provide sperm and before aspiration is done. Sperm
cryopreservation has proven to show itself effect in dealing with infertility. Sperm is able
to remain cryopreserved for decades.
b.

Embryo
Embryo cryopreservation has been available since 1984.144 The development of

in vitro fertilization made for better understanding of the creation and development of
fertilized eggs. Instead of implanting the fertilized egg during in vitro fertilization, the
embryo is cryopreserved. In order to make an embryo, there needs to be both an oocyte
and sperm. In these cases their either needs to be a partner for the patient or a donor.
If the patient is a woman, then either a male partner or a sperm donor is needed to
create an embryo. The woman needs to undergo hyperstimulation of her ovaries in order
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to release many oocytes to be retrieved. Hyperstimulation is on average a two week
process that requires injections of medication in order to stimulate the ovary, mature the
oocytes, prevent premature ovulation, and prepare the uterus all while being monitored
by vaginal ultrasounds and blood tests.145 When the matured oocytes are ready to be
retrieved, a physician goes with a transvaginal ultrasound to aspirate the oocytes or in
rare cases laparoscopically.146 On that same day, either the male partner or the donated
sperm are retrieved and once prepped, the oocytes and sperm are placed together into a
petri dish. One the fertilized oocytes have matured for five days, the embryos are frozen.
For male patients, either a female partner or an egg donor is needed to create an
embryo. In this case the same procedures take place, including retrieval of sperm and the
hyperstimulation of ovaries of either the female partner or the egg donor. The male
patient can donate his sperm as needed and could even freeze the sperm if the male
patient cannot wait for the oocytes to be retrieve before undergoing treatment of disease
(like in the case of cancer).
In either scenario, embryo cryopreservation is an invasive and more expensive
option than simply sperm cryopreservation. However, embryo cryopreservation has been
around longer and proven safe for decades over the newer cryopreservation of oocytes.
c.

Oocyte
In 2013, the American Society for Reproductive Medicine announced that oocyte

cryopreservation moved from being research to standard of care even though the first
reported live birth from frozen oocyte was in 1986.147 With the advancement of
vitrification, more knowledge was gained about oocyte cryopreservation and with enough
studies, a decision by the American Society for Reproductive Medicine was made to no
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longer label it research. 148 The complexity of freezing oocytes is the water content.
Water expands as it freezes and in the case of oocytes this expansion and the defrosting
of the water, can cause irreparable damage to the oocytes. Many studies for oocyte
cryopreservation focused on speed of which the oocyte is frozen. According to the
American Society for Reproductive Medicine's "Mature Oocyte Cryopreservation: A
Guideline" over 981 studies were conducted. Common understandings from these
studies show that length of cryopreservation had no statistical impact on the live birth
rates, while maternal age at time of cryopreservation played a major role.149
Additionally, it is shown that oocyte cryopreservation can be a cheaper option than in
vitro fertilization for women over age 38, provide they cryopreserve their oocyte in their
twenties.150
The medical indicators for oocyte cryopreservation are the same for embryo
cryopreservation: cancers, genetic conditions, delay of child bearing. However, it should
also be noted that this is a good option for a women who cannot cryopreserved embryos
either due to lack of sperm, or simply refusing that choice.151 Oocytes are retrieved
through hyperstimulation of ovaries just like for embryo cryopreservation. The
procedure is invasive and comes with risks. These risks do not include a higher rate of
congenital abnormalities as compared to cryopreserved embryos.152,153 There is also no
long-term studies due to the new nature of these procedures and protocols.154 Newer
research is focusing on the variations within oocyte cryopreservation like the difference
between mature and immature oocytes.155 In one study, while the original hypothesis
was that the immature oocyte would be protected, instead; other structural parts of the
oocyte were damaged.156 While a singular study does not stop research, it demonstrates
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that even with the best of intentions, science and medical research still have a long way to
go for many things, despite all the technology and knowledge we as a society have
already gained.
The problem with new standard of care is that not everyone is well trained in the
procedure and finding healthcare professionals with high success rates takes time that a
patient may not have. It is always an issue of disseminating medical information to the
public and in the case of oocyte cryopreservation, a survey by Brooke Hodes-Wertz,
demonstrated that there is much confusion about the decline of fertility and the
availability of oocyte cryopreservation.157 Healthcare professionals need to be vigilant to
ensure than women are aware of their decline in fertility in their twenties at not just at age
thirty-five as many women assume.
2.

Research in Fertility Preservation
There are many different research protocols available that are exploring new ways

for fertility preservation. Due to the fact that there is over a 75% survival rate among
pediatric cancer patients, finding ways to support quality of life and long-term goals of
cancer survivors is a major concern.158 The most common research studies in fertility
preservation are ovarian tissue cryopreservation and testicular tissue cryopreservation.
There are additional variations on these research studies which change the hormones
involved, the type of freezing process, and other variables. These protocols are only
available at places that conduct research.159 There are rules for enrolling in these studies
and not every patient is eligible. Unfortunately, not all patients live near places that
conduct research and may never be told about such protocols. Healthcare professionals
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have a professional responsibility to do their due diligence in order to ensure they are up
to date on research protocols or at least have a resource they can contact.
a.

Ovarian tissue
Ovarian tissue cryopreservation has been around for more than a decade. The

main focus of most of these studies have been conducted with adults, but more recently
has shifted towards the pediatric population.160 While the cryopreservation technique of
ovarian tissue is fairly consistent, the transplantation and subsequent pregnancy in adult
women and live birth is rare.161 Even with the decade of time for research, by 2010, ten
babies were reported and by 2015, fifteen babies have been born after successful
transplantation.162,163 The goal of ovarian tissue cryopreservation is to freeze ovarian
tissue through a proven freezing process.164 Some research focuses on the different
freezing techniques, like vitrification, for storing the ovarian tissue to ensure that there is
not damage to the tissue when defrosted. In some cases, immature oocytes can be
removed from the tissue and matured in vitro for preservation.165 A separate research
study can then be done to transplant the ovarian tissue back into the patient.
Transplantation studies have only been conducted on adults.166 In a few of those cases,
spontaneous pregnancy took place, but in vitro fertilization is also an option.167 For now,
studies continue to pursue knowledge of how to approach ovarian tissue cryopreservation
and eventually get a better read on the indications for when it is most medically called
for.168
It is unclear what recommendation should be made for those under age eighteen
and more specifically for those who are prepubescent.169 Little data is known for
successful transplantations especially in pediatric patients because of the newness of the
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research.170,171 In most cases, the study starts in adults and is eventually expanded to
pediatric patients and slowing include younger and younger girls.172,173 This unknown
does not halt the research, but it does force those involved both from the researchers',
parents' and patients' perspectives to be cautious.174 During this time of research, there is
a learning curve as to what type of patient will benefit most from this type of procedure
and who should be enrolled in this study.175 It is important to not only focus on the
research and the knowledge that is being acquired, but also the individual patient. While
the focus of this type of research tends to be on infertility due to the side effects of
chemotherapy in treating cancers, some studies have been indicated for those with a risk
of premature ovarian failure in cases of Turner syndrome, repeated surgeries causing
ovarian torsion, or Fragile-X.176 Parents should be made aware and clearly understand
that the nature of these procedures are strictly research.177,178 It does not mean that it will
successfully be transplanted back into the patient at a later date, nor does it promise that it
cannot be transplanted.179 All this means is that the patient is currently enrolled in a
study that is cryopreserving prepubescent ovarian tissue.
b.

Testicular tissue
There is no proven method for fertility preservation in prepubescent boys.180,181

Testicular tissue freezing is conducted one of the research protocols aimed for this
demographic. It is considered highly experiment, and no lives births have resulted from
this research as of yet.182 The hope is that the cryopreserved tissue can be transplanted
back into the patient to return spermogenesis or potentially grow sperm in vitro for future
use.183 This is experimental protocol is possible in the future184 and so it fosters the
hopes for better medicine in the fertility preservation.
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Similar concerns are present for testicular tissue cryopreservation as is present for
ovarian tissue. The parents and patients that are involved need to be certain they
understand the nature and purpose of the research protocol.185 The idea of sensationalism
is a major concern as parents are looking for any possible means to preserve the fertility
of their son.186 Additionally, healthcare professionals should communicate that this type
of study does not yet have conclusive evidence to move forward with either
transplantation or potential to grow sperm.
There are some that are pushed for wider access and more involvement of those
eligible for research studies. The more participants enrolled, the more knowledge gained.
One of the issues in trying to conduct these studies is the long time frame between
cryopreservation and transplantation.187 This means that by preserving the tissues of boy
now, by the time the boys have matured, there may be a transplant study available for
him. It is important though, that parents understand they are only preserving testicular
tissue and not enrolling in a transplant study.
c.

Ovarian transposition
Another research study is ovariopexy and ovarian transposition. The proposed

studies seek to displace the ovaries to shield them from exposure to radiation. This can
be beneficial especially for those cancers like cervical, rectal, pelvic bone sarcoma,
bladder are the main diagnosis that can indicate the use of ovarian transposition.188 Due
to the natural flexibility of ovaries to move, this type of study works well for treatments
that have a specific location for radiation to be aimed at. This type of study is not
indicated for someone who is also undergoing chemotherapy at the same time because
the ovaries would still be affected no matter their location. However, after the
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completion of chemotherapy and before starting radiation is a time for healthcare
professionals to consider using ovarian transposition.189 After the radiation is complete,
the ovaries can be potentially moved back into position so natural, spontaneous
pregnancy can be attempted.190 The long term consequences and any functional
problems of moving the ovaries is still unknown.191 This also does not factor in any
damage done to the uterus or fallopian tubes from the treatment. Essentially in some
cases, ovarian transposition may be recommended, but it does not eliminate the risk for
infertility due to other causes; it simply seeks to eliminate one cause. One of the risks
though, is that cancer cells could still spread to the ovaries and in those cases, the ovaries
may need to be permanently removed.192 The overall success rate of ovarian
transposition varies. While it has been shown to be as high as 85.7%193 and as low as
33%194 in saving the ovarian function in adults, there has not been solid evidence for
ovarian transposition in children.
IV.

Demographics of Patients

When determining what type of fertility preservation to pursue, it is critical to
consider the demographics of the patients. Demographics determine what fertility
preservation the patient is eligible for and also what is not. Gender of the patient
automatically eliminates certain options by virtue of the patient not having either sperm
or oocytes. Men have had options to cryopreserve without the need of a partner for a
longer time than women. However, women are often the focus when it comes to
discussions about fertility and future family planning. Gender also plays an important
role in research. Because fertility preservation is more complex and requires more steps
for women, there tends to be trend of more studies aimed at finding new and innovative
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ways to preserve fertility for women than men. Age is also a limiting factor due to the
need for patients to have already undergone puberty in order to access sperm or oocyte
cryopreservation. For those who are too young to undergo puberty, they are limited to
only research protocols. Other demographics like socioeconomic status tend to dictate if
a patient has access to fertility preservation. Demographics like geographic location,
race, sexual orientation, and socioeconomic status are factor into this issue.
A.

Gender
Gender automatically puts patients into a specific grouping for certain types of

fertility preservation. Infertility and fertility preservation decisions can affect
males195,196,197 or females.198,199,200 Standard of care for men (sperm cryopreservation) is
less invasive and has been proven effective for a long time. No partner is required.
However, women's standard of care embryo fertilization, requires a partner (or at least a
sperm donor) and oocyte cryopreservation is highly invasive and is only recent
considered standard of care. According to one study, there is even gender disparity in the
communication of fertility preservation to patients.201 More fertility preservation
research is focused on female fertility because of it being more complicated and more
invasive than males.
1.

Male
Male fertility preservation is focused on sperm cryopreservation which has been

available since 1953. This procedure is non-invasive, simple to conduct, and requires
little time and preparation. The discussion of fertility preservation is often more focused
on female patients rather than male patients. It creates a unique situation in that the
procedure is simple, but the discussion is tough. Stereotypically men do not have the
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same biological clock issue that women face. It creates the false belief that men do not
need to think or plan for their future children. However, it is just as important to discuss
fertility with men as it is with women. It should be standard in discussion at primary care
appointments (to ensure men are being smart and aware) and especially necessary during
diagnosis for disease appointments. If a man is diagnosed with cancer, he should be
made aware of the details of which treatments are most effective, but also which is best to
preserve fertility. Patients should be allowed to make well informed decisions regarding
their current treatment, but also long term for their quality of life.
The process of getting the sperm can be embarrassing for the male too. Having to
masturbate into a cup during a time frame can create a stressful and pressure filled
environment. Sometimes bringing in his partner or using electric stimulation can help the
process along, but if necessary a physician can aspirate the sperm out for the man. If the
healthcare professional is not well-versed in the issues of fertility, than the man should be
referred to a reproductive specialist.
2.

Female
For many years, female fertility preservations is focused on embryo

cryopreservation which required access to sperm either through a partner or a donor.
However, since the development of oocyte preservation, females have another option.
Fertility is a common discussion for women. Fertility should be standard discussion at
primary care appointments, and in the serious conversation of diagnosis, fertility needs to
be one of the many topics to discussion with the patient. Women are born with a finite
number of eggs, and as women age, the quality of the eggs decrease.
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The biggest problem with fertility preservation for women is that the procedures
are invasive. For women who are facing a diagnosis, time is often not on their side and
the patient must consider the risks and benefits of delaying treatment to do fertility
preservation. Discussions and decisions must be done thoroughly and quickly so that
fertility preservation can be started and treatment of disease can start afterwards.
Researchers are working on ways to remove immature oocytes directly from the ovaries
with stimulation so that there is little waiting time, and other methods that are less
invasive.202 These types of studies will take time to perfect, but if/when they do, it will
provide a greater variety of options for women.
B.

Age
Age places fertility preservation patients into one of three age brackets-

prepubescent203,204, adolescents,205 and adults.206,207,208,209,210 Age factors into what the
risk of infertility the person may face and what types of fertility preservation is available
Age automatically places the person into a category but should not factor into how they
are treated by the healthcare professional. All available options for that age should be
discussed in order to promote an ethical approach to informed consent. Adults have
standard of care options available, and can seek out fertility preservation for a diagnosis
or in case of delaying having children. Even without a medical diagnosis, adults,
especially females, are facing the risk of infertility due to natural aging, which can be
sped up by a medical diagnosis and treatment. Fertility preservation has been around the
longest for adults and the issue of consent are fairly standard in these cases. Adolescent
patients are caught between the same needs as an adult, but involve the consent of their
parents of legal guardians. For adolescents, they are seeking standard of care fertility
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preservation in the case of diagnosis. It is rare that an adolescent would be seeking
fertility preservation because they are delaying having children. The informed consent
process in this case involves both assent (and sometimes consent) of the adolescent and
consent by the parents or legal guardians. This is in contrast to prepubescent which
involves the consent of parents as the main form of consent. Prepubescent patients
should only be seeking fertility preservation in the case of a diagnosis and there is a risk
for infertility or sterility. Prepubescent patients only have experimental protocols
available which make the decisions for parents much more nuanced.211 The approach for
each of these varies because of the age of the patient. Healthcare professionals need to be
sensitive to the age of the person and make the discussion age appropriate to effectively
communicate.
1.

Adults
As discussed before, adult patients have access to sperm, oocyte, and embryo

cryopreservation. All are considered standard of care, and have proven to be safe and
effective methods of cryopreservation. Adults are assumed to have decisional capacity
and therefore consent for themselves. Adult patients may also seek advice and support
for others. The person may consult with partners, spouses, family, and friends prior to
finalizing a decision. Having children may be a far off future discussion, but when
discussing fertility preservation, it suddenly goes from being in the future to being a
current relevant discussion. Some of the issues involving a partner could be any of the
following: it could be too early in a new relationship, the relationship could be in facing
troubling times, the partner in the relationship may not want children, or some
relationships may already have children and are feel their family is complete. In rare
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cases, a couple may currently be trying to get pregnant, but discovered an illness instead
and now have to delay becoming parents in order to seek treatment.
Whatever the scenario, the patient needs to understand the impact their age has on
fertility. Fertility preservation decisions that are made before treatment or at a younger
age, impact the potential decisions for the future. Some suggest that by pursing fertility
preservation, one is keeping all avenues open instead of taking the greater risk of
potentially shutting the door on having a biological child in the future. However, some of
the risks associated with disease while highlight the importance of fertility preservation,
make the timeframe very narrow for these people to make a decision. Patients also have
to keep in mind that certain types of treatments can affect fertility differently for each
patient. Aggressive treatments could send a female patient into early menopause.212
Male patients could end up completely infertile. Female have a limited number of eggs
which decrease in quality with age.213 Ovarian function and ovarian reserve may also
decrease with treatment. These factors must be taken into consideration prior to
treatment or delaying having children.
If the patient (or the couple) chooses to pursue fertility preservation, discussions
need to be had regarding any unused gametes or embryos. The couple may feel their
family is complete and no longer need the gametes or embryos, the couple may break up
and ownership of the gametes or embryos are questioned, or one of the people may die,
and the remaining person may need to consider what to do with the gametes or embryos.
In rare cases, there is a custody battle for rights to the gametes or embryos which can
create financial and legal burdens. The nuances of these discussions with be addressed in
Chapter Five.
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2.

Adolescents
For adolescents usually between the ages of twelve to seventeen (although some

consider adolescents until age nineteen), since they have undergone puberty, they have
access to the same sperm, oocyte, and embryo cryopreservation as adults. The
procedures are the same, but the approach to decision making and informed consent is
what differs. In the case of adolescents, there is more than likely, no partner to consider
in the cryopreservation process. In the case of embryo cryopreservation, an egg or sperm
donor needs to be identified. This can be done through either a known or anonymous
donor, but this needs to be a serious conversation to have between the parents and
adolescent.214 Since sperm and oocyte cryopreservation is a viable, safe, and effective
options, healthcare professionals should recommend that over embryo cryopreservation
for adolescents. In rare cases, embryos can be cryopreserved, but there is the need for
donor gametes. Parents or legal guardians should be involved in this decision making
process to ensure that the adolescent is not overwhelmed and can fully appreciate the
nature and nuances of their decisions. There should also be a discussion of the
maintenance and financial expectations with the cryopreservation bank. More than likely
these cryopreserved material with be in storage long term. Patients and parents need to
be aware of the arrangements of who is paying for how long and when does that financial
burden change from the parents to the patients. There needs to be regular contact with
the cryopreservation bank to ensure that everything is ok and that the finances are up to
date.
For adolescents though, the most important difference is the concepts of assent
and consent. For the patients that are still minors, parents still have to give consent in
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almost all cases. However, the assent that the adolescent gives has much more nuanced
meaning that of a prepubescent child. These adolescents have started to form hopes,
wants, desires, values, and goals for their live and dealing with a diagnosis can disrupt
those plans. They are being forced to think about the future in a real way which may or
may not include having children someday.215 These adolescents should have an
important say in the decisions being made not just for their fertility preservation, but for
their entire treatment. By including adolescents not just in the discussion, but in the
decision making process, it can better integrate them into adulthood and help them to take
charge of their healthcare both now and in the future. In some cases, adolescents may be
legal adults (over eighteen), but are still live at home with their parents or are in college
and on their parents insurance. While legally, they may be adults, their decision making
ability may still need to include parents in the process. Having a support system is
important in healthcare and these patients are especially vulnerable and parental or legal
guardian support is vital to the process of fertility preservation.
3.

Prepubescents
Prepubescent children create a difficult dynamic for fertility preservation. This

age group, typically twelve and under, have not undergone puberty. They have a more
limited set of options. Since the child has not undergone puberty, they cannot
cryopreserve sperm oocytes, or embryos. It is a widely held belief that it is unethical for
force puberty on a child. Because of this only experimental protocols are available for
children. The option for prepubescent girls is ovarian tissue cryopreservation.216 This
option is only in the research phase. Ovarian tissue transplantation has never been
performed prepubescent children yet.217 It is important to understand that just because
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the child is enrolled in a research study for ovarian tissue cryopreservation, it does not
enroll the girl in a transplantation study automatically. Parents should ask how and when
transplantation should be discussed. It is also important to understand that parenthood
may not be a want or desire of the children when they are of age to make that decision.
For boys that are pre-pubescent, it is also unethical to force puberty. The risk of
infertility due to disease is dependent on the type and dosage of chemotherapy.218 Since
sperm cannot be extracted from prepubescent boys, the option here is testicular tissue
cryopreservation. There are currently no lives births recorded from this research.219
Again, the same parameters concerning study enrollments apply to boys as it did to girls.
All of these cryopreservation studies, while important in the knowledge they
gained, require that a parent or legal guardian consent. Prepubescent children cannot
consent and if assent is done, it should be age appropriate. 220,221 For instance, a two year
old will not be able to understand the nuances of illness and the different between
treatment and research. However, an eleven year old may better understand that if they
are undergoing surgery, the physician may remove a tumor, but also collect testicular
tissue in the same procedure. Healthcare professionals needs to ensure that expectations
of parents are realistic. The mindset of parents is often riddled with fear, apprehension,
concern, survival, treatment, not to mention the risk of infertility in the future. Parents
are still expected to make decisions in the best interests of the child no matter their
personal feelings or emotions.222 There is the possibility that the treatment will not affect
fertility or puberty, and the child can go back to living a normal healthy life. In those
cases, parents should think about what to do with the cryopreserved tissue.
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C.

Other Demographics
Fertility preservation is expensive and may not be readily available for those who

cannot afford it. Most insurance plans do not cover cryopreservation. The
socioeconomic status of a patient dictates the issues of access for fertility preservation.223
Additionally, socioeconomic disparities also play a role in referral patterns.224 Living in
urban or rural locations also can create an unfair access to fertility preservation.
Living in urban or low socioeconomic creates an access issue for not just fertility
preservation, but for healthcare in general. Access to primary care physicians, good
health insurance, transportation all factor into the issues. In many cases, just having
access to things like antibiotics, and vaccinations can be a struggle. Those living in urban
areas tend to be diagnosed for disease like cancer at a later stage and their need for
treatment quickly is more serious.225 This means either fertility preservation will
postpone treatment too long or it is completely ignored. All patients should be given the
option of fertility preservation and the financial impact will considered, should not
determine or prevent someone from preserving fertility.
According to a study from 2010, around 95% of oncologist claim to discuss
infertility risks with patients about to undergo cancer treatments, only 38.9% refer
patients for fertility preservation consultation with a reproductive specialist and only 30%
of oncologist consider fertility when developing a treatment plan.226 These statics are
troubling consider that those who are already at a socioeconomic disadvantage may not
have easy access to their oncologist let along access to a reproductive specialist. The cost
along could determine some from pursuing fertility preservation. Patients should be
given equal access to information and allowed to make decisions of what they choose to
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pursue and why. Healthcare professionals should never make judgment of what a patient
can and cannot afford, but instead provide options and work with patients to pursue those
options.
In another study conducted in 2012, found that age was the biggest factor in
demographic disparities.227 Women who were in their twenties were more likely to be
referred to a reproductive specialist than women over age 35. The possible reason for
this is the assumption that women over age 35 already may have fertility issues or have
already had children.228
Other disparities that may factor into referral patterns is sexual orientation and
race. In general, not enough data has been collected to effectively detail the rate of
referral to a reproductive specialist for those who identify as homosexual. There is a
belief that those who identify as homosexual will not have a need to seek fertility
preservation, but that is an unfair assumption that has not been proven true or false. As
for race, the 2012 study did see a high rate of Caucasian women over Latina or African
American, but not a significant rate. Although the same study, did find that African
American women did delay in seeking fertility preservation than Caucasian.229,230
All of these findings are not a surprise that younger, Caucasian women tend to be
referred to reproductive specialist and encourage to seek fertility preservation.231 It is
important that healthcare professionals, particularly oncologist, are well trained to discuss
fertility preservation to every patient in every instance. They should be willing to refer
interested patients to reproductive specialists.
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V.

Conclusion

By examining fertility preservation, one can better understand the complexities
that accompany the decision making process. Reasons for fertility preservation due to
side effect of disease is unpredictable, just as predicting infertility due to aging. While
generalities can be made, specific statistics and hard to calculate because there are too
many variable include gender, severity of disease, age, geographic location, type of
treatment, dosage level of the treatment, and location of the disease in the body. By
understanding the difference between standard of care and research, it becomes clear that
those who only option is research may be in a more vulnerable position. Care should be
taken to not mislead patients making difficult decisions that may have a small time frame.
There is a need for fertility preservation options and open and honest discussions that best
fit the specific patient that a healthcare professional is working with to pursue
options.232,233,234,235 Understanding the standard of care and experimental options are just
as important as understanding the possible demographic issues that a patient may be
facing as they move forward with their highly personal decision. Healthcare
professionals need to do their best to fully explain the risks for infertility, but also the
risks of fertility preservation. Because fertility preservation is a preventative treatment,
there is a risk that patients may have unrealistic expectations. The hope that patients put
in fertility preservation and in healthcare should be addressed.
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Chapter Three: Hope
I.

Introduction

Chapter Three seeks to analyze the concept of hope specifically using insights
from philosophy and theology. In addition it will detail what hope is specifically in
relation to healthcare and research. It will consider the issues of hope in the different
contexts and turns. It will discuss related words and even how hope it used as both a verb
and a noun. Finally, hope will be examined for authenticity. When hope is discussed,
false hope is often brought up. This will take a what false hope means, what it does not
mean and how that affects someone’s approach to hope.
II.

Defining Hope

Defining hope is a difficult task without having a case scenario to frame it around.
Philosophy and theology have different approaches to defining hope and the worldview
of the different writer affect how they describe it. Philosophers like Ernst Bloch, Gabriel
Marcel, and Immanuel Kant and theologians like St. Thomas Aquinas, Jurgen Moltmann,
and William F. Lynch, have written extensively about hope in various contexts. Hope is
a difficult word to define because of the numerous complexities associated to it.
Defining hope by itself outside of a context can prove difficult because of its intangible
nature.1 Often when the word hope if used, the person may mean wish, desire, or
expectation, all of which are slightly different than hope. Each of these writers defines
hope slightly differently. Some prefer outlining the parameters for the outcome itself,
while others focus on describing the ability to hope itself. It is important to understand
what is meant when using the word hope before trying to discuss it within a context. In
the circumstances of healthcare, most often hope is seen and studied in the context of
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death and dying,2,3 but that is not the only place that in healthcare where hope should be
considered and discussed.
Hope does have limitations; mainly to what is realistic. Hope should also have an
authenticity to it. The hope placed in outcomes should be reasonable and possible.
These outcomes however are unknown or beyond the individuals control.4 Additionally,
it should make the distinction between how hope comes about in a given circumstance.
Hope can have different connotations depending on the use of the word. It can take a
more complex turn because hope can be used as either a noun or a verb. A patient can
acquire hope; a physician can foster hope; a patient hopes. This section aims to clearly
lay out the definitions of hope and which apply best in the healthcare context.
A.

Philosophy
Philosophers like Ernst Bloch and Gabriel Marcel have written extensively about

hope. Even Immanuel Kant in his work commented on defining and describing hope.
Ernst Bloch is known for his writings on utopia. His concept of hope focuses on desiring
and wishing. Utopia is not limited to just the perfect future, but is demonstrate in the
culture around us. Gabriel Marcel wrote about existentialism and the connection of hope
to something or someone outside itself. Marcel says that hope only exists when there is
trust in something outside of itself. It requires intelligence to have hope or to hope for
something. Kant describes hope through possible experience and imagination that is able
to be constructed. All of these philosophers connect hope to the future. Hope only exists
because there is a motive to improve the present.
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1.

Ernst Bloch
Ernst Bloch was a German philosopher from 1885-1977. He is primarily known

for his philosophic writings about utopia and Marxism. His most widely known work is
entitled, The Philosophy of Hope. Published in three volumes in 1954, 1955, and 1958,
Bloch writes about the aim for a utopian society which he describes as the ability to wish
and embodying what is wished for.5 The idea stems from looking at the culture and
world around that provides examples of perfection. Unless man lives in a world where
fate determines everything, utopia is always a possibility.6 He acknowledges not that
everything is possibly, and those road blocks can make seeking utopia difficult to
achieve.7 In his work, Bloch uses this logic to not only justify, but support the actions of
Marxism. Douglas Kellner describes Bloch’s work in the following way:
For Bloch, hope permeates everyday consciousness and its articulation in
cultural forms, ranging from the fairy tale to the great philosophical and
political utopias. For Bloch, individuals are unfinished; they are animated
by “dreams of a better life”, and by utopian longings for fulfillment. The
“something better” for which people yearn is precisely the subject matter
of Bloch’s massive The Principle of Hope, which provides a systematic
examination of the ways that daydreams, fairy tales and myths, popular
culture, literature, theater, and all forms of art, political and social utopias,
philosophy, and religion – often dismissed tout court as ideology by some
Marxist ideological critique – contain emancipatory moments which
project visions of a better life that put in question the organization and
structure of life under capitalism (or state socialism).8
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Kellner goes on to describe Bloch’s work as one that is not just about negatively
critiquing ideology, but rather finding the positive utopia. Bloch is developing a
philosophy of hope for the future, which looks forward to a utopia.9
According to Jack Zipes, one of the major criticisms of Bloch’s work is that he
labels the opposing views, (what Bloch calls bourgeois) as irrational and does not take
the time to refute it, but just dismisses it.10 He describes Bloch’s view of utopia is based
in an active hope or belief.11 The utopia that Bloch describes is one that fits into a
Marxist worldview while moving towards something better than the present.12 While
Bloche’s work title contains the word hope, what he is really describing is the possible
future. This use of the word hope is very typical in literature in that word is actually
being used to describe varying things. What Bloch is describing is placing faith, trust,
wishes, and beliefs in a desired future- mainly utopia. The existence of hope (of beliefs,
wishes or desires) highlights the troubles in the world around us and moves us to search
out utopia.13
2.

Gabriel Marcel
Gabriel Marcel was a French philosopher from 1889-1973. He is identified as

one of the earliest known existentialist, focusing on technology’s influence on society.
His most well-known work, published in 1951 entitled, The Mystery of Being, focuses on
existential philosophy. His focus on Christian existentialism distanced himself from
other atheistic philosophers of his day. As an existentialist he wrote about the material,
the physical realm. In his description of hope, one can see that as an existentialist he
connects hope to something tangible, and permanent.14
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Hope as described by Marcel is the relation to something outside of itself that is
brought about on the basis of trust.15 This means that hope has to have a connection to
something or someone else so long as it is plausible.16 Martin A Bertman describes
Marcel’s stance on hope as an aspect of experience, rather than from desire because hope
is based in intelligence.17 Because of this intelligence, hope is focusing towards
something meaningful, while desire is temporal or even impatient.18 Hope, for Marcel,
ultimately has a connection to salvation, love and Christianity. Hope is rooted in the
belief in Christianity and the ultimate hope for the future is based in that. Those who are
non-believers can hope, but it more closely resembles desire or even wishing.19
The criticism of Marcel is that there are times when hope and desire are not as
dissimilar as Marcel’s claims.20 The argument is that desire and hope can feed into each
other which mean that desire and hope can both be based in intelligence and the temporal
while still having meaning. Hope ultimately keeps possibilities open and that openness is
to something difference or better than what is in the present.21 It is looking to something
greater to interact with and make a change.22 Hope keeps the individual looking outward
and moving forward in order move one from something that brings despair to pursue
something that has been deemed valuable by the individual.23
3.

Immanuel Kant
Immanuel Kant was a German philosopher from 1724-1804. He is known as one

of the most famous modern philosophers in the world. His most famous work, Critique
of Pure Reasons, focused on the relationship between reason and human experience. His
deontological theories, also known as Kantianism, focus on duty dealing with
epistemology and ethics. Within Kant’s ethics is the categorical imperative. Kantianism
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discusses the concept of what is possible versus what is actual. Hope is often discussed
within the context of possibility. Sydney Axinn asks the question, “Can one hope for
anything one desires, even for something inconsistent or irrational? Are we not free to
think what we wish, or hope what we wish? The Kantian answer is, ‘No.’”24 This is
because according to Kant’s postulate of possible, possible is not based on thought or
logic, but on possible experience.25 This means that if a person imagines to hopes for
something, if must not just be possible, but a possible experience. In order to imagine
something, based on Kant’s work, one must be able to construct it. If a person is unable
to construct what he or she is hoping for, that it is unreasonable hope.26
B.

Theology
For theologians, hope is described in relation to God and Christianity. Hope is a

world that is found in the Bible, often relating to faith and love. St Thomas Aquinas was
one of the earliest writers about hope. His focus for hope is on the realistic and what is
possible. His description of hope grows out of his discussion on the existence of God and
the purpose of man. Jurgen Moltmann’s approach focuses on the hope of a specific
future, based on the promise given by God. God’s promise for and fulfillment of
salvation is a demonstration as to one can hope. William F. Lynch focused his
description of hope based on imagination. He is the most practical of the writers in that
he gives parameters of what can be hoped for and what is simply a want or desire.
1.

St. Thomas Aquinas
St. Thomas Aquinas was an Italian Catholic priest from 1225-1274. He is known

as a philosopher that wrote extensively about topics such as theology and epistemology.
His work Summa Theologiea was written in 1265-1274, focuses on basic theology of the
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Catholic church including the existence of God and the purpose of man. Aquinas
identified faith, hope, and love as three theological values that work best together.27,28
Aquinas further says that love without faith and hope is impossible.29 Faith is the firth
virtue, but must have hope and love. This theological virtue of hope is not the same as
passion of hope.30 This is essentially the difference between hoping for something and
having hope. The passion of hope is a feeling, which is an internal response to an
external something. Theological virtue of hope is just the opposite. It is an internal
decision moving towards an external something. For Aquinas, God is the definitive
object of hope.31
Aquinas wrote about hope within his book, Summa Theologiea. Aquinas simply
says that hope is for a future good that is difficult but not impossible to achieve.32
Essentially, there has to be realism and struggle for hope to be present. People have to be
able to reason through realistic options and possibilities. If the thing someone is hoping
for is unattainable, then there is no purpose to strive for it. If something is too easy to
attain then there is no effort to make it worth hoping for. Aquinas also discusses that
within the concept of hope that has to be rational thinking and the ability to make
judgments. For instance, if one hopes for a cure from an illness, that one has to rationally
understand what it means to be healthy or ill. One has to be able to judge if there is
improvement or decline in health. By hoping to get better, this person is aiming for
realistic possibility of health (due to the nature of colds not being life threatening) and the
ability to strive for it (by resting, drinking fluids, taking medication). According to
Donald Penelhum, hope is somewhere between the despair and presumption.33
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Aquinas does warn against in putting hope in other people.34 This is due to the
belief that man is born with a sin nature and is unable to do right all of the time. Even for
those who believe they are doing right, it may not be the right that the person hoping is
aiming for in this specific instance. It is impossible to guarantee that the other person
will participate.
2.

Jurgen Moltmann
Jurge Moltmann is a German, reformed protestant theologian born in 1926. His

most well-known work is Theology of Hope. Moltmann connects faith in Jesus hope of
the resurrection together. He wrote about liberation theology with culminates in the hope
of the resurrection of Jesus. In today’s world, while one hopes for the future, one cannot
achieve that in the current world because it is filled with sin and depravity. Moltmann’s
description of hope is about promise of a specific future.35 The resurrection of Jesus in
the New Testament was the fulfillment of a promise made God in the Old Testament.
Because of this hope of the resurrection, Christians have something to build their own
hope on.36 For now, the world is not perfect, but there is the promise from God that it
will be one day, and since he has fulfilled other promises in the past, he is trustworthy for
the future. Knowing that the world is filled with sin, man can still focus on God’s
promise for the future. The focus is not on what the world is not, but more of what it can
be someday.37 There is hope of God fulfilling his promise.
One of the criticism of Moltmann’s Theology of Hope, is the focus on Christianity
and theology itself. Additionally, there is criticism of links to politics. Moltmann was
heavily influence by Ernst Bloch, who as discussed earlier, focused his writing on the
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hope of utopia and its use in Marxism. David P. Scaer writes that Marxism and theology
have similarities in focusing on the changing society.38
3.

William F. Lynch
William F. Lynch was a writer from 1909 to 1987. While he was a Jesuit priest,

he also was a college professor and psychiatrist and author of many books about
philosophy, literature, and theology. His book, Images of Hope: Imagination as Healer
of the Hopeless, sought to address the psychology of hope and its connection to
imagination. His focus of hope was in the realm of mental illness and the overwhelming
presence of hopelessness. He describes hope in its relation to help, wishing, and even
specifies that there is a growth or maturation process with hope.39 Lynch believed that
there was a cultural issue in an attraction to hopeless over hope, and despair being too
connected to hope.40 Those who said, they hoped for something were actually aware
(maybe too much) of the despair they are in and hope is a last ditch effort. Instead of
focusing on the hope itself, people are actually focusing on the despair. Donald Capp
writes about the three central ideas in Lynch’s book:
1. The first is the equation of the life of hope with the life of the
imagination, that is, the realistic imagination.
2. The second is that this imagination is not a private affair but an act of
collaboration or mutuality.
3. The third is that there is a strong relationship between hoping and
wishing.41
Capp writes that hope and its connection to the imagination allows for a wider
perspective than the present situation.42 Wishing has no limitations, but once realistic
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possibility sets in, there is the presence of hope. This does not mean that the end result it
easy to obtain, but it must be at least plausible.43 It is recognizing the current situation
for what it is and focusing on a way out of that current situation.44 Lynch argues that is
one veers outside of what is realistic and is unaware of the limits of hope, than
hopelessness and despair set in.
A criticism of Lynch, by Christy Simpson is that Lynch seems to assume that
hope and imagination always heads towards the positive.45 In some cases, imagination
can go negative to worse case scenarios and that does not lead to hope, but rather to
despair, concern, fear, and avoidance. There are even some who despite knowing the
limits of hope, may still hope in unrealistic imagination and set themselves up for
disappointment.
C. Comparisons of Descriptions of Hope
These theologians and philosophers have defined hope based upon their
worldview. It has influenced how the rest of the world approaches and defines hope.
There is commonality in their approach to hope. Hope is more than a feeling. As
Thomas Aquinas described there is a difference between the passion of hope and the
theological virtue of hope. Hope is can be described as a belief, desire in a specific
future. Most of these writers focus on the positive nature of hope. People are hoping for
something. That something has to be determined. Hope cannot be for something vague.
For Bloch, hope was in utopia, but for Marcel it is hope for something specifically
outside of itself. The determination of what to hope for is based on the ability to
understand the current situation and to make a judgment of what could take place. Hope
requires an imagination which means the ability to think about the current situation with a
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different outcome. Both the philosophers and theologians focus on the positive outcome,
hoping for a better situation than before. However, there are cases when someone may
hope for the absence of something or are hoping to avoid something worse than the
current situation. For the theologians, hope has a connection to God and without that
basis, hope it no longer hope, but rather wishes or wants. There is also a problem with
hopes of people may conflict. These authors address the individual hoping, but what
about hope of more than one person. Lynch describes hoping as a collaborative process,
but the collaborative in the effort to reach the outcome, not in deciding what to hope for.
III.

Aspects of Hope

There are many different aspects to hope. Hope can be described in many
different ways, with many different contexts. Each situation highlights something
different. Based on the discussion of the definition and descriptions of hope in the
previous section, this section aims to look at three things.
First, hope in differing terms. Context for how hope is used is important to
understanding the discussion. One can better comprehend how hope is defined by
examining it in a specific situation. Hoping for something has a specific description to it.
Living in hope is more vague and existential. It does not require details to the situation,
but rather a demonstration of action. Hope can be specific to a situation or it can be a
state of being.
Second, the key factors in hope will be examined. Words like desire, want, wish,
belief are all used interchangeably with hope many times, but there is a slight difference
in the mean and implication of each of those words. Concepts like imagination, the
future, possibility, uncertainty and realistic all are associated with hope in how it is
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described. These synonyms needs to be considered so there is a clear understanding of
hope.
Third is the word usage of hope. When hope is used as a noun or a verb it can
mean very different things. Hope as a noun is an object that can be given or taken. It
implies that something can do to make hope appear or disappear. When hope is used as a
noun, the focus tends to be on the hope itself, how to get it, how to keep it, how to lose it.
Hope as a verb reflects an action taken by the person who does the hoping. It gives
action to the person. Hope as a verb focuses the potential future outcome. Hope is
simply one of the means to the end. This does not mean that using hope as a noun versus
a verb is right or wrong. There needs to be clarity in the discussion as to what the
purpose of hope is and is not. By considering hope in differing terms, key factors, and
word usage, it clears the way to discuss hope within a specific context like healthcare or
more specifically in fertility preservation.
A.

Hope in Differing Terms
In order to better understand hope, context needs to be discussed. By providing

descriptions and parameters, hope moves from being a feeling to a practical virtue that
can participate in a given context. Hope can be specific to a situation or it can be a state
of living. Living in hope can be vague and non-specific. It comes across more as a state
of being. This type of hope can be unclear when try to explain it or define it. When
someone hopes for something, it has a specificity to it. There is an identified outcome or
future.
Judith Fitzgerald Miller writes about hope within the context of nursing and pulls
useful observations from her experience with hope and patients who are dying.46 She
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argues that hope is essential to life. If one does not have hope, one does not move
forward in life. She describes hope in two ways: living with hope and hoping for
something.
Living with hope is complex state that has no specific outcome in mind. It is a
general way of being that does not consider the reality of situation. This is the nature of
hope, it describes what hope is.47 For Fitzgerald Miller, this is dangerous when dealing
with end of life patients.48 Living in a perpetual state of hope, means living in a state of
denial. The patient is unable to identify the reality of death and the finality or life. Futile
treatments are sought out and attempted based on the push to keep hope alive. While it
may keep the patient in a positive mood, it also can make those around uncomfortable or
unable to deal when death happens. It is important to seek closure at the end of life, not
just for the patient, but for those around them. Facing death is a process that will
eventually leading to dealing with grief. If a patient is living in hope that they will not
face death, it is can be hard for them to have tough end of life discussions. Death is
inevitable; no makes it out of this life alive. There is nothing wrong with being positive
and focusing on the good in life, but living in a state that is unrealistic. This is
reminiscent of Ernst Bloch’s description of hope. Bloch describes hope in its relation to
utopia.49 As Bloch encourages people to look at culture for examples of utopia, it can
keep a person from understanding the realistic issues around them. While there is
nothing wrong with setting future goals, making an effort to have a good life, or avoid
suffering, it does not guarantee that everything will go smoothly. While Bloch does
discuss the roadblocks, it is not necessarily used to decide an outcome to hope for.
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Rather noticing the roadblocks is just that- noticing. In the end of life illustration, the
roadblock is death. It does not change the outcome- living in hope.
Hoping for something on the other hand has a specific context. It gives a personal
narrative to the discussion. It provides a context and a framework for the realistic,
possible future outcomes making it much easier to understand.50 According to Kant,
having the ability to construct what one is hoping for aids in the personal narrative of
hope. These outcomes however are unknown or beyond the direct control of
individuals.51 Nothing in life is definite and the same is true regarding hope. This type
of hope, is really describing the characteristics of hope.52 This includes possible
experience, imagination, and ability to construct what is being hoped for. According to
Webb, when a person hopes towards something, it is important to have basic trust and
feeling of safety and security.53 Trust, especially in the healthcare setting, is between the
many different stakeholders. This could include the patient, a healthcare professional,
family and friends. The feeling of safety and trust comes from having experience.
Knowing (because of the ability to construct the goal) provides the feeling of safety and
security to continue hoping. It does not actually provide security or safety, just the
feeling of them. By hoping for something, a person is automatically goal and future
minded. St Thomas Aquinas emphasized the importance of being future oriented which
also must be possible, but difficult to achieve.54
B.

Key Factors
Within the philosophical and theological definitions and discussions of hope,

authors find commonality. Hope can be describes in terms of desire and wants,55
relation to the future,56,57 and imagination.58,59 Most often discussions on hope usually
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have two key factors: realistic possibility and the future. In order to better understand
hope, it is important to know what other factors play into the discussion and how that
affects context. According to Christy Simpson, there are four aspects of hope that need
to be considered when describing hope.60 First are the desires and wants. Second is the
connection to values and goals. Third is the role of imagination and uncertainty. Fourth
is the action component. The four components were identified because hope is directly
tied to an emotional attitude.
1.

Wants and Desires
Hope as desires or wants is one of the most common descriptions.61 Hope at its

most basic level involved the need, want, or desire for a specific future outcome for an
individual. These wants or desires can branch either out of the current circumstance or
the second aspect of connection to values and goals. When describing hope, many times
the word want or desire can easily replace hope and the context would still make sense.
However, want or desire is not always the same.
2.

Connection to Values
Hope that is identified and held is a reflection of their values and reveals meaning

and importance of their lives.62 When dealing with a serious illness, understanding the
meaning of life and clinging to ones' values can become very important and reinforce the
idea and action of hope. Hope roots itself in the goals of "promise, potential, provision of
curative treatment for a disease."63 However, goals or values can change or be prioritized
differently in the face of serious illness.64 This instance tends to reflect a long standing
belief, like living to old age or refusing to compromise morals. Values are different for
each person and therefore hope can manifest itself differently.
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3.

Role of Imagination and Uncertainty
While the description of imagination and uncertainty may seem a little out of

place when dealing with a serious medical concern, they play an important role in the
description of hope. Imagination and uncertainty allow the individual to look forward
beyond the time of illness or disease. It allows for the creation of a future.65 It builds
into the desires, wants, goals and values of that individual as well. Imagination is a
powerful motivator in creating hope.
4.

Action Component
The action component of hope mainly refers to hope as a verb. The individual

hopes for something; the individual conducts themselves in a way indicating hope. This
could be a simple as taking medication or continuing with a specific medical treatment. 66
This action whatever it may be not only instills the idea of hope, but also helps to reach
the outcome that is hoped for by the individual. This means that there must be something
to hope about. Hope in its most general state, can fall flat. It may not inspire someone to
take initiative. Hope with action is specific. It gives context and meaning to the
situation.
C.

Word Usage
Understanding how hope functions as a part of language can aid in the

examination of hope. Jaklin A. Elliot and Ian N. Olver write about hope focusing on the
two different it as a noun and a verb.67 This means depending on the context, hope
functions in two different roles. When someone uses hope as a noun it reads like this,
“Hope changes people’s lives.” It is more of a general statement that a specific context.68
As a verb, it would read, “I hope this book changes someone’s life.” It is more of a
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specific statement as opposed to the general concept.69 There is a distinct difference in
what these words are implying. This different uses of the word, hope, is sometimes one
of the explanations as to why it is so difficult to define or describe.70 The context
changes and so does the connotation. Even within the same conversation, a person can
use hope as a noun or verb interchangeably.71 There are even times when hope is used as
an adjective (hopeful) or an adverb (hopefully).72 Those words are simply used as
descriptors to add to the main text so they will not be discussed here.
When hope is used as a noun, is an object that can be given or taken. Something
or someone acts in a way to change the idea or amount of hope. In this case, hope can be
quantified which reinforcing it as an object. Therefore hope must have an object or a
state that it is also affecting.73 Hope is something that can be possessed.74 By possessing
hope, someone can feel encouraged, optimistic, happy, or joyful. It is in these situations
that hope should be fostered and encouraged to at least maintain a consistent level of
hope.75 According to Begley, hope can be desired or one can place confidence in it.76 To
just desire something it to lust after it, but to hope, there is confidence that understands
that something good can take place. Taking it one step further, hope can even be
identified as a resource or motivator for a specific action or feeling. For instance, one
could say, “Hope sustained her in the tough times.” That is not to say that without hope
she would not have survived or that hope is the only resource she relied on. Instead it
just attributes some of the success to a concept that kept her optimist and looking towards
the future. The more that hope is instilled, the more it aims to dictate a specific action or
idea.
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There is also times when hope as a noun is in the negative context. One could
say, “There is no hope.”77 This phrasing is more similar to the feeling of hopelessness,
despair, or disappoint. It could also mean that there is a loss or absence of hope.78 In
these cases, it is usually because someone faced a situation where the outcome was not as
expected. Hope let someone down, it made the person feel discouraged. In those
situations, it can be hard to foster hope. Bad experiences have a way of defining people
internally.79 When saying there is no hope, it implies futility and in the case of healthcare
that means there are no more medical options. A patient may have to face the reality of
death.
When hope is used as a verb, is usually implies the idea of possibilities. There is
also an element of the unknown and the future being outside of the individual’s control.
Hope as a verb reflects an action taken by the person who hopes.80 It implies the
possibility of a positive future.81 To hope is to have a wish for a future outcome, to trust
or believe in something.82 It looks at this possibility with anticipation or excitement.83 It
stems from imagination and seeks to better what is the current situation. Positive
outcomes could mean many different ideas for patients - whether it is a complete cure,
prolonging life, or managing symptoms, amongst other outcomes. It allows patients to
see and chose to hope in outcomes for which they see as possibilities. Hope as a verb is
about possibility in the future, not about promised and foregone conclusions. Because
hope as a verb does not guarantee any outcomes, it allows the patient to change their
mind and to dream and imagine new possibilities. There must be a limit to these
possibilities however, otherwise, the hope turns into wishing. In contrast to hope as a
noun, hope as a verb makes the person the subject of the situation.84,85 Joe hopes he get
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the new job. Mary hopes she is not seriously ill. Matt hopes to get married one day.
Hope as a verb tends to be more focused on the future than hope as a noun.
There are cases where hope as a verb can go negative too. In those cases (similar
to hope as a noun) reflecting on something that has happened. One can say, “I had hoped
the treatment would work, but it did not.” This response confirms that what someone had
hoped for did not happened as the person wanted. The possible, future outcome was not
to be expected. In healthcare, this usually means that a treatment or medication did not
work. The body did not respond as was anticipated. It can be discouraging to the patient
when this happens. Trying to get that person to hope again can be a struggle.
IV.

Authenticity of Hope

One of the biggest concerns regarding hope is making sure that hope is authentic
or preventing what is often called false hope. Some argue that in order to create true
hope there is a direct connection to trustworthiness and honesty.86,87 Others write that
hope can be authentic when connected to autonomy while protecting the vulnerable to
prevent exploitation.88,89 Hope is limited to what is realistic.90 Hope must base itself in
the concepts and outcomes that are possible. When a patient hopes in a specific outcome,
it is important that the outcome is within reach. In healthcare, this can be a delicate
balance because research is conducted with hope of a certain outcome, but that does not
guarantee it. In order to better understand the realism of the hope, a patient must have an
honest, truth-telling relationship with any member of the medical team, whether a
physician providing recommendations or a researcher conducting a research protocol. If
hope is not based in realism, then one is being set up either by their own expectations or
someone else's, to fall into the trap of hopelessness which can lead to despair and

91

resentment. When patients know and understand that their hope is limited to that which
is realistic, it becomes authentic hope.91 Hope because of the importance of being
realistic and authentic, hope will vary.92
Hope needs to have an authenticity to it in order for it to be the best version of
itself. In order to foster hope, the authenticity of hope needs to be rooted in truth-telling
and a balance between beneficence and autonomy. There is an argument made by some
that beneficence should be the most important principle even over riding autonomy.93
While some may do this in order to create hope, it is not authentic hope. It fails to foster
hope that has a realistic outcome, that is possible, that is both something that one can gain
and do. In order to foster this type of hope, there must be a relational aspect to hope. It
connects the patient, the family, the healthcare worker to each other, all feeding off each
other to foster realistic, authentic hope.
A.

Hope and Healthcare
Adrienne Martin identified two ways that hope tends to be approached in

healthcare. First is the approach to hope studying its relation to physical and mental
health. It is a set of beliefs about oneself as it relates to healthcare. This is similar to the
concept of living in hope. The second approach is hope as a commodity. This is to hope
in something. The first approach, hope as it relates to one’s self, was used to create
Snyder’s Hope Scale back in 1991.94 The premise is that people are goal-oriented. This
scale measures hope based on the individual looking inward. The test itself does not
evaluate the type of goal that the individual is aiming towards. The difficulty in any of
these, is trying to measure a feeling or intangible concept.
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1.

Snyder Hope Scale
Snyder defines hope as “cognitive set compromising agency (belief in one’s

capacity to initiate and sustain actions) and pathways (belief in one’s capacity to generate
routes).”95 This scale was developed as way to self-evaluate hope. There are 12
statements. The first four evaluate pathways thinking. This is belief in one’s capacity to
generate routes. Pathway thinking is the planning of how to meet one’s goals. The next
four are to evaluate agency thinking. Agency thinking is the motivation or energy to
generate the routes. The remaining four are filler statements.96 The statements are as
follows:
1. I can think of many ways to get out of a jam. (Pathways)
2. I energetically pursue my goals. (Filler)
3. I feel tired most of the time. (Agency)
4. There are lots of ways around any problem. (Pathways)
5. I am easily downed in an argument. (Filler)
6. I can think of many ways to get the things in life that are important to
me. (Pathways)
7. I worry about my health. (Filler)
8. Even when others get discouraged, I know I can find a way to solve the
problem. (Pathways)
9. My past experiences have prepared me well for my future. (Agency)
10. I’ve been pretty successful in life. (Agency)
11. I usually find myself worrying about something. (Filler)
12. I meet the goals that I set for myself. (Agency) 97
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For those which are labeled pathway (#1, 4, 6, 8), each sentence reflects solving an issue
or problem. For example, number 6 reads, “I can think of many ways to get the things in
life that are important to me.” As a pathway statement its purpose is to evaluate whether
the personal believes they have the ability to generate a route to get to a solution(s).98 For
those labeled agency (#3, 9, 10, 12), each statement is determining the energy/successful
of the person taking the test. For example, number 10 reads, “I am pretty successful in
life.” As an agency statement its purpose is meant to evaluate the motivation to reach
those routes. It gives a sense if the person is headed in the direction they are headed.99
For those labeled filler (#2, 5, 7, 11), these statements give an over of what would affect
pathways or agency.
So when taking the evaluation, the original design was to rank each state on the
following four point scale: 1) Definitely False, 2) Mostly False, 3) Mostly True, and 4)
Definitely True. 100 The goal is to total the points from 12-48. The higher the score, the
more hope someone has. Originally this scale was test on college students. One of the
conclusions is that pathway and agency are indistinguishable on the scale.101
These numbers were compared to the actual goals that the students set for
themselves. The study revealed that those who had a higher score, set harder goals for
themselves.102 It is difficult to know why this is true, but for those who score higher and
set harder goals, they appear to experience smaller risk factors. This is due to their
agency of being hopeful and accomplishing their goals.
2.

Children’s Hope Scale
After the success of Snyder’s Hope Scale, he created one that could be used to

evaluate children ages 8-16.103 It uses the same concepts of pathway and agency.
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Developed in 1997, the idea came from the concept that if sick children can think
hopefully than they can imagine a future where are no longer sick, or at least better than
they were. If these children are goal-oriented as, assumed by the study, than there is a
constant need to continue creating new goals.104 Overall, the relationship between
children and goals is has shown that children who meet their goals feel positive, while
those who struggle feel negative.105 While the initial thought is that this scale applies to
physical health, there is consideration that it could apply to mental health as well.106
There are six statements. The even numbers evaluate pathways thinking. The odd
numbers are to evaluate agency
1. I think I am doing pretty well.
2. I can think of many ways to get the things in life that are most important
to me
3. I am doing just as well as other kids my age
4. When I have a problem, I can come up with lots of ways to solve it
5. I think the things I have done in the past will help me in the future.
6. Even when others want to quit, I know that I can find ways to solve the
problem.107
So when taking the evaluation, the original design was to rank each state on the following
six description scale: None of the time, A little of the time, Some of the time, A lot of the
time, Most of the time, and All of the time. The results of the scale showed similar
results found in the adult hope scale. Those who were found to be hopeful, were goaloriented, and set high goals for themselves purposefully.108 The reason is that those who
set high goals did so because they knew they could reach them.109

95

3.

Evaluation of the Hope Scale
These studies, as with all studies, have limitations. Snyder’s premise is based on

the intersection of goals, pathways, and agency. His interrelationship approach is unique,
but it leaves out other descriptions of hope including optimism. Snyder also assumed that
children behaved the same way adults do, which in subsequent studies is only true some
of the time.110 Both the adult scale and the children scale are used to evaluate goals that
are tangible. For Snyder, he compared the test score and academic achievements of
college and high school students.111,112 These goals are things that the individual can take
action to increase the odds to achieve them. This same strategy may not be as applicable
in healthcare. While one can take medicine or consent to a procedure, one cannot force
the body to heal itself or to improve by action alone. Healthcare professionals have noted
over the years that health care is both a science and an art form. It is unpredictable.
B.

False Hope
Hope that is based in fiction or a false reality leads to the term known as false

hope. Unrealistic expectations sometimes set of an individual for disappointment. Hope
must be based in reality.113 Hope that is not based in reality can leave a patient vulnerable
and there is a risk for exploitation or manipulation.114 When the patient, the family, and
the healthcare professional are honest and realistic with the circumstance, hope that is
realistic and authentic is fostered.115
There are some like, Charles R. Snyder, who do not believe that false hope
exists.116 As the developer of the hope scale, he is well versed in the discussion about
hope. He argues that hope is a sliding scale that can either be more or less, but the term
false hope is incorrectly used. The term false hope is an illusion and should not be used.
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He prefers the term loss of hope which implies that it move to a lower point on his hope
scale. He writes that hope is lost when goals are undermined.117 He cites three criticism
of why the term is inappropriate.
1. False hope are illusions that are out of touch with reality.
2. False hope are built on inappropriate goals.
3. False hope reflects poor planning.118
Snyder’s criticism of false hope is based on his own, though well known, definition of
hope based on goals, pathways, and agencies. The problem is if one does not subscribe
to his definition of hope, that his criticism of false hope is mute. Paul Kwon notes that
Callahan who argues about the importance avoiding false hope and fostering genuine
hope119, his definition of hope is different than Snyder’s.120
For the purposes of this dissertation, the definition previously established will
continued to be used while discussing false hope. Hope being the ability to believe in a
future outcome that is realistic as possible. Based on this definition, believing in
something that is unrealistic or impossible is false hope.121 It is wishing or wanting, but it
is not hope. It might be described as misguide hope or unrealistic hope. False hope
would better be described as hope that is untrue. Meaning the person that claims to be
hoping is not really hoping in whatever they are claiming.
For better clarity, the issue is not whether or not false hope actually exists. It
exists based on the definition society as assigned it. Meaning, that false hope is the same
as misguided hope or unrealistic hope or even wishful thinking.
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1.

Hope and Imagination
Hope is not the same as doing. Hope cannot heal. Hope cannot restore. Hope

cannot prevent. Hope is not a promise. Hope is not a guarantee. Hope can motivate.
Hope can encourage. Hope can inspire. Hope is limited by two main things: imagination
and possibility.122 Hope can only be hope when the imagination is involved. Imagination
is only limited by the individual. Imagination is free; it does not require education or
creativity. Imagination is a thought process that allows the mind to wander. For hope,
imagination is important. Imagination allows one to dream, desire, or fantasize.
Imagination pushes the boundaries of what is possible.123 Inventions and discoveries
would have never happened without imagination. However, imagination is reined in by
reality and possibility.
2.

Unrealistic Hope and What is Possible
Now that false hope, misguided hope, and unrealistic hope are all identified as the

same thing, it is important to understand what is meant by unrealistic. This term is a
subjective word. It implies that something is not based in reality, but that may not be
enough. Using additional descriptors like possible and probably help to create a better
understanding.124 By trying to define hope, false hope, unrealistic hope, it ends up being
a game of words and alternating definitions. It is easier to just try to clarify exactly what
is meant rather than try to define the term (that may actually use the wrong words
anyways).
For instance, someone can hope there is a pizza in the oven. It is completely
reasonable to think that someone made dough, added sauce, cheese, and pepperoni to the
top. It is even reasonable to think that a mom is baking pizza in her oven. If the day is
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Friday and mom always made pizza on Fridays when one was growing up, then again it
is a reasonable assumption. Now, if a mom even mentioned that she would be making
pizza on Friday when you visit, the hope that there is pizza in the oven is a belief in
something that is possible and realistic. However, if anyone of those parameters is
known to be false, than hope has become realistic. For example, if one knows that Mom
is sick and has not been to a grocery store to buy ingredients, than hoping for a pizza in
the oven is impossible. This may seem like an overly simplistic example, but it makes
understanding the concept of realistic and possible easier to grasp. Hope in something
unseen is to be expected. Hope in something that is not a one hundred percent guarantee
is to be expected. However, hope is misguided if one bases it on false or inaccurate
information.
In the case of healthcare, this is where healthcare professionals need to be
proactive in preventing false hope. Patients are not medical experts, there are many who
are well read, highly intelligent, but they are not the expert. It is vital that a healthcare
professional inform the patient of truth and any false information that is affecting the
patient’s judgment.
3.

Despair and Disappointment.
The opposite of hope is despair and disappointment.125 It is the belief that nothing

good will happen in the future, or that every option is impossible or unrealistic. Despair
keeps someone from feeling hope. It leaves one feeling hopeless. Lynch wrote that
hopelessness is the sense of impossible, too-muchness, or just a lack of feeling.126 It is
leaves the person feeling only futility. Hopelessness grows just as hope can die. One of
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the ways to combat hopelessness is to confront it.127 Hope than has the opportunity to
grow. This is why fostering hope is so important.
4.

Fostering Hope
Also known as nurturing hope, fostering hope is important. Being hopeful for

good outcomes and impressive goals keeps humanity moving forward. By fostering
hope, one encourages people to think beyond themselves. William F. Lynch says that the
best way to grow hope is to live contextually.128 It means having an understanding of the
world around you. It means getting outside of one’s own head and into the world. When
one does this, one fosters hope. It deepens and grows. There is a risk when trying to
nurture and instill hope. If the outcomes that had been hopes for does not happen, the
patient may turn very quickly to despair.129 When talking about hope in healthcare, hope
in a future outcome is not the same as hope for a cure. Hope for a cure is not an
unrealistic or impossible outcome, but it needs to be managed with probability. This is
where healthcare professional keep the conversation honest. The healthcare professional
cannot provide hope.130 Hope is from the perspective of the patient and healthcare
professionals cannot predict the future one hundred percent of the time. They can
evaluate diagnosis, prognosis, risk, and benefits, but it is not a fool proof system. Even
patient temperament plays into how a patient accepts information and responds with hope
or despair. When fostering hope a key element is to consider quality of life. This takes
into account how the patient wants to live his or her life. Fostering hope can connect the
patient and healthcare professional in a meaningful way that creates a trustful
relationship.131
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V.

Conclusion

Hope as a realistic possibility and hope in the future allows for authentic
expectations and understanding of a given situation. However, without understanding
how the individual is using the word hope, it is difficult to manage and to foster such a
concept. Defining hope can be a difficult task and it can be a question that goes in
circles. Moving forward, the definition of hope that will be used is one that says hope is
a belief in a future outcome that is based in reality and possibility.
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Chapter Four: Hope in Fertility Preservation
I.

Introduction

Chapter Four will examine the ethical role of hope in its relation to fertility
preservation. It will discuss why hope is different in this context as opposed to other
areas of healthcare. It will address the communication of hope to the patients in fertility
preservation. It will analyze what role and impact the notion of hope is playing in the
interactions between patients and health professionals. Hope is defined with the concepts
of the possibility and future, and fertility preservation has those same two components.
In the previous discussions though, both hope and fertility preservation were discussion
in the abstract, and in reality, they are part of a personal narrative for patients and
families.
There is a shift from the abstract concept of fertility preservation and hope to a
personal discussion of the relation between these two. Fertility preservation has standard
of care options of sperm, oocyte, and embryo cryopreservation. Research protocols
include ovarian and testicular tissue cryopreservation. These methods have estimated
success rates that change and adjust on a regular basis. However, the probably of having
success can be more closely determined when dealing with a specific patient. Hope is
defined as a belief in a future outcome based what is realistic and possible, the personal
experience and information affect the reality and possibility of the situation. With
specific information, one can better understand what is realistic and possible.
In fertility preservation the considerations for what is possible deals with
addressing the two perspectives- that of healthcare professionals and patient. Healthcare
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professionals are expected to know and understand their roles and responsibilities, how to
function as part of a team, respect and adhere to professional standards, and how to
address conflict of commitments. Patients need to remember their roles as the primary
decision maker, an advocate, and the sick role. Together the healthcare care professional
and the patient relationship is critical accomplishing anything in healthcare. It is
important for the healthcare professional to attempt to know the patient as a way to
establish trust and be transparent. The trust that is established in this relationship allows
for the patient to have an easier process of decision making, both in the decision to
preserve fertility and the later decision to attempt to get pregnant.
In fertility preservation, the considerations for what it in the future and how to
address the future centers on determining values and quality of life. Patients need to
consider what is important and how to go about accomplishing that. Fertility
preservation is a way to attempt to have genetic children, even if the patient is deemed to
be infertile. It is necessary to consider why there is such an importance place on genetic
(biological) children. The desire for children is strong and it follows a linear narrative
that is determined by tradition. However, there are alternative ways to seek to have
children that do not involve genetics. The potential for grandparenthood as a future
outcome can also steer parents to make decisions for their child. Grandparenthood is a
conflict of interest and should not factor into the decision making or consent process to
determine if it is appropriate for fertility preservation in minor patients. The question
becomes is there an obligation for parents to consent? Lastly, there is the impact of
research protocols on determining the future. The decisions for research are very
different than the decisions for standard of care.
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It is crucial to examine the way the patients, partners, families, and healthcare
professionals approach fertility preservation with the inclusion of hope. The
considerations for what is possible can influence the patient’s thoughts about the future.
Because of that, there needs to be critical look at the ethical issues in the connection
between hope and fertility preservation.
II.

Shift from Abstract Argument to Personal Narrative

Authors such as Kalbian (2005), Garvelink et al. (2013), Chambers (2013), and
Corbally and O'Neill (2014) discuss the importance of the personal narrative.1,2,3,4
Kalbian expresses the distinct regarding moral abstracts and personal experience, but the
same can be said for approaches to healthcare.5 As part of their personal narrative,
patients are choosing fertility preservation. They are doing this to prevent the risk of
infertility. However, in some cases of fertility preservation, there is the possibility of no
standard of care options, but rather patients must enroll in a research study for any "hope"
for successful fertility preservation. In order to make the best choice according to Quinn
et al. (2008) and Gracia et al. (2012), both the patient and the healthcare professionals
must work together to choose the best option for this personal narrative.6,7
A.

To Be In the Abstract
Defining the abstract simply means to talk in generalities. The discussion does

not focus on one particular case or patient. This means discussing issues in the broadest
sense of the situation. It gives a summary of the situation and applies to the most typical
of circumstances. It considers the definition and development of the topic.
For fertility preservation, in the abstract, it focuses on the methods and reasons.
As discussed in Chapter Two, standard of care includes oocyte, sperm, and embryo
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cryopreservation and research protocols include ovarian and testicular tissue
cryopreservation. In Chapter Three, for hope, this means consider both the philosophical
and theological definitions and descriptions of hope. The definition of hope used for the
purposes here is the belief in an outcome that is based on a realistic and possible future.
When discussing hope in fertility preservation, it is important to consider the
discussion of fertility preservation in light of the definition of hope. For those pursuing
fertility preservation, there are considerations that are specific to the concepts of
possibility and future. When considering possibilities in the abstract, the focus for
fertility preservation is based on the medical facts of the general concepts. For those
diagnosed with a serious disease, the risk of infertility is due to the side effects of disease.
The possibility of the risk of infertility is a genuine concern. As discussed prior,
infertility can be a concern due to the risk and benefits of chemotherapy for treatment of
diseases such as cancer or lupus. Infertility has many factors and predicting the exact risk
is difficult in the abstract. Fertility preservation allows the patient to consider preventing
infertility. Part of thinking about the future is the consideration of patients as to their
desire to have children in the future.8 While many people think about having children in
the abstract, it is usually in the distant future. When patients are told that there is a risk
for infertility, the reality of having children becomes a necessary discussion. For many,
they desire to have children when they are old enough, have enough money, have the
right partner, or are far along enough in their career. For those postponing children for
reasons other than disease, they are thinking about the age-related fertility decline. For
those considering fertility preservation as a result of a diagnosis, they are thinking about
preventing infertility. Either option is thinking that in the future; the patient would like
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the option to attempt to have a child. There is no guarantee of a successful
cryopreservation, a successful attempt to get pregnant, a successful live birth, or healthy
child. The patient is hoping for the best in the situation. Patients are aware of risks and
know that nothing is guaranteed.
B.

To Focus on Personal Narrative
To shift to the personal narrative is to put a name and a face to the case at hand.

Patients are more than just a name or a number. They are people with a personality,
family, friends, jobs, and hobbies. It is to make the abstract become personal. It
becomes a part of the person’s story and life. To consider the personal narrative is to
think about the specifics that makes a person’s story unique and stand out from the rest.
Personal narratives come in different forms, one of which, the linear narrative will be
explored later in the chapter.
When considering a personal narrative in healthcare, it takes into account all the
details of a person’s life including age, race, gender, geographic location, family life, past
experiences, health, illness, intelligence, personality, likes and dislikes to create a wellcrafted story. It considers the good and the bad, the easy and the hard. The personal
narrative is not about generalities, but about specifics.9 When a patient and a healthcare
professional are dealing with a specific case, it can influence the way that they approach
medicine in the future.10 It can either reinforce or teardown perceived truths or biases.
Personal narratives can be powerful to change someone’s mind.
In fertility preservation, that means focusing on the person’s specific reason for
considering fertility preservation. If a 22 year old female patient has breast cancer, this
means looking into the specific treatments that are most beneficial and least risky for her
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specific case. This can include looking at research protocols for disease if she meets the
demographic and clinical requirements to be a participant. This means looking at the
current state of her fertility and investigating for specific odds for risk of infertility when
she undergoes cancer treatment. It may mean referring the patient to an oncofertility
specialist who can give specific numerical risks for infertility, survivability, and
longevity of life. Additionally, it may mean investigating into the specific type of breast
cancer to understand the nature of her disease because there are cancers that love
estrogen. This means in rare cases, the method of fertility preservation that requires
hormone injections may actually speed up the rate of the cancer cells spreading.
Oncofertility specialist may need to even refer the patient to a plastic surgeon if a
lumpectomy or mastectomy is recommended. The reason for this is trying to preserve
what is necessary so the mother could possibly breast feed once she has a child. As part
of this example, all of this information is still in the abstract. It still is not a specific
patient, but rather a representative of this type of patient.
In some cases, patients do their own homework and search for methods and
reasons that best fit their story. They connect with others on social media, support
groups, organizations, and events. The personal narrative can be tricky to navigate for
healthcare professionals who are used to focusing on the numbers based on trends,
research, and data evaluation. Many healthcare professionals do not feel comfortable
pursuing a treatment if a patient can only provide the personal narrative of one individual.
There may be too many differences in the patient and the person in the story that the
healthcare professional recognizes, the patient fails to acknowledge or understand. The
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healthcare professional may believe that the personal story took too many risks and is not
a recommended protocol by the professional organization.
For many years, this was true about oocyte cryopreservation. It was not until
2013, that oocyte cryopreservation was recognized as standard of care by the American
Society for Reproductive Medicine.11 Still it was gaining attention from the media
including celebrities that were openly talking about oocyte cryopreservation. While
celebrities may have had access to experienced physicians, other physicians were still not
comfortable with the method as it was still being studied, understood, and skills were still
be acquired by many. It created a false story that as long as you could afford it, oocyte
cryopreservation was available to the masses. When in reality, before 2013, these
celebrities may have been enrolled in a research protocol to cryopreserve their oocytes.
While the personal stories of celebrities are valid, it is not always applicable to everyone.
Delay having children and choosing to cryopreserve material still does not guarantee a
pregnancy or live birth. A woman at age 25 could already have oocytes that are
decreasing in quality, while another woman at 32 may not have any signs of aging in her
oocytes. So while fertility preservation may be done at 25 and 32, it does not mean the
odds of having a successful pregnancy or live birth are the same. It also depends on the
sperm, the uterus, and any other risks that affect pregnancy and live birth.
What this means is that although patients are told they have autonomy, can act as
primary decision maker, and advocate, it does not mean that every method for any reason
is available for every patient. It is a very complex statement to say that a patient is
completely autonomous, fully informed and decisions are not affected by any outside
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influences.12 The personal narratives that include the specifics of the patient
automatically limit the options that a patient has available by a healthcare professional.
III.

Hope as a Possibility in Fertility Preservation

As discussed before, hope has various concepts and considerations that help to
define and describe it. Hope involves both the need to be realistic and possible. The
focus on hope is on the future. Part of being realistic and possible is the different
approaches to fertility preservation. There are two key perspectives- the healthcare
professional(s) and the patient (family). The healthcare professional must approach
fertility preservation keeping the goal in mind, to preserve the fertility of the patient.
Healthcare professionals have specific roles and responsibilities that must be done and
maintained in order to keep the process of fertility preservation moving forward.
Knowing ones role and responsibility is important to being part of a functional and
effective team. The healthcare professional must know their own expertise and what
expertise is not their own. In fertility preservation that means know how one’s role
relates to the patient. Since the healthcare professional is the gateway to healthcare, the
healthcare professional must know how to access what the patient needs and wants (when
appropriate) and how to access other members of the team who are better equipped to
aim the patient in their treatment. There are also concerns that come with the healthcare
professional’s perspective. The healthcare professional may have conflict of
commitments which is a form of conflict of interest. This conflict can affect how to the
healthcare professional approach the team and the patient. Patients (family) are the other
perspective. The patient is the most important role because the patient is the reason that
there is an issue in the first place. The patient is seeking to determine whether fertility

112

preservation is possible for the future. As part of the consideration, patients have to
consider their role as the primary decision maker, an advocate, and the sick role all as
part of their identity. These roles influence how they approach fertility preservation.
In conjunction with the two perspectives is the actual division of the decisions at
hand. In fertility preservation, there are actually two separate decisions. First is the
decision to during the initial diagnosis. The patient has to decide how and when to
cryopreserve materials. They have to consider the risks, benefits, and harm that are
associated with fertility preservation. They need to talk to the various stakeholders and
maybe consider their opinions. The second decision is deciding to attempt to get
pregnant. This means that the patient has to consider the method that best suits what
materials they cryopreserved and what are the best benefits, risks, and harms of the
various methods to attempt to get pregnant. Methods such as artificial insemination, in
vitro fertilization, donor gametes, and surrogacy can all be considered.
A.

Two Perspectives to Fertility Preservation
There are two key perspectives when it comes to fertility preservation. First are

the healthcare professionals which can include physicians, researchers, nurses, and any
additional team members. The healthcare professionals have a unique perspective that
includes knowing their roles and responsibilities, working as part of an interdisciplinary
team, and maintain professional standards. The healthcare professional must be careful
to be aware of any conflicts that may appear to exist or actually exist. Altogether, the
goal of the healthcare professional and the team are seeking to aid the patient in fertility
preservation. Second is the patient which can also include family. The patient as the
primary decision maker must be heavily involved. They must be their own best advocate
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if they decide to move forward so that there is proper care and treatment and no medical
errors. The patient may be labeled as various roles such as primary decision maker,
advocate, and the role of being sick. These roles influence the patient’s considerations
for deciding to do fertility preservation. It is also important for the healthcare
professional-patient relationship to be one of trust and transparency. This dynamic is the
most important part of the process and the interactions of the two perspectives. Both of
the participant’s perspectives need to be considered and approached with respect and
support. All those involved are aiming for one goal- to preserve the fertility of the
patient.
1.

Healthcare Professional(s)
Healthcare professionals have a major role in the process for fertility preservation.

When patients consider the possibility of fertility preservation, there are those who can
help them reach this possibility. The healthcare professional at every stage is an
important member of the team. There are many roles that are a part of this process.
Physicians can include someone from oncology or immunology or other areas depending
on the patient’s diagnosis. Oncologists are probably those who are most familiar with the
risk of infertility caused by chemotherapy and other cancer treatments. Understanding
ones roles is important in order to work as part of the team dynamic. It is vital to know
one’s expertise and the expertise of others. These healthcare professionals should be
familiar was at least how to refer a patient to each other. For instance, an oncologist may
diagnosis a patient with cancer, but cannot speak to the success rates of fertility
preservation. In that case the oncologist can refer to a reproductive specialist who is
willing to talk through the various fertility preservation options or research new options.
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The physicians are usually the gateway to the various referrals so that the patient can see
the best healthcare professional for their needs. Nurses can help to support the patient
through the tests and procedures. These men and women are the ones carry out the tests
and procedures and often spend the most time with the patient. Having good rapport
between the nurses and the patient is vital. Reproductive specialists are the ones who
have the expertise regarding fertility preservation and should always be brought in. They
are the ones who oversee the fertility preservation process including possibility doing any
necessary surgery like mature oocyte extraction. Clinical ethicists, social workers,
psychiatrists, psychologists, and spirituality are other disciplines that may be an
appropriate resource to talk with the patient regarding any questions or concerns.
Patients may struggle to accept their diagnosis and choose to ignore the need for fertility
preservation. A healthcare professional that can talk about the patient’s needs and wants
can be a valuable contribution. It can help the patient to identify what they are hoping for
in terms of a realistic and possible future outcome.
a.

Roles
Roles and role morality is about defining the rights and duties of the individuals

and others that are a part of the organization.13 Roles define relationships among
individuals and relationships between institution and individuals. Roles can be as simple
as job descriptions and expectations of employees. However roles go much further than
that. Roles also define how professionals are to act in general and sometimes in specific
statements. Role morality examines whether the individual is fulfilling the duties and
obligations of the role. This role can either be taken on or assigned by the organization,
professional standards or the individual. Judith Andre argues that the roles were establish
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to create a steadiness and a direction because humans are familiar and open to
establishing relationship.14 Roles were created because there is a sense that individuals
are willing to follow and fulfill what is asked of them. The sources may vary, but the end
result is the same – act according to the assigned role.
Roles can be defined from three distinct sources.15 These sources together make
up a role complete. The organization defines descriptions and expectations of roles based
upon the mission, vision, and values. They describe the job and the actions that an
individual part takes in. The organizational ethics must make sure that they are
consistent across the organization. Roles should not conflict with one another. The
organizational ethics balances the roles between the individual and the organization. The
organizational ethics addresses the problem that organizations cannot act on by
themselves. The organization lays out expectation of that relationship between the
individual and the organization because individuals act for the organization. There are
obligations laid out by the organization. They are to act in accordance with these
obligations.
b.

Responsibilities
Healthcare professionals have a responsibility to educate themselves on the

current methods of whatever treatment is being discussed. They are to ensure that
information is current and accurate. Healthcare professionals (physicians and researchers
alike) are expected to maintain an up to date understanding of the protocols.16 The
physician is the person who is the gateway to all the medical expertise available. They
are to lay out all of the options and provide recommendations for treatment and referrals
to other specialists. The researcher is trying to enroll patients into their study. They
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accept or reject a patient based on an approved protocol. They can also be a source for
medical information. It is important to each member of the healthcare team to ensure that
they know what their responsibility and role is and what it is not. Expertise in medicine
can be very narrow and no one should speak outside of their own. Expertise is developed
based on education, training, testing, and experience. Unless someone is qualified to give
an expert opinion, it should not be included in the discussion. When asked as question
that is outside the expertise, it is acceptable to indicate that someone cannot answer that
question because it is outside their scope of expertise. In many cases, the lines get
blurred and individuals who have the experience (and may even know the answer)
struggle with not addressing an issue. It is better to bring up an issue as a question, rather
than stating is as an expert. For instance, a clinical ethicist may be asked a question
about informed consent. A clinical ethicist can speak to the function, purpose, and
process of the document, but he or she cannot speak on how it relates to a specific law or
comment on legal implications. It is important for healthcare professionals to stay
vigilant that they do not speak to what is not their expertise.
c.

Teamwork
Healthcare professionals cannot possibly know everything about everything (in

fact no one can). This means there is a need to find other experts to share in the
professional responsibility of caring for the patient. Teams should be made up of a
diverse group of experts from various professions and disciplines. A team should
identify a leader and as a group work together to care for the patient. In cases of a cancer
patient, the team that cares for the patient may not meet on a regular basis or collaborate
with each member of the team. This does not mean that the team is dysfunctional. If
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teams are truly working together, they may be making referrals, reaching out to others to
discuss an issue, and following up on the patient’s care.
Teamwork is not an easy process. It takes time and effort to purposefully work as
team and to strive for the best care of the patient. The best teams communicate well and
resolve conflict even when it is difficult. It takes effort and time to commit to being a
good team. The patient should be the number one priority. Understanding the patient’s
needs and wants is vital, and so is knowing the way to access those needs and wants.
When a patient decides to pursue fertility preservation, they are considering the
possibility of the procedure. They are considering benefits and risks, listening to
opinions from family and friends. When the patient then decides to pursue it, they can
only do so with the involvement of the healthcare professional team.
In one study on ovarian tissue transplantation, Gracia et al. (2012) has discussed a
more multidisciplinary approach to fertility preservation. No one single healthcare
professional can be expected to know all information. The more collaborative the
process, the better the outcome for the patient. For this study the team included a
pediatric oncologist, reproductive endocrinologist, pediatric surgeon, pediatric and adult
clinical/research nurse and a psychosocial counselor. The goal was to spread the
responsibilities to the appropriate team members.17 It found that patients were
comfortable knowing that each member of the team had a designated role which allowed
the patient the freedom to ask questions and seek out various answers.
d.

Professional standards
Professional standards describe a person that has a specific set of skills.18

Professional standards lay out guidelines, ethics, actions that are to be held not just by an
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individual, but all individuals that claim a specific role. These professional guidelines are
not law and are not necessarily bound by the organization. The role can be guided by the
professional standards so that there is a consistency across a role.
The individuals can lay out their own roles because they are moral agents
themselves. As mentioned before, individuals are their own moral agents. They act
according to their own decisions. While in a specific role an individual can choose to act
in accordance with the role description by the organization and the role description by
professional standards. If they act in accordance with their obligation and
recommendations of that role, then the individual is in compliance.19 A nurse can be a
good example. A nurse is to act in her role according to the job description, the nursing
license board, professional nursing standards and any of the moral standards chosen to
live out. However if a nurse, chooses to act outside the obligations and
recommendations, it cannot only cost them their role, but also in a certain organizations
affect the consumers as well. This is where role morality steps into play.
However, healthcare professionals must adhere to their professional organizations
for licensing and credentialing. The professional organizations are meant to ensure that
healthcare professionals are kept up to date on current best practice and maintaining skills
and knowledge. For these professional organizations, they keep healthcare professionals
up to date on changes to standard of care and new research discoveries. For instance, in
2013, the American Society for Reproductive Medicine officially announced that mature
oocyte cryopreservation is no longer to be considered experimental. They reviewed the
literature to look for trends and success regarding this procedure. As part of standard of
care, healthcare professionals who deal with fertility preservation (reproductive
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specialists) need to ensure they are trained on the methodologies and best practices for
success. They need to gain both the intellectual and physical skills to do fertility
preservation. Oncologist and immunologists, or any other physician recommending
fertility preservation, need to inform themselves about the current benefit and risk so that
they can have a conversation with their patients that is informative and beneficial to the
informed consent process.
e.

Conflict of commitment
Conflicts of commitments are the struggle between several sets of commitments

that compete for preference in honoring those commitments adequately.20 This often is
seen in professional roles. Conflicts of commitments are impossible to avoid. Everyone
has them in their lives. By trying to avoid the conflict of commitment, means that one
commitment is either ignored or placed below another.21 The conflict that is ignored or
placed below others, may be just as important as the other commitments, but not treated
as such. Individuals may have conflicts of commitment within themselves and
organizations can have conflicts of commitment within itself. Healthcare professionals
have multiple obligations in their roles. There are the commitments to their patients, to
their profession, to their employers, to committees they are on, to their personal lives, or
to their research. Each commitment has a value and has the potential to make the
healthcare professional’s life better or worse. The conflict of commitments not only
affects the healthcare professional, but also those around. The first step to addressing
conflict of commitment is to acknowledge that it exists. Conflict of commitment is not
inherently wrong, but it needs to be kept in check to ensure it does not have harm to those
it may affect. Patients, especially those who are recently diagnoses, are vulnerable.
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There needs to be serious consideration to protect those who are vulnerable in order to
ensure ethical actions.
For example, an individual may sit on an ethics board and be a transplant
physician. He has an obligation to his patient to get an organ, but also an obligation on
the ethics board to act evaluate cases with integrity. He cannot abuse his seat on the
ethics committee in order to get an organ for transplant. The physician must act in the
patient’s best interest and yet he must act ethically on the committee. He must choose
which obligation is more important for him to honor. The organization can also give a
recommendation as to how the physician’s role should be laid out in the conflict of
commitment predicament. Sometimes in cases of conflicts of commitment and conflict
of interest, there is an important need to gain outside help and this is where clinical ethics
can come into play.22 This is true of the dynamic between physician and researcher.
Because fertility preservation is only in research phases for prepubescent children, there
may be a conflict if a physician is recommending a patient to enroll in a research study
they are conducting or involved with. The institutional review board needs to ensure that
the conflict is disclosed and monitored.
2.

Patient/Family
The patient holds the most important role. It is their diagnosis (or delay in having

children) that brings about the entire discussion. If the patient is an adult, assuming they
have decision-making capacity (which is always presumed), they have the autonomous
right to make decision about fertility preservation and treatment. Cancer survivors are
more determined than ever to live life to the fullest, which for many includes biological
children.23,24 Patients who are realistic understand that to receive medical care can mean
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weighing the risks and benefits of the care. The responsibility of aiding the patient in
understanding the risk-benefit ratio is the health care professional. The patient trusts the
health care professional has minimized the harm and risk and maximized the benefit.
The trust of the patient in the health care system plays an important part of relationship
between not just the patient and physician, but also between the patient and the system as
a whole. The level of trust that the patient puts into the system, reflects the confidence
that the patient has in the competence and best interest of the health care professional and
the health care system. Patients trust that the relationship with their health care
professional is based upon honesty. They trust to be included in the discussion of their
own health.25 While medical error can erode this trust, the health care professional and
health care system must constantly work to earn and maintain the trust of the patient.
One way to earn and maintain this trust is for the health care system to involve the patient
in the medical care process. The patient should be treated as a member of the team and
not just the means to an end in the medical care process. This can create an extra layer of
safety to increase the quality of the medical care experience. Ultimately, patients have
the right to expect safety and high quality of care in medicine.26 There is no exception.
However, health care professionals do need to help the patient maintain a balance
between expectations and reality of the health care system.
The involvement of patients is healthcare is an expectation that some patients
have. More and more patients want to know more than ever before. For many years
patients were passive victims in medicine, but now they can be active safety advocates in
medicine.27 There are three roles that the patient plays that will be considered: primary
decision maker, advocate, and the sick role.
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a.

Primary decision maker
Patients have a level of expectation in terms of the medical care that they seek

out. No one wants to seek out a health care system that will cause harm, increase their
risk, or be unconcerned with safety or quality. To a limited extent, patients have the right
to certain expectations. Patients expect to get the medical care they seek. As primary
decision maker, the patient exercises autonomy on a regular basis. The healthcare
professional is to ensure that beneficence and nonmaleficence are considered in the
decision making process. In addition, the patients can expect to have the personal right
not only acknowledged but also promoted. These rights can include autonomy, truth
telling, informed consent, confidentiality.28 While these expectations are reasonable,
there is a fine line between the expectations and the reality of what medicine can provide.
Patients’ views of medicine whether realistic or overly reaching, affect the current
medical system and how patients respond to their medical treatment. As primary
decision maker, the patient should be involved in the entire process. Signing the
informed consent form is not the only responsibility they have. Asking questions is
important. If they are uncomfortable with something that is happening, patients need to
speak up. By patients increasing their involvement, they can create an extra layer of
safety to their medical treatment. This is important and built into the system of medicine
now. The patient should take their involvement seriously. Because of the importance of
autonomy and informed consent, assuming the patient is competent, the patient is the
primary decision maker before any medical procedure is done. They have the final say to
go forward or refuse treatment.29 Making the patient highly involved in their treatment is
crucial. The patient can easily control the treatment by not following instructions on

123

therapies or medications. This can be on purpose or by simply having ignorance about
the circumstances.30 Patients, in most cases, also witness their own medical care. They
see the health care professional check them for symptoms, diagnose, and perform
treatments.31 This witnessing can give the patients an active role to make sure the safety
measures are being met.
b.

Advocate
Patients need to be their own advocates for health. They need to speak out to be

clear what they want and speak out to be clear what they do not want. Patients cannot
expect a healthcare professional to do both their own responsibility and the patient’s
responsibility. It is a partnership that both must be active in to have the best possible
outcome.
Some simple ways things that patients can do include double checking
medications or making sure that the healthcare professionals wash their hands. This
involvement of the patient makes them an advocate for their own safety. This
involvement though, does not make the patient solely responsible for their safety. The
organization and individuals within the system ultimately have the most responsibility for
the patient safety, but patients can take part.32 Patient can advocate for their own health
include speaking up about concerns, paying attention to the received care, participating in
decisions, asking questions, knowing medications, educating oneself about diagnosis, and
using health care organizations that have proven themselves to meet quality and safety
standards.33 This allows patients to take part in their safety while health professionals
provide care in a safe manner.
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Where it gets complicated is when a patient requests treatment that is medically
unnecessary or not medically necessary. In those cases, healthcare professionals have to
weigh autonomy and nonmaleficence. There are times when patient request medical
treatment that is not indicated for the circumstances, but patients are willing to take the
risk anyways. Patients need to keep in mind that being a decision maker and an advocate
is not an opportunity to demand any and all treatment. Healthcare professionals have to
consider other factors when recommending treatment. The relationship between the
patient and healthcare professional can be very difficult, if neither is willing to listen to
the other.
c.

Sick role
Sociologist Talcott Parsons suggested a concept he termed the sick role. The sick

role is social concept that is meant to describe a patient that has been diagnosed with
medical ailment and their goal of getting well.34 The concept of the sick role is based on
the idea that those who are sick are unique in their situation. The sick role addresses
rights and obligations that a patient may have as they address their diagnosis. This
concept is debated as to how appropriate it is to label someone into the sick role. The
sick individual is not responsible for their diagnosis (although some argue that this is not
true in every circumstance) and can be exempt from social norms due to the illness.35
The individual needs to prioritize their health over other priorities in order to get well.
The sick role is also described to have obligations to seek to get well and to seek
appropriate medical treatment.36 In cancer diagnosis, instead of focusing on the negative
connotation of the sick role, there are those who prefer the term survivorship. This
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focuses on the long term goals of surviving and thriving, not just on being labeled by a
single diagnosis. Survivorship will be discussed more thoroughly in Chapter Five.
While it is an easy explanation of the role, the execution is not as simple. There
are additional external barriers that affect these obligations. Individuals, who are sick,
depending on the severity, can struggle to accept their role and may be in denial for a
period of time. Seeking counseling can help someone to at least accept their illness.
There are some who once diagnosed, do not want to be treated as such. They want to
continue their lives as close to normal as possible. They refuse to be vulnerable and work
hard to maintain normalcy. Being vulnerable and asking for help can be a challenge.
Also a problem with the obligations is that seeking appropriate medical care may not be
readily available. Healthcare is expensive even with insurance, and that cost can become
a burden and may even affect the way patients make decisions regarding their healthcare.
Healthcare costs is one of the leading causes of bankruptcy in the United States and the
financial burden that healthcare creates can be troubling for many.37 It can be a
continuing issue when patients have to continue to seek medical treatment for chronic
conditions.
3.

Healthcare Professional-Patient Relationship
The healthcare professional-patient relationship is a vital part of the concept of

possibility for future outcomes. This dynamic is built upon trust and transparency. The
patient and healthcare professional are a team that together determine goals for the future
and work together towards those goals. It is imperative that they work together and not
against each other. The patient is in a vulnerable place and needs someone who can be
straight with them on benefits and risks. The healthcare professional is expected to do
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everything that can to help the patient get well. If either party does not feel that the other
is being trustworthy or transparent, it can create a hostile environment. It is important for
the healthcare professional to know the patient- who he or she is, what are his or her
values and preferences, and how he or she thinks. Healthcare professionals need to be
aware of non-verbal cues to understand the patient. Trust needs to be established
between the two in order to function as a team. Trust includes honesty, integrity, and
care. Transparency also needs to be established. Transparency means that there are no
secrets or deception between either party. If trust is broken, it is very hard to reestablish.
This dynamic is not always easy to establish or create. It may take multiple interactions
to establish the patient-healthcare professional relationship, but it may only take one
interaction to ruin it.
a.

Knowing the patient
Eric J. Cassell correctly points out that knowing someone is incredibly difficult.

In fact he goes so far to say that “individuals are unknowable.”38 The philosophical
debate of knowing someone will always occur. It takes effort and purpose to know
someone, but knowing and understanding someone for everything they are or are not is
challenging. An individual has many parts to them beyond the physical. In order to
know that individual one must understand the characteristics, past, family, experiences,
personality, culture, roles, relationships, jobs, behaviors, spirit, emotions just to name a
few. There is no way to know the individual as well as one knows the self. An
individual struggles with knowing oneself, which means knowing another is
impossible. The struggle to apply compassion upon another is then even more difficult
because one never really knows them. In medicine, it is almost impossible for the
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healthcare professional to really know the patient for the whole person that they are.39
This should be done by attempting to know the person as best as they can even despite
recognizing that this relationship cannot be perfect. This does mean that the attempt to
know that patient should be made. Healthcare professionals should strive to know the
patient in a meaningful way that allows the patient to open up and work together. If a
patient trusts the healthcare professional, they are more willing to share about
themselves. This means it is important to strive to know someone, despite the fact that
one can never really know someone.
b.

Importance of trust
Patient expectations always come with a level of trust in the system of healthcare.

If they did not trust the healthcare system, they would not seek any level of medical
testing or treatment. Patients place their trust in the organization and the individuals in
the system with their health and lives. Medical error can not only weaken the level of
trust, but can irreversible destroy the trust as well. Trust is an essential part if the
relationship between the patient and the healthcare professional is to function well.40 If
there is no trust, there is no patient; then there is no relationship. While to a certain
extent there is an unequal power between the healthcare professional and the patient, the
assumed trust of the patient towards the healthcare professional accepts this.41 The trust
of the patient towards the healthcare professional is made up of two parts – trust that the
healthcare professional is competent and trust that the healthcare professional has best
interest of the patient.42
The competency of the healthcare professional of course is crucial, healthcare
professionals need to know their job better than anyone else. No one would purposely
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seek out a healthcare professional who did not know the anatomy of the human body.
Healthcare professional are expected to maintain their knowledge and expertise as well as
learn new skills. This trust allows the system to function well. When a healthcare
professional is incompetent, it puts the patient at unnecessarily at risk. It is the
responsibility and obligation of the healthcare professional to protect the patient and one
of the ways it to maintain competence.
Trust that the healthcare professional has the best interest of the patient is as
important as trust that the system has the best interest of the patient. A patient does not
want a healthcare professional or a healthcare system to only have their own interests in
mind. They need to have a conscious about conflicts of interests that are present is vital
to safety and quality of care for the patient. This means that there is accountability and
transparency for everyone in the healthcare system.43 Trust is easy to lose, but hard to
gain back. Patients put their trust in the system, but one mistake, one error can destroy
that trust. The trust that the patients puts into the healthcare professional, gives an
opening to a relationship between the patient and the entire healthcare system.
B.

Decision Making Process
Ultimately, the patients have the decision making authority. The decision to

pursue fertility preservation can be quick decision for some, but a long draw out process
for others. However, the longer the delay for a decision regarding fertility preservation,
the longer the delay for treatment.44 Patients must determine if they want to attempt to
have children in the future.45 These concepts together allow the patient to move forward
with a procedure which ultimately is two separate decisions.46 The first is the decision to
preserve fertility. The second major decision is later, after the treatment of disease is
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complete- the attempt to get pregnant. Ultimately, there are two separate decisions that
must take place in order to attempt to have a child. The decisions are not to be decided at
the same time. There needs to be focus on the decisions as completely separating
entities. The informed consent process for both of these should also be completely
separate. This allows the patient the opportunity to focus on the medical treatment and
focus on health. Once a patient is in the clear regarding their treatment, there is a period
to ensure they are healthy and recovered. It is only then that the patient can pursue the
decision to attempt to have a child.47 Patient values and goals may shift in the time
between these decision one and decision two, not to mention life and circumstances
change as well. An individual may undergo embryo freezing, but later decide that he or
she wants to adopt or remain childless instead. This is why the decisions are completely
separate.
Patients who are minors do not make the first decision. The parents are to act in
the best interest of the child.48 If the parents do consent, they do it on behalf of the
patient, and the patient provides assent.49 In the case of the minors, the first decision is
technically not theirs to make. There are circumstances where mature minors opinions
are heavily considered in the informed consent process, (emancipated or married minors
are categorized differently). However, since informed consent is also a legal document,
those under eighteen cannot legally sign the document. This means that for anyone under
eighteen, the decision is only assent, though usually required by the institutional review
board, and is not legally binding. However, the mature minor patient is generally not
forced to do something if they have a well-thought out reasons to oppose such a
decision.50 In any case, legally the only decision the mature minor can consent for is the
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decision to attempt to have a child in the future once that patient is over eighteen. This
ability to attempt to have a child is dependent on many factors including what materials
were cryopreserved and what the current standard of care and research protocols are
available at the time. The children are adults at the time of the second decision. By
separating these two decisions, parents are not forcing their child into having biological
children, but rather giving them the option in the future.51
1.

Decision One at Initial Diagnosis
Fertility preservation is a two-step process that emphasizes hope in the first part,

and either confirms or rejects the possibilities in the second part. It is necessary to
separate the initial preservation of fertility gametes, and the second step of actually trying
to have a successful pregnancy.52,53 The first decision is the method of preservation.
This is an autonomous decision made by either the patient, if an adult, or the parents or
legal guardian, if the patient is a minor. The age of the child and the parent’s interest in
the child’s welfare are all important in involving the child in the decision making process.
This decision and procedure should take place before the treatment for the disease by the
patient or the parents. The patient must consider the risk, harm, and benefit of moving
forward with fertility preservation. They must consider whether the risk of infertility is
more or less compelling than the risk of the procedures for fertility preservation.
Infertility is unpredictable as a side effect of disease treatment. For those delaying
having children, there is a consideration as to risks of the procedures as well, but this is in
contrast to the decision to address age-related fertility decline. Unless, there is a need to
remove reproductive organs (ovaries, testes, uterus, etc.) there is the possibility of being
able to have a spontaneous pregnancy, but the odds are different for each person.
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Fertility preservation is a preventative method just in case infertility happens. This is a
chance that the preserved materials are no longer needed. This decision is a result of
identifying that the patient believes the value of having children in the future as a realistic
and possible outcome. This is the hope that patients are placing in healthcare to
potentially reach a specific outcome. This hope not only encourages them to do fertility
preservation, but to also decide to attempt to get pregnant in the future.
a.

Concept of risk, harm, and benefit
The concept of risk, harm and benefit is very important in the discussion of

ethical considerations and patient expectations. Anyone who seeks medical care should
know there is a risk to medicine, because medicine is not an exact science. Risk is
always present in medicine. The level of risk is what changes. The amount of risk is
based upon the exposure to harm.54 Risk is also based upon perception of the hazard and
the probably of the hazard taking place. 55 What both of the explanations amount to is
that presence of risk is situational and the effect of that risk is dependent of the views of
those involved. In healthcare, health professionals and patients each have risk to
consider. The health professionals’ job is to judge the risk and the patient (or the
surrogate decision maker) is to decide whether to face that risk. However, risk is not a
guarantee for negative results. Risk only shows the possibility of harm.
Harm on the other is the negative result. Harm also has various levels though
from minor to death.56 According to the Hippocratic Oath, a physician is to do no
harm.57 This basic mandate has changed over time. Now, harm is to be minimized and
benefit is to be maximized. This means that harm is acceptable to an extent. This extent
is when the harm is appropriate is to ultimately support the final benefit. For example, to
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perform an appendectomy, a surgeon must cut open a patient and remove the inflamed
appendix. The risk here is two-fold. To remove the appendix is to open the patient up,
which can lead to a risk of infection or cutting too deep or many other complications that
can come with surgery. The opposite risk is that to not remove the appendix is to leave
the patient vulnerable to the appendix bursting and causing a greater harm internally. By
performing the surgery, there is a minimal harm, but the maximization of benefit here is
important. Sadly there is not standardization to determine harm, or risk, or even
benefit.58 In every case, everyone involved should acknowledge and understand all
possible risks, harms, and benefits. The patient however, is not guaranteed to always
understand or comprehend all of the risks, harms and benefits involved in health care.
This is why the patient looks to the healthcare professional for guidance and reassurance
as to the decisions that the individual has to make. They put trust that the health care
system is competent and has the patient’s best interest in mind.
b.

Assent
Assent is a type of consent for those who do not have capacity or competency.

They do not have the legal or medical right to consent. The assent process still involves
informing the individual and ensuring he or she understands, all at an appropriate level.
Assent is important for those who are minors. In the case of fertility preservation,
prepubescent children do not have any standard of care options available. This means
parents can only choose to enroll their child in research studies to cryopreserve either
ovarian or testicular sperm. Patients who are prepubescent may not understand the
implications and intricacies of the protocols. It is important that the researcher
communicate with the patient at the appropriate age level to obtain assent. Minor
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patients are all different ages, different levels of intelligence, and different levels of
understanding. There are various ways to effectively communicate with minor patient
but it may take extra effort. The goal of assent is to see if the patient agrees with the
parent’s decision. This is not a test or a compliance question. It is to better understand if
the patient and the parents are genuinely on the same page. As the patient ages, it is
important to understand that so does the patient’s understanding. Mature minors have a
greater say that a two year old. Mature minors are included in the discussion because it is
important to grow them into the role of being an adult patient. At eighteen they are
expected to take full responsibility for their healthcare. The patient is expected to be the
primary decision maker, their own advocate while maintain the sick role. Eighteen is an
arbitrary number. There is not magic age when patients suddenly gain capacity. 59 A
sixteen year old may have a better understanding that a twenty-one year old. The age of
becoming an adult that makes his or her own decisions at eighteen is a legally established
number.
The rule of sevens is a concept that is aimed to help in approaching the
involvement of minors during decision making. The rule of sevens is a recommended
grouping that describes capacity for variously age children. This rule of sevens is not in
fact a rule, but a guideline for how to approach decision making for minors. Healthcare
professionals and parents should be sensitive to the intelligence and maturity of the
patient and adjust accordingly.60 This is true for any standard of care or research
participation for a minor. For those who are under seven, they do not have capacity to
make his or her own choices. Under seven, patients can understand some of what is
going to be done in the treatment, but they are not able to appreciate the benefits and risks
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of the treatment. Patients should still be included in the discussion at an age appropriate
level. Parents and healthcare professionals should work together to communicate
effectively with the young patient. From ages seven to fourteen, children are presumed
not to have capacity, unless there is a proven exception. This means there is a higher
level of understanding and comprehension than children under age seven, but not full
understanding and comprehension. There is concern if these children can truly be
voluntary, pressure from parents or the healthcare professional or even the desire to
please them. Those over fourteen are presumed to have capacity and make their own
decisions. This age group can best appreciate the information being given and decide if
they are willing to consent. Still in this age group, there is a need for parental consent in
most cases. This group if often referred to mature minors, but not all patients in the age
group are necessarily mature. There is a presumption of maturity, but healthcare
professionals should still evaluate. However, none of these age ranges allow for a minor
to consent for themselves without the parent or legal guardian also consenting. There are
a few exceptions including emergency medicine, specific reproductive medical procedure
and treatments, and in some states mental health treatment.
In 1999, Dr. Foreman wrote about something he deemed the family rule. This is a
type of collaborative effort between child and parents in order to gain informed consent.
Foreman argues that a child consents to the rules as established by being a part of their
family. Within this family, this rule is based on importance of promoting the welfare of
the child. By promoting the welfare of the child, the parents then have the right to
consent on behalf of the child.61 Children can provide consent within the context of the
family, but cannot consent outside of that context. As the child ages, the parent’s right is
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decreased because the child’s ability to consent for themselves increase. When
considering a decision, there are five steps that take place during the process.
a) Inform the child what will happen if nothing is done.
b) Describe the intervention.
c) Describe how the proposed intervention will improve things.
d) Whether the child agrees with the practitioner that the proposed
intervention does indeed produce a better outcome than doing nothing.
e) Only then, should the child's consent to proceed be sought.62
It may take time and some navigating through these steps in order to make a final
decision regarding consent on behalf of a child. Foreman clarifies that in cases of
disagreement, there must be attempt to reconcile the opposing viewpoints.
2.

Decision Two to Attempt Pregnancy
The second decision should be about having a child. The patient should make this

decision with input from the physician, when or if the time is appropriate. This may be in
a few months or few years after the treatment is complete. It is important to note that if
the parents made the initial decision for fertility preservation, the patient, once they
become an adult, now have full decision-making capacity to make the second decision.
The decision to attempt to get pregnant could take years before it is attempted.63 Patients
and the healthcare professional should work together to determine if the patient is in fact
infertile. This could be from conducting tests and blood work and attempting to get
pregnant spontaneously. In the cases of those who have a partner, it may be valuable to
have the partner tested for infertility as well. Patients and healthcare professionals then
must consider what type of reproductive technology is best based on the current health of
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the patient and the current methods available. This second decision may also mean a
change of heart. Patients may be exhausted from undergoing treatment and no longer
desire to do the same to attempt to get pregnant. They may have reconsidered the option
of fostering or adoption. The second decision is a separate decision and a separate
informed consent process. For minors, it could take many years before this option is
available. Minors need to wait until they are at least eighteen, but it may mean waiting
until later in life, when they are ready to be parents. This shift from a minor patient to a
legally consenting adult is significant. Parents cannot and should not force the formerly
minor patient to attempt to get pregnant. Because the minor is now an adult, they have
the same autonomy as any other competent and capable adult to decide for themselves.
Patients are still focusing on the hope they places in order to have a child in the future.
For the second decision, the decision to attempt to get pregnant is the attempt to fulfill the
hope. This is where the accuracy of the realistic and possibility is discovered.
a.

Current state of methods to attempt to get pregnant
When attempting to get pregnant, there are many methods and procedures to

consider. Patients can continue to attempt to get spontaneously pregnant, but at the same
time they can purse options like artificial insemination, in vitro fertility, donor gametes,
or surrogacy. The biggest issue here is the limited resources of the cryopreserved
material. Healthcare professionals need to carefully consider how and when to use the
cryopreserved materials. They want to ensure the most responsible use and the use with
the highest potential to get pregnant. This may mean that the sperm is used carefully for
an attempt at artificial insemination, while still considering to save sperm to use in intracytoplasmic sperm injection during in vitro fertilization to increase the odds that an
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embryo can be created. This also means that the partner if involved should also be tested
for risks of infertility. For example, if a male patient is attempting to use his sperm to get
his wife pregnant, it is important to consider the quality of the woman’s oocytes. If she
has oocytes that are damaged or she has inconsistent menstruation, there may be an issue
with attempting artificial insemination or intra-cytoplasmic sperm injection during in
vitro fertilization. It is a team effort with the patient, partner, and healthcare professional
working diligently to attempt to get pregnant in the most effective and responsible
manner. After all, the goal is still to have a child, and the hope from fertility preservation
hangs in the balance.
IV.

Hope in a Future in Fertility Preservation

Part of the concept of hope as discussed earlier, focuses on the future. It is
impossible to know the future. People can create the ideal future in their minds. They can
imagine how they want any given to scenario to play out. They can even think of
alternatives or ways to troubleshoot if the situation does not go according to plan.
However, all the thinking in the world will not predict the future. No one can make
perfect predictions. So what can be done in order to address the future? People can make
decisions that will help them to obtain the future that they are seeking. They can
participate in activities and reach out to experts to provide assistance. However, they
cannot force the future to happen exactly the way they want it too. They can set goals
and attempt to reach them, but it does not guarantee anything. For fertility preservation,
the future plays a major role in the decision making process. Thinking about the future,
is part of the process for fertility preservation. It is important to consider what the future
means and what it looks like for those who are considering fertility preservation. Does
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the future include attempting to have a child? Is the goal to contribute to research?
Maybe the goal is to not do fertility preservation, but attempt for a spontaneous
pregnancy. There are even some who would rather not have children. All of these
options are part of the imagination of the future. Each patient has to consider what values
are most important and how they work towards those goals.
For those considering fertility preservation, there are parts of the discussion that
are specific to the concept of future. The discussion of genetic children,
grandparenthood, and research protocols are all focused on the future. Patients have to
consider why they want children and what would life look like if that never took place. It
is interesting the emphasis on having genetic children and the length patients will go to
make sure that happens. Additionally, parents of adolescents can be thinking about
grandparenthood. Since the parents are the decision maker for minors, the decision to
preserve fertility may be affected by the desire to be grandparents. Additionally,
contributing to research may affect the future as well. Most patients are not well-verses in
research lingo and beyond having to sign for informed consent, may not understand the
difference between research and standard of care. Patients need to understand how
research affects their future.
A.

Future Considerations
When considering the future, what should be the parameters? Imagination can go

in any direction. When is there a shift from thinking something to working towards it?
There are many self-help books and seminars that teach about how to envision the future,
how to set goals, how to manifest what you want. However, the future decisions
discussed here are about quality of life. What does a good life look like to the patient?
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Each and every person answers that question differently. It can be hard to identify what
makes a good life. It is impossible to reach a consensus.
For those considering fertility preservation, the patient has to decide the
importance that attempting to have a child plays into his or her life. For instance, there
are some who would identify themselves as not kid friendly. That does not make them
bad people. It just says they are unsure or uncomfortable being around children. That
does not mean the person does not want children. While the person may not enjoy
other’s children, they know they will love their own. By considering the future with and
without children, one can better understand the personal values and quality of life that are
important.
Future concerns are usually determined by two distinct things. First are the
personal values of the person. So where do values come from? Values are beliefs about
one’s own self and the world around them. Values determine how a person acts, thinks,
and lives. Values vary person to person and so it is hard to have a consensus on all
values. Determining those values is part of the experience of being a human. Values
then help to inform choice and actions that are taken. It can help a person determine their
own quality of life they want to lead.
1.

Determining Values
When a patient is considering fertility preservation, there should be a lot of

thought and consideration before choosing or refusing it. Patients need to consider their
values and preferences at an overview level which can better inform the choices they are
making. For instance, a patient may say that family is the most important thing in their
lives. They enjoy spending time with their parents, siblings, nieces and nephews, aunt
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and uncles, and cousins. They have always wanted to have a family to raise and enjoy.
This may means that having children is very important to the patient’s definition of a
good life. Maybe the family values freedom, the ability to go and do whatever they want,
whenever they want. This may be a life style that the patient is unwilling to ever give up.
In that instant, the patient’s values may indicate, they have no interest in having children.
While these are examples are straight forward, it is almost always more difficult to
identify someone’s values in a singular meeting. The patient may express competing
desires which in turn may express competing values. Determining values may include
discussions with partners and families to get a better sense of what is truly considered a
value to them.
2.

Determining Quality of Life
Once values are determined, one can begin to consider what impact these values

have on determination for quality of life. Quality of life can help a person to determine
what type of future a person can envision for themselves. The forming of an exact,
consistent definition for quality of life is difficult. It is a subjective determination that
can have many different inputs. What one person considers good and important another
person may consider it irrelevant. Quality of life is important to the individual patient or
the family involved. Even if the determination is left up to the patient there are still a
plethora of concepts of quality of life. Some include endurable, higher than survival,
returning to ordinary life; and still other patients use their own criteria. Healthcare
professionals need to place the quality of life of the patient at high importance, because
ultimately, assuming the patient is competent and capable, the patient gets to make the
final decisions. The autonomy of the patient relies of the healthcare professional because
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the patient is to work within the framework provided for the patient. For example, if a
patient is facing cancer diagnosis, they may be given several options for how to approach
treatment of disease. Though the healthcare professional may have a personal opinion,
the patient has the right to make the decision to have the best possible quality of life
according to the patient. In the same example, the patient also has the negative right to
all treatment because they do not want to deal with a specific side effect or found it too
risky. For fertility preservation, the consideration is that the quality of life focuses on a
future filled with health and children.64,65 These two outcomes are not guaranteed or
necessarily tied together. When considering quality of life, the patient has to consider
their personal values which may include the desire to have genetic children and in the
case of women, carry a child to term.
Studies have shown the younger cancer survivors place a greater importance on
having children and losing the ability to have children, can negatively affect a person’s
quality of life.66 To some losing the ability to have children is a grieving process and
they have to adjust to a new normal for their lives. This pursuit for the specific goal of
children in the future and the important of the quality of life does not necessarily
encourage patients to seek out fertility preservation. In a 2012 study regarding quality of
life and fertility preservation, about 60% were counseled about fertility preservation, but
only 4% actually did fertility preservation. The fact that only 60% of patients were
informed is much too low. Healthcare professionals have a responsibility to inform
patients about the side effects of treatment and taking the time to address fertility (which
is highly associated with high quality of life) is vital. Excuses such as lack of knowledge,
lack of time to discuss the issue, the importance of not delaying treatment or the belief
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that patients should bring it up are unacceptable in making sure patients are making an
informed, capable, and voluntary decision regarding their pursuit for what they deem as
necessary for their quality of life.
B.

Genetic Children
Fertility preservation is chosen by patients with the hope to have children in the

future. The importance of genetic parenthood is evident by the increased discussion of
fertility preservation67 even though genetic children are not the only way to have
children. Having the desire for genetic children is considered normal and the most
traditional route to having children. Genetically related children are a want and desire
that many people have. They hope to have children someday; women want to experience
pregnancy. People desire to have a family. For many women it is a not only a personal
hope, but a social expectation as well.68 When a disease such as cancer interrupts a life,
sometimes desires and wants change; others times it reinforces them. Values and goals
may change or adapt based upon the circumstances as well. The importance of family
and being parents69 are often instilled from an early age and are built into the values and
goals of an individual. Because of this, many seek medical intervention when faced with
possible infertility. This obviously does not guarantee children, but establishes the
possibility of children. This is said not to deter patients from taking the appropriate steps
in fertility preservations, but to better understand the realistic circumstances that they find
themselves in currently. This is done by reconsidering an individual's values and goals.
In the case of facing infertility from aggressive treatment, patients may reconsider the
importance of genetic parenthood. For pediatric patients, this is more difficult to do.
This is where parents step into the discussion. Parents (or legal guardians) are the once
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who give consent and decide the values and goals for the life of the child. It means trying
to act in the best interest of the child to ensure them the possibilities for the future. They
are providing hope for fertility in the future should this become an issue. The desire for
children is a valuable goal and desire and the pursuit of that should be respected by
healthcare professionals. There does need to be consideration for alternative ways to
have children. Having genetic children is part of a linear narrative that encourages
traditions and normalcy. There is concern that the pressure to pursue genetic children
above all else may not be the end all be all of parenting. Alternative are important to
consider and some may choose to pursue parenthood through other options such as
fostering or adoption or may choose to not have children at all.70
1.

Desire for Children
Hoping to have children someday is considered normal. Most people in the world

at some point in their life get pregnant and raise those children. For some, it is a plan in
place since they were young. At a young age, being a mom or a dad is so far off in the
future. They want it to happen someday. As people age, there is more to the imagined
family life. What type of person to marry, how to raise the kids, names that are beloved
(or hated). The imagination focuses on the excitement of raising children- teaching the
children sports or music, creating memories at the amusement park, or celebrating the
place first in the spelling bee. The focus is not on the process of how to great pregnant.
Everyone that wants children starts by assuming, it is easy to have a spontaneous
pregnancy. Infertility is a taboo subject that is avoided in conversations. The desire to
have children for many is strong so being told that there is a risk of infertility can come as
a shock and disappointment.
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Once the patient understands the risk of infertility, decisions need to be made
regarding infertility. Fertility preservation tends to be time sensitive. Those who may
delay having children need to cryopreserve sperm, eggs, and oocytes, as soon as they
decide because age their age increases, the health of the sperm, eggs, and oocytes
decreases. For those who need to start treatment for disease, the sooner fertility
preservation can be done, the sooner treatment can start. Even with the hope for children
being addressed with fertility preservation, it does not guarantee a pregnancy, a live birth,
or a healthy child. The process of becoming a parent can be long and difficult.
2.

Linear Narrative
In 2000, Douglas Ezzy conducted a study on HIV/AIDS patients about how they

viewed themselves and their lives.71 By quantifying the results, Ezzy looked for trends in
how the participants answered. One of the most common was what Ezzy entitled, linear
restitution narrative. The idea is fairly simple. People, who are ill, hope to do everything
they can in order to restore back to their normal pre-ill self. They want to return to
normal. In Ezzy’s description he included the notion that linear narrative is oriented
towards the future, no matter how uncertain it is.72 What is being described is hope. For
someone with HIV, since there is no cure for the disease returning to normal is
impossible. For patients diagnosed with a disease, fertility preservation is one thing that
patients can do in hopes to return to normal after treatment is complete. There is no
guarantee, but the hope is based on what the patient has identified as important for their
quality of life.
The problem with describing something as normal is the subjectivity of it.
Normal is based on culture, society, other external influences, and personal bias. Having
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children is considered normal, but attempting to get pregnant with reproductive
technology may not be considered normal. This does not mean that normal is wrong or
immoral. It only means that normal is in the majority, encouraged by society and culture,
while abnormal is the minority. For cancer patients, it is very difficult to return to normal
during or even after treatment. Their perspective on life has changed. Survivorship
programs support cancer patients to adjust to their new normal. It recognizes that disease
changes someone’s life even if they are no longer ill. It affects perspective, values,
finances, relationships, work or school, even one’s view of self.
3.

Alternative to Genetic Children and Families
As there is great importance place on the need for genetic children, there are other

alternatives to having children. Using donor gametes and fostering or adoption are ways
of becoming a parent, but it does not have the biological component that many desire.
There are actually different types of parents that can be involved in the creation and
development of a child. This list of parents can be confusing because varying sources use
different terms, but may mean the same thing. The following are a list of the types of
parents:
Biological: a parent who contributed genetic material to the child
Gestational: a parent who gestated the child in the uterus (also known as a
surrogate, birthing mother, or carrier)
Intended: a parent who raises the child with the expectations of taking
charge of the child’s physical, emotional, mental, and financial well-being.
This may or may not be starting with the child from birth or
fostering/adopting at an older age.
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The patient that is seeking fertility preservation in order to have a biological child in the
future is the intended parent. In the case of fertility preservation, the patient who is
fertilizing gametes or embryo made from their own DNA is the biological parent. When
it becomes time to attempt to get pregnant the intended mother can either attempt to get
pregnant or they can contract a surrogate. There can be a number of combinations of the
roles applying multiple roles to one person. In fertility preservation being a biological
parent is one of the important factors. That is not the only way to become a parent though
There are some who despite doing fertility preservation are not able to attempt to
get pregnant, or stay pregnant. This may be discouraging to the patient, whose future
goal was to have biological children. It may mean revaluating the desire to have
children, or to find alternative methods to have children. It at least forces the patient to
consider changing their future goals. In those cases, patients may consider using donor
gametes (with or without a surrogate) or even fostering, and domestic and/or international
adoption. Being a biological parent is not the only way to become an intended parent.
There are many families that have fostered or adoption and are just as happy and
successful as biologically related families. There may be concern over not knowing the
history or the background of the adopted child, but there is no guarantee for a wellbehaved, healthy biological child either.
There is also the future outcome of not having children. There are people who are
content to not have children either by choice or due to age-related fertility decline. The
imagination of a future may not have included children. Often, this group is negatively
judged for their choice not to have children. Many (usually those who already have
children) voice concern that these people are making a selfish choice and will regret not
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having children. It is vital to remember that because of autonomy and positive rights,
one can seek out a way to have children, people also have autonomy, and negative rights
reo refuse to have them.
C.

Grandparenthood
In cases of patients who are minors, parents are making the future decisions for

their children. The possibility of becoming grandparents should not be the primary
reasons for pursing fertility preservation. There is an inherent conflict of interest when
parents are the decision makers for a child regarding fertility preservation. Parents have
the added benefits of preserving fertility for grandparenthood. Parents are to make
decisions that are the best options for their child, which may or may not preserve
fertility.73 The importance of best interests in decision making will be discussed more in
Chapter Five. As part of making a decision on behalf of a minor patient, there is also a
consideration if parents have an obligation or duty to consent for fertility preservations.
Some of this obligation is often discussed within the context of the child’s right to an
open future.
1.

Conflict of Interest
Conflicts of interest come into play many times while seeking medical care. The

Association of American Medical College defines conflict of interest as a conflict
between the personal and professional interests. This can include financial or
compromises in judgment.74 However, there can be times when conflict of interest is true
in a person’s daily life. In the case of parents, they are to make decisions for their child
based on best interests standard. However, it is hard for parents to make decisions for the
child without having any of their personal feelings affect the decision. Just as people can
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desire to have child, so can those same people desire to have grandchildren. This desire
to be a grandparent could, in theory, be so strong, that is influences the decision to freeze
their child’s material so that the child, when an adult, can attempt to get pregnant. The
thinking of the parents in this case is over stepping their bounds. When a parent consents
for fertility preservation, they are consenting only for the first decisions, to cryopreserve
material. They are not consenting for the second decision, to attempt to get pregnant or
in the case of research, attempt to transplant the ovarian or testicular tissue back into the
patient. The expectation maybe that because the parents made the first decision, give
them the right to decide the second decision is false. Due to the nature of patient
autonomy, once a patient is deemed to be capable and competent, in this case turning
eighteen, then authority to consent shifts from the parents to the newly legal adult. Now,
in many cases, eighteen year olds are still living at home or at least still no their parent’s
insurance plan. It is reasonable to expect that the eighteen year old patient may bring his
or her parent to appoints and ask the parent for their opinion. However, the patient is the
one who ultimately signs the informed consent document.
Parents need to be sure that their personal desires do not get in the way of
deciding what is best for the children. Parents need to engage with their child, especially
adolescents, to understand the child’s values and hopes for the future. By including the
adolescent in the discussion, the parent is engaging with the child which in the future can
help to adolescent, once they become a legal adult, to feel more comfortable navigating
the world of healthcare. One thing to note here is that the conflicts of interest relay on
the individual with the possible conflict to act with integrity and the honesty to
acknowledge a conflict of interest.75 Individuals need to be able to see the ethical
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dilemmas and any conflicts that may come their way. This requires the individual to
know their role, know their situation and independently identify any problems.
There are ethical concerns for conflicts of interest. Conflicts of interest are not
unethical just because they are conflicts of interest. Everyone has a back-story or
involvement in something – whether good or bad. No one can predict the future and
know what is going to be presented to them all the time. The problem is acting despite a
conflict of interest.
2.

Parental Obligation to the Child
So what is the parental obligation to the child? Does a parent have to preserve

fertility because it protects the future for the child? Do the parents have to refuse
research because the science is unrealistic and impossible today? Does the parent have to
defer to the assent of the child or the authority of the healthcare professional? The
concept of duty and obligation is a tough concept to establish. Duty or obligation means
that there is something greater than the individual compelling them to act in a certain
way. The most common duty to discuss in healthcare is the duty to warn, but that is not
what is being discussed here. Duty or obligation here is a positive right. Does that parent
have a duty or obligation to do something- in this case fertility preservation?
There are some who hold to the concept that parents have the duty or obligation to
act in a ways that protects (or promotes) the child’s right to an open future. This means
that the child should be given the opportunity to every available future that is possible. In
the case of fertility preservation, the right to choose to have children is based in the
future. But the question is still is there a duty? (More on right to an open future is
discussed in Chapter Five).
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For prepubescent children, because there is not standard of care option for fertility
preservation, there is a strong argument that parents do not have an obligation to consider
fertility preservation research. It is well established that those who choose not to
participant in research have the right to refuse to participate. One of the purposes of
research is to add to the body of knowledge and it cannot guarantee any therapeutic
benefit for the participant.
For adolescents, parents must consider the wants and desires of the mature minor.
Parents have a duty to consider the opinion of the mature minor patient. These patients
have the ability to think about their future. They can reason and consider risks and
benefits. They can understand the risk of side effects and concept of harm. While
parents still sign the consent form, adolescents should be involved in the informed
consent process.
D.

Research Protocols
Research is crucial to the development of science and medicine. Research seeks

to gain information in order to add to the body of knowledge with the hope of helping
patients in the future. Today within the field of bioethics, research ethics has developed
into its own discipline.76 In research, a patient must understand that they are no longer a
patient, but rather a participant in a study. Participants must join the protocol willingly
and free from exploitation, coercion, or manipulation. These participants may have their
hope in a specific outcome, but that is not the purpose of research. Those conducting
research need to be aware if this is guiding the patient's decision making. Fertility
preservation is not unlike other areas of medicine that have both standard of care or
research protocols available to patients/ participants.77 It is crucial to building a realistic
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hope for a specific outcome that patients/ participants are able to make the distinction
between standard of care and research when choosing a type of fertility preservation.
Consider the future in light of fertility preservation can be difficult, because
reproductive technology is constantly changing. While hope is a universal concept, it is a
very individual experience.78 The way that hope is describes is better understood within
the context research. Hope in the future of research is more abstract than hope in
standard of care. The hope, having children in the future is the same, but the possibility
and realistic nature of that coming true varies. Patients need to consider why they are
aiming for children and if the pressure from partners, family, or friends plays a role in the
decision making process. It is important to keep in mind though, that the decision to
preserve fertility is not the decision to attempt to get pregnant. The fertility preservation
decision is in the present regarding the future, while the attempt to get pregnant is a
future decision. The decision now may affect the ability to have the decision in the
future. For some patients, the only options are experimental and can add to the body of
scientific knowledge that may one day make fertility preservation standard of care for
those who do not currently have that option. More will be discussed on research, fertility
preservation, and hope in the following chapters.
VI.

Conclusion

Since hope and fertility preservation both involve the discussion of realistic
possibility and the future, it is tough to adequately manage and maintain realistic hope.
There is a responsibility of both the patient and the healthcare professional to thoroughly
understand the truth and the realistic expectations of fertility preservation. By moving
from taking about abstract to discussing personal, there is a context that provides valuable
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and specific information that inform the perspectives and ultimately the decisions being
made. Personal narrative allows patients to take ownership of the situation and work
together with the healthcare professional to examine the realistic and possible outcome
for the future.
Healthcare professionals and patients have specific roles and responsibilities to
consider when dealing with the situation. While having a commitments to their
profession, healthcare professionals also need to consider their commitments to the
individual patient. The patient and seeking health should be the priority. Working
towards honoring beneficence and nonmaleficence can do a long was in establishing trust
with a patient. When healthcare professionals know their role and responsibilities, they
function better as part of a team and can refer patients to those who know better when
necessary. Patients in turn need to understand their roles. Being the primary decision
maker can be challenging, but it also allows the patient to take charge. As an advocate,
patients work tirelessly to keep themselves involved and safe. In the sick role, patient
can take ownership of their interactions with healthcare professional. By examining the
two perspectives, those involved can better understand where the other is coming from
and how to address issues of understand being realistic and possible.
The decisions with fertility preservation are to be separate. Decision one should
focuses on the risk from the side effects of treatment or aging, and the consideration as to
which fertility preservation method is best. Some may find that gamete cryopreservation
is a better option that embryo cryopreservation and should be allowed to pursue one over
the other. The decision of choosing fertility preservation, being separate from the
decision to attempt to have a child, is focusing on the risk of infertility and the future
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outcome of having a child. The second decision of having a child is separate and must be
done so in a separate informed consent process. Patients should be legal adults and know
and understand the complications that can come with attempting to get pregnant.
Material that is cryopreserved is limited and so resources need to be used carefully.
When it comes time to attempt to get pregnant, patients need to still maintain the desire to
have children. Patients are allowed to change their mind to not pursue attempting to get
pregnant even if they choose fertility preservation in the first place.
When looking at the future, patients may consider the importance of having
biological child, but it is in their best interest to consider what that means and the
alternative options. Working towards having biological children is not simple and
methods like artificial insemination and vitro fertilization take time and money.
Additionally, there are other factors that may still prevent the patient from attempting to
get pregnant like problems with the uterus or legal confusion over the rights to embryos.
Understanding what it means to hope for success of fertility preservation can be
confusing and overwhelming. Patients, with the guidance of healthcare professionals,
need to determine what their future outcome to aim towards is and to evaluate the
realistic and possible natures of that outcome. Ultimately, to pursue fertility preservation
or not is the patient’s decision. There are ethical issues to consider that are brought about
when discussing the connection between hope and fertility preservation.
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Chapter Five: Ethical Issues with Hope in Fertility Preservation
I.

Introduction

Chapter Five will present an ethical analysis of the reliance on hope in fertility
preservation. It will discuss what specific ethical principles and practices need to be
considered in relation to hope including autonomy, beneficence, nonmaleficence, justice,
informed consent, and truth-telling decision making. It will also develop a critical ethical
analysis of the advantages and disadvantages of the reliance on hope in fertility
preservation in light of the ethical principles and practices. Advantages include right to
direct care, optimism, and survivorship, while disadvantages include projecting the future
of research, false expectations, and the involvement of other people.
II.

Ethical Principles

In the United States, the four principles as developed by Tom Beauchamp and
James Childress dominate the discussion for ethical principles. Autonomy, beneficence,
nonmaleficence, and justice were developed out of the Belmont Report. After the
Tuskegee Syphilis Experiment a committee was formed to create a report in order to
respond to the terrible actions that took place. Respect for autonomy, beneficence, and
justice were three principles that were identified as necessary for ethical research.
Beauchamp and Childress expanded this in the four principles in the Principles of
Biomedical Ethics. These four principles can be applied and discussion anywhere in
healthcare. While these are not the only principles, they are the main ones. Balancing
the principles can be difficult because to a certain extent prioritizing one principle of any
another can be at times subjective. Balancing the principles can be difficult because to a
certain extent prioritizing one principle of any another can be at times subjective. These
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principles then affect ethical practices like informed consent, truth-telling and decision
making. When these ethical issues and practices are considered in light of hope and
fertility preservation, there are advantages like right to direct care, optimism, and
survivorship. However, there is also a risk of false expectation, inappropriately
projection the future of research, or the inability to manage the involvement of parents or
partners.
A.

Autonomy
Autonomy is the most prominent ethical principle in the United States. This is

due to the US being a rights based society. Individual rights are important to the
foundation of the country and it manifests itself in every area of the culture.
1.

Defining Autonomy

Autonomy in health care is the ability to direct one’s own care. Respect for autonomy is
respecting the right that people have to direct their own care. Patients are assumed to be
competent and capable to make their own decisions. Those same patients often base their
decisions on the hope for a specific outcome in the future. When a patient is diagnosed
with an illness like cancer, the patient has the right to direct their care include who their
healthcare team encompasses, what treatments are important, and how to approach the
risk of infertility. In order to make the best decision for themselves, patients need to be
given all the information available and provided expert recommendations. In fertility
preservation, patients are hoping to avoid infertility and one day and hope to have a
successful pregnancy. Hope gives patients the ability to look to the future for
possibilities like having children, and because of the principle of autonomy, not only can
patients seek out health care to preserve fertility, but also through positive liberty seek
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out medicine the attempt a successful pregnancy. There are two mains parts of autonomy
when dealing with diagnosis: 1) the deliberation, and 2) choosing and acting.1 Together
this is how a patient acts with autonomy. Patients have to consider all their options.
Healthcare professional are most often the gateway to those options and need to be
prepared to provide all the necessary and relevant information. Once a patient chooses
and acts, the healthcare profession either supports the patient or refers them to someone
who can.
There are times when respecting patient autonomy may conflict with professional
responsibility. A patient’s right to direct their own care cannot encroach on a health care
professional’s right to provide medicine.2 If a health care professional cannot in good
conscience provide the type of care that the patient is requesting, they should refuse and
refer the patient elsewhere. Refusing a patient should be in rare cases, rather than the
norm. It should only be in cases of moral uncertainty.
2.

Positive Right in Fertility Preservation
Deciding how to approach fertility preservation can be difficult with so much

information communicated to a patient all at once. Autonomy has both positive and
negative rights in how healthcare is addressed. Positive rights mean that patients have
the right to seek out specific care. This may mean patients actively do their own
research. They may disagree with the healthcare professional’s recommendation. They
may choose to seek out a physician that actively supports their decisions for their
treatment. Healthcare professionals need to be supportive of patients that want to be
active in their care.
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Reproductive autonomy is a term that has been used to describe a women’s right
to access infertility treatment. This term is a bit of a misnomer. As stated earlier,
autonomy is the ability to direct one’s own care. However, it does not guarantee access
to every treatment or technology available. This is especially true for research protocols.
For many years oocyte cryopreservation was only considered experimental. There was
not enough data to support it as standard of care. 3 This meant that women could not just
walk into a doctor’s office and demand to freeze their eggs. They need to enroll in a
research study where they fit the criteria. Trying to communicate the difference between
research and standard of care can be difficult. Before 2013, many assumed oocyte
cryopreservation was a valid option, but it was not until 2013 the American Society for
Reproductive Medicine announced guidelines for oocyte cryopreservation and the official
stance that it was no longer experimental.4 Reproductive autonomy also does not mean
that patients can throw out healthcare professional recommendations and demand care
that is not appropriate for them. Healthcare professionals walk the link of respecting
patient autonomy while maintaining professional expertise. In cases where patients are
seeking a specific treatment or procedure, they may have to search for a healthcare
professional willing to do what they are asking. For a long time, fertility preservation
was a new concept; many did not know the term or the options available. Today, there
are now oncofertility doctors and experts who sole focus is fertility preservation. For
those who are diagnoses with disease that can affect fertility, it is critical for healthcare
professionals to discuss fertility preservation with them. This dialogue allows that patient
to decide for themselves what is appropriate and best for their situation.
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In some cases patient can be over eager to seek out medical treatment. This is
where hope may no longer be rational, but can verge into the false hope area. In some
cases, patients are requesting procedures that are unproven or for which they do not fit
the demographic and it makes for a difficult conversation. Patients may be placing hope
in something that is no longer possible. The line between hope and wish fulfillment is
narrow. While imagination of what is possible reinforces hope, in some cases it may be
too much. It is the responsibility of the healthcare professional to ensure that the patient
understands what options are realistic and possible. This can better manage hope in a
way that is supportive, and yet based in reality.
3.

Negative Right in Fertility Preservation.
Patients also have the right to refuse treatment. This negative right means,

provide the patient is competent and has capacity, that he or she can refuse treatment or
care being offered. They may need to sign a waiver acknowledging their actions, but
healthcare professional cannot force them to start or continue unwanted treatment. (Side
note: This discussion may or may not be true for those suffering from mental illness, but
that is a separate discussion). It may seem irrational for a patient to refuse treatments.
There are a number of factors that go into why a patient refuses treatment- fear, unwilling
to enter research protocols, tired of all the medicine, tired of the side effects, ready to die,
cannot afford treatment, want to go home, and many others. When the patient is younger,
it can be especially heartbreaking. In the case of fertility preservation, a patient is
making a decision (fertility preservation) in time that may or may not be true at a future
date (infertility or ability to have a biological child). In refusing care, patients are
weighing their benefits and risks and deciding that the risks are too high, and the benefits
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are too low. It may not appear rational and patients may be stubborn and difficult, but
that does not mean they do not have autonomy. So long as they are competent and have
decisions capacity, they have the right to refuse.
There are times when patients are refusing treatment because they no longer have
hope. They have determined that the options are impossible or unattainable. It is also the
responsibility of the healthcare team to make an effort to restore or instill hope. One of
the most consistent ways to address hope is through a solid patient-healthcare
professional relationship.5 This is done through providing support in the demonstration
of truthfulness and empathy. Both Marcel and Lynch note that hope must have a
plausible outcome. It is the healthcare professionals’ responsibility to address that when a
patient seems to see no plausible outcome. This is not to say that beneficence is thrown
out the window, but it does acknowledge that plausible outcome is a broad term that does
not have to focus solely on health and recovery.
There are times when someone may refuse a type of treatment for moral or
religious objections. It is crucial that the healthcare professional does not reject the
patient simply on their moral or religious objections. In an effective patient- healthcare
professional relationship, a healthcare professional must still move forward supporting
the patient, but also not retreading a topic that the patient has already decided upon. In
fertility preservation, a patient who is Catholic may refuse to cryopreserve sperm,
oocytes, or cryopreservation. Because the Catholic Church does not condone artificial
reproductive technology, there are patients who follow the church’s doctrine.6 If a
patient is facing cancer and the risk of infertility, healthcare professionals should still
outline the risks of infertility and the benefits of fertility preservation, but the healthcare
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professional must respect the patient’s autonomy. Healthcare professionals can provide
additional support but look for chemotherapy or radiation options that are effective in
treating cancer, but low risk for infertility. The healthcare professional can also be a
support system as treatment, when the patient is ready to attempt to get pregnant by
providing resources for addressing fertility in a way that supports the patient’s moral and
religious views.
4.

Autonomy for Children
When dealing with pediatric patients in fertility preservation, the view of

autonomy is a bit different. It is assumed and well accepted that pediatric patients cannot
consent for themselves. While there are exceptions, but this is the general rule. Parents
are expected to consent on behalf of their child, and if the child is age appropriate provide
assent.7 There is then a high level of trust that is placed in parents that they act in the best
interest of the child. In the case of fertility preservation, parents make their decision for
the best interest of the child's current health and future.8 The child, when old enough,
may decide to have a child, but in some cases, an early childhood diagnosis could make
this difficult, but not impossible. By enrolling the child in a fertility preservation study,
one could argue that the parents are preserving the child's autonomy.9 The child's right to
an open future is not only considered, but respected and encouraged.
a.

Best interests of the child
In the case of pediatric patients, parents or legal guardians are to provide consent

on behalf of the child. This does not just include signing the informed consent document,
but also includes making the decisions for the child. When a parent is to make a decision
for their child, it is hard to stay objective and neutral. Parents have their own set of
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expectations for the child’s life, but it may not be the same as what the child would see
for themselves. When deciding on behalf of their child, parents are expected to make
decisions using the best interests standard. Best interests standard is when a surrogate
decision maker maximizes the benefit and minimizes the risk in order to decide what
happens next.10 The parents are to consider the benefit of the treatment, the risk of the
side effects, the quality of life, the values, preferences, and perspective of the child. The
problem is that with a child so young, it is difficult to determine the values, preferences,
or perspective of the child because parent’s own values, preferences, or perspective may
get in the way. Healthcare professionals can step in if they believe that the parents are
not acting in the bests interests of the child, especially when direct harm may result.11 As
the child ages, he or she can begin to participate in the decision making process.
b.

Child’s right to an open future
Joel Feinberg originated a concept in 1980 called a child’s right to an open

future.12 His argued that child have future autonomy that needs to be protected at all
costs. His claim is the by protecting an open future for the child, then there possibilities
are not limited by decisions that some else made in the past. In theory, this may sound
grand, but determining what is good and bad, and what constitutes open versus close, is
one of the biggest criticisms of this concept.13 It would be impossible to keep all options
for a child’s future open at all times. Feinberg notes that keeping all options for
everything open at all times would be impossible, but he strives to provide most to allow
the child to be happy and self-fulfilled. This means that the child’s right to an open
future is to protect, the natural and typical future options available.
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Claudia Mills give the example in choosing a career. In the attempt to provide
education for a child, there are certain subjects that are taught in school over others.14
Now, according to this argument, all information should be taught equally so that a child,
when of age, can choose whatever career path. Since that have had equal education in all
subjects, then the child’s future career path is completely open. In practice, this is
impossible. There are certain topics that society has deemed necessary for a good
education to become a contributing member of that society, and others which are not bad,
but are more optional in their broad need for education.15 Additionally, there is not
enough time in the day or in a lifetime to learn all information equally. This does not
mean that there are times when the determined education needs to be reexamined or
changed. This illustration is just meant to highlight that keeping a child’s future
completely open is too difficult to do all the time.
In the case of fertility preservation, there is a limit to what healthcare can do to
keep a child’s future open. If an adolescent girl is diagnosed with lupus, there will be a
life-long battle with symptoms of the disease and side effects of the treatment. Some of
the treatments for lupus, including chemotherapy, can affect fertility of the patient.
Parents should consider oocyte preservation as a way to keep the option for a child open
for the adolescent girl.16 This should only be done though if it is in the best interest of the
child, and not just about the parent’s desires.17 However, in cases where the patient has
not undergone puberty, it would be irresponsible to force puberty on the patient as a way
to do fertility preservation. Forcing puberty on a young child can be dangerous and many
consider it to be unethical even though the production of a mature oocyte or sperm would
be the best methods of fertility preservation. Instead, parents have to consider research
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protocols like ovarian or testicular tissue cryopreservation that are available.18 By
enrolling the child in a fertility preservation study, one could argue that the parents are
preserving the child's autonomy.19 The child's right to an open future is not only
considered, but respected and encouraged.
B.

Beneficence and Nonmaleficence
Beneficence and nonmaleficence are discussed as part of fertility preservation,

emphasizing risk, and its contrast to realistic benefits versus possible benefits.20,21 The
protocols for fertility preservation have risks just like any other invasive procedure in
medicine. In the case of fertility preservation, while the initial risk, preserving one's
fertility, is undertaken as soon as a decision is made, the benefit, a successful pregnancy,
may not happen for many years. Cancer patients are recommended to wait up to two
years after remission to ensure that there is not a relapse of cancer.22 Therefore
beneficence and nonmaleficence are not just part of the short term decision to preserve
fertility, but also a part of the long-term future decision.
1.

Defining Beneficence
Beneficence was first identified as an important healthcare principle in the

Belmont Report as part of the benefit-risk assessment.23 In Principles of Biomedical
Ethics, there is a distinction between beneficence and nonmaleficence. Beneficence has 3
norms: “1) one ought to prevent evil or harm; 2) one ought to remove evil or harm; 3) one
ought to do or promote good.” Nonmaleficence is only “one ought not to inflict evil or
harm.”24 More specifically beneficence is about positive action. For many, beneficence
creates an obligation to provide care. For healthcare professionals that can be difficult to
work through, when healthcare professionals are supposed to respect patient autonomy at
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the same time. For some the competing principles of autonomy and beneficence can
create a difficult dynamic in the patient-healthcare professional relationship.
Jennifer Beste writes that the competing values in situations where prognosis and
survival is troubling, can justify beneficence to override autonomy.25 She writes that
paternalism is justified because patients are vulnerable and need to be protected from
themselves. Healthcare professionals have the obligation to instill hope in patients who
are struggling with accepting their current diagnosis. With cancer patients, acting in a
way that promotes beneficence can reflect the importance of promoting a hopeful
outcome for patients.26 However, it is risky move by the healthcare professionals to
withhold information. This contradicts informed consent both ethically and legally.
Even in the best patient-healthcare professional relationship, withholding information can
appear as manipulation. The most common argument against this is that the positive
attitude or optimism towards the diagnosis and treatment can provide actual better
outcomes.27 There have been protocols that have studied the correlation between attitude
and outcome, but what is really being described is hope for recovery.
For fertility preservation, beneficence focuses on how to promote good and
prevent harm. By preserving fertility, one is avoiding the harm age or the treatment of
disease may cause. Promoting good may involve seeking out the best cryopreservation
technique for the current circumstance. For prepubescent children, there are no standard
of care protocols available for the only option is research protocols. Parents have to
weigh the benefits and risks of the research, knowing that it is an unproven option.28 This
means there may not be solid data or recommended protocols for things like ovarian or
testicular tissue cryopreservation. This also means there is little data for transplantation
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of the tissue back into adults, and no data for transplantation into children. However, if
this is the only way to potential preserve fertility, parents may strongly consider doing so.
It is important for the healthcare professional to consider beneficence and
nonmaleficence before conducting fertility preservation research on prepubescent
children. There is the risk that parents can have hope for a medical procedure
(transplantation in the future) that does not and may never exist.
2.

Defining Nonmaleficence
Nonmaleficence was originally incorporated in the principle of beneficence in

The Belmont Report. However, Beauchamp and Childress, however, separated it when
developing their Principles of Biomedical Ethics. Nonmaleficence as mentioned before
has a norm of “one ought not to inflict evil or harm.”29 Inflicting harm could be
intentionally leaving out information during the informed consent process or could be the
side effect that come from treatment of disease like chemotherapy.
In the case of fertility preservation, the harmful thing is infertility. This could be
due to either age-related fertility decline or side effect from treatment of disease. There
are two perspectives for this harm. One, the prevention of infertility describes
beneficence; and two, the not inflicting infertility describes nonmaleficence. By doing
fertility preservation, the patient is preventing the harm of infertility which is more
similar to beneficence. By choosing treatments that does not inflict infertility is more
similar to nonmaleficence. By considering future fertility, one is protecting the autonomy
of an individual. In addition some would argue that even non-maleficence, the idea of do
no harm, suggests that fertility preservation should be considered because removing the
autonomous choice of possible reproduction in the future can be harmful to that patient.30
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Harm should not come to these patients especially because they are in a vulnerable place
already. By protecting their future, harm can possibly be avoided.
3.

Balancing the Principles
There is an argument made by some that beneficence should be the most

important principle even over riding autonomy.31 Balancing the principles is highlighted
by understanding the patient’s values and preferences. Whether the focus is on avoidance
of harm or actively seeking a preventative solution, the end result is the same- trying to
preserve the fertility of a person. The benefit-risk assessment is one that can focus on a
number of things.32 When a patient is diagnosed with cancer, the benefit-risk assessment
tends to center on the cancer diagnosis, treatment, and long-term survival. Within this
assessment is the consideration for fertility preservation. It is important to have a
separate, but equal consideration for the benefit-risk assessment for fertility preservation.
For instance, benefit-risk assessment for cancer focuses on the type of treatments
available, the side effects of the treatment options, the effectiveness of treatments both
for short-term and long-term survival. For the benefit-risk assessment of fertility
preservation the consideration are about delaying treatment for disease, invasiveness of
preservation technique, cost of preservation both the initial cost and the long term
cryopreservation fees, the importance of children for the future, the opinion of a partner,
or the lack of a partner.

These benefit-risk assessment is more straight forward when

dealing with adults (or adolescents) than when dealing with prepubescent children.33
C.

Justice
Justice was originally included in The Belmont Report and also in Principles of

Biomedical Ethics. The idea of justice is fair and equitable treatment of all people.
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Someone who has a justified right to claim something, is due that claim.34 The
According to Beauchamp and Childress some of the biggest issues in dealing with justice
is determining fair opportunity, dealing with unfair discrimination35, racial, ethnic, and
gender disparities,36 vulnerability,37 exploitation,38 and allocation.39 Two very prominent
writers, John Rawls and John Stewart Mills have written extensively about what justice is
and how it applies.
1.

John Rawls
According to John Rawls, justice is all about fairness.40 Rawls theory of justice

starts with the original position of thought. This is to say that hypothetically individuals
and societies promote principles of justice in a manner that is based upon free and fair
cooperation. The idea of a “veil of ignorance” is used are part of this thought experiment.
The “veil of ignorance” is the idea that you do not know your defining characteristics are
to you social situation prior to determining what is just.41 Rawls concludes two
principles of justice from the original position thought experiment.42 First, everyone has
equal right to the most extensive liberty compatible with the same liberty for others.
Second, if there must be inequalities, then social and economic inequalities are arranged
so that positions are open to all and provide the greatest benefit of least advantaged.
These principles apply to the “basic structure of society and govern the assignment of
rights and duties and regulate the distribution of social and economic advantages.”43
Rawls theory says that everyone should be guaranteed liberty. This means in
terms of healthcare, should everyone have that as a right? As a society, we agree that at a
minimum level, vulnerable populations deserve health care. Medicare and Medicaid both
serve and provide health care to the poor and elderly. Legally these groups are protected
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and given justice. But what about those who currently do not have access the health
insurance? Rawls might argue that people deserve to have health insurance in order to
receive the minimum amount of health care.
2.

John Stewart Mill
John Stuart Mill explains justice from utilitarianism. Utilitarianism is all about

promoting the good and by doing that there is a greatest total of happiness. Mill has five
attributes of justice. First, it is unjust to deny someone their personal liberty, property
and legal rights.44 Individuals should be able to pursue their personal liberty and legal
rights without interference. The justice is found in the respect for these and injustice is to
infringe on the legal rights of an individual. Second, some laws may have been unjust
and deny a person moral right, but legally allowed.45 This is to say that although legally,
someone’s actions may be permitted, that does not make them just or morally right.
Third, it is universally just to have individuals get what they deserve and to not get what
they do not deserve.46 This essentially means that promoting good results in deserving
good and doing wrong results in deserving wrong. Fourth, it is unjust to break your word
with someone.47 Keeping someone’s trust is very important however, it can be overruled
if there is someone more. Fifth, showing favorites is unjust and impartiality is in line
with equality.48 Impartiality is not a duty in and of itself; however, Mill says is helps
support other duties. Injustice is created by two things – a wrongdoing and an individual
was wronged. Injustice is not just about breaking laws that are established and but also
about breaking the laws that ought to be exist. Mills examines justice in light of utility.
He says that justice is the most important obligation in the span of social utility. The
moral requirements that set a high standard for justice and in turn create a great duty or
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obligation. The connection here is found in the principle of utility – making sure that the
great good (or as the case may be happiness) is achieved.
As for Mill, his theory of justice is also difficult to apply to a specific model like
healthcare. The attributes easily apply to the legal system, but not as easily to healthcare.
In attribute three, there is not clear definition of good or wrong. This gets more
complicated in healthcare because of the issues of life and death. There are few who
would refuse medical care if it spared a child from death. But to declare something
unjust in healthcare is difficult. Mill says that injustice is created by two things – a
wrongdoing and an individual was wronged. Again, who defines the wrongdoing? It is
also important to think about whom the individual is – the patient, the family, the medical
team, or the insurance company. There are so many people to consider in any healthcare
case. In theory it seems easy to say you take away a healthcare worker’s license. But
how do you punish a patient who breaks the rule? In terms of utility, there are the same
arguments that were presented with Rawls. Promoting the good or happiness is important
and this should allow for patients to make decisions for themselves, but this is not always
the case.
3.

Application of Theories of Justice
In the case of fertility preservation, what is considered just? According to Rawls

and Mill, it is just to promote the good. Again, defining good in fertility preservation is
difficult. Is good considered preserving fertility, or is good no becoming infertile in the
first place? Or maybe good is being able to get pregnant when one chooses. Good is
subjective and if everyone demanded their own version of good, it could become a drain
on the entire system. There are only certain number of resources and allocation of those
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resources have to be done in a just manner. As stated before, it is important to be just for
those who are vulnerable, but if everyone is deemed vulnerable, than no one is
vulnerable.
III.

Ethical Practices

By applying principles of autonomy, beneficence, nonmaleficence, and justice,
there are practices that have been developed. They play a significant role in how patient
approaches healthcare and how they hope in something. The application of these
principles is demonstrated in the practice of informed consent, truth-telling, and decisionmaking. Informed consent, truth-telling and decision making directly connects to how
hope is fostered in fertility preservation.
A.

Informed Consent
Several sources such as SAGE Handbook of Health Care Ethics,49 Clinical Ethics:

A Practical Approach to Ethical Decisions in Clinical Medicine,50 and The Oxford
Textbook of Clinical Research Ethics51 discuss informed consent. Informed consent has
become a main tenant in health care because of past abuse, changes in the patienthealthcare professional relationship, and the defensive medicine due to the litigious
society.52 Inadequate informed consent has been shown to be one of the major ethical
and legal issues for reproductive technology.53 Informed consent is not just a signature
on a form, but a process of communication that patients and healthcare professionals
must participate in together.54,55 It is a reflection of the autonomous choices made by a
patient.56 All three components to informed consent- fully informed, fully capable, and
fully voluntary need to be addressed adequately for all patients pursuing any type of
fertility preservation.57,58 Informed consent for fertility preservation is not the same for
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every patient. Because fertility preservation has many different demographics, and some
types are standard of care, while others are research protocols, informed consent needs to
be adequately addressed and approved by the institutional review board.59
1.

Fully Informed
To be fully informed is to know all the information for a given situation. This

does not just mean the process of the treatment and the risks (side effects) of the
treatment. This means patients should be told how effective the treatment is, how
experience the healthcare professional is with this particular treatment, alternatives that
may better suit the patient’s needs, or even changes in protocols.60 Disclosure of
information is critical to the informed consent process and healthcare professionals have
a professional responsibility to disclose all necessary and relevant information.61 While
there are many different ways to disclose information, the end result should be the samethe patient has understanding about the information provided. In rare cases, it may be
appropriate to withhold information, but that must be justified on a case by case basis.
Healthcare professionals are also expected to give their professional recommendations.
They are well versed in health care and understand the nuances of the side effects,
benefits, and risks.
This information being disclosed to the patient affects the concept of hope.
Hoping in something can only be done when the patient is given all the information and
can imagine a realistic possible outcome. Without all necessary information, patients
cannot hope in a way that is realistic. Hope based on false or missing information can be
problematic because the outcome that is imagined may not be the same as the outcome
that happens. This may create distrust in healthcare for the future.
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2.

Fully Capable
Being fully capable is the ability to understand and reason. Every adult is

assumed to be both capable and competent. Having capacity is a medical determination
while competency is a legal determination. Unless there is a formal medical or legal
determination, every person makes decisions for themselves. This means that decisions
made by patients are the decisions to be followed. This could mean either refusing to
consent or consenting to a treatment. Healthcare professionals are expected to treat
patients as they are capable and competent unless there are signs otherwise indicating
they are not.62 This does not mean that everyone has the same level of intelligence.
When providing information, healthcare professionals need to be aware of the
intelligence of the patient in order to best communicate with them. It make take a few
different techniques to ensure that a patient has understood the information being
presented.
Hope in something can only be done if the person has the ability to understand
and reason in the situation. The person needs to be aware of the current situation, what
can or should be done to make the change, and what the potential outcomes are. If a
person is unable to appreciate those things, or make reasonable sound judgments, there
may be an issue with capacity or competency. However, either an evaluation from a
medical professional or an evaluation by the court can remove capacity or competency.
For adults, being capable of informed consent is part of the ability to hope. Patients that
can provide consent, have the intelligence and ability to appreciate the nature and risks of
the medical treatment and hope for a future outcome. Parents who consent on behalf of a
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child must have capacity and as the child ages, getting assent can be a way of making the
child feel included.63
3.

Fully Voluntary
Being fully voluntary, means that patients are making decisions on their own,

without the influence of others. Manipulation, coercion, or persuasion are all potential
ways that patients may not be making their own decisions.64 Guilt from family and
friends may also be a factor in continuing futile treatment. Being voluntary does not
mean that patients cannot take advice or opinions from family, friends, or healthcare
professionals. It means that the patient has the final say and their opinion matters more
than anyone else. One form of undue influence could be the withholding of information
or questions a patient’s ability to reason.
The decision to do fertility preservation must be voluntary. Patients be fully
informed and fully capable to voluntarily consent. The purpose of fertility preservation is
to attempt to get pregnant in the future. Patients should only consider fertility
preservation, if having a child in the future is even remotely in the future plans. Many
people have the hope of having children one day. If the risk of infertility is imminent,
preserving that hope is important. If someone is undecided about future children, they
should still consider fertility preservation, because if infertility is a risk, they may not
have another chance to take any preventative measures. Their hope may be more for the
option of having children in the future. However, no one can force someone to do
fertility preservation. Partners should be supportive, but they should not force fertility
preservation if the patient is not interested or participate in fertility preservation if the
partner does not want children. Cryopreservation of sperm and oocyte eliminates the
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complication of involving a partner. It allows the decision and hope for the future to be a
singular person’s voluntary decision. In the case of minors, it can be more difficult to
determine if parents are acting voluntarily on behalf of their child when agreeing to
informed consent. Parents are biased in the process and dealing with a sick child is
already difficult, but adding have to make decisions about an unknown, but hopeful
future can be problematic.65
4.

Informed Consent in Fertility Preservation
Being informed includes know exactly which is best recommended for the

patient’s situation. If there is a partner involved, embryo could be better than sperm or
oocyte cryopreservation.66 It is important to at least approach the topic of alternative is
fertility preservation does not work. For instance, if there oocytes have poor quality,
discussing donor gametes or adoption may be appropriate. Healthcare professionals that
are in any way connected to risks of infertility or fertility preservation need to state up to
date on the current state of fertility preservation. For example, oncologists should be well
versed in the basics of fertility preservation and have a reproductive specialist for
referrals.
Men and women should be fully informed of all the process and risks of fertility
preservation. In the case of research, patients should be fully informed about the
unknown and uncertainty that goes along with cryopreservation. This should include
maximum storage time and any data on efficiency and safety of the process.67 A major
part of clarity that should be discussion before procedures take place is the ownership of
the cryopreserved material. Patients who are consenting for fertility preservation do with
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the understanding that it is their gametes and only that patient has the authority to access
it in the future.
B.

Truth-telling
Hope and truth-telling have an interesting relationship. One would assume that

by telling the truth, hope would be encouraged. However, this is not always the case.
There is concern that truth-telling can either promote or destroy hope depending on what
information is being shared or withheld. Truth generally concerns being factual about
prognosis, treatments, benefits, risks, side effects, or longevity all attached to the health
care issue being addressed. As healthcare professionals are sharing this information, they
are editing and subjectively deciding what is relevant and adequate to share with the
patient.68 There is so much medical information to know and not enough time to explain
everything to every patient. That is why it takes healthcare professionals such a long time
to earn their degree and become licensed to practice medicine. So how do healthcare
professionals determine what truth to share with a patient and by extension their family
and friends? Many question if is there is an ethical obligation to tell the truth or it is
better to exercise professional judgment in order to have the best chance for a positive
outcome?69 There are several examples of how truth either promotes or destroys hope.70
And finally, how should the patient-healthcare professional relationship be approached to
encourage hope, when there is an assumption of truth-telling by the patient, but not
necessarily by the healthcare professional?
1.

Ethical Obligation
So do healthcare professionals have an71 ethical obligation to tell the truth? Some

would argue that no, healthcare professional do not have a moral obligation to the truth
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based on the four principles by Beauchamp and Childress. By looking at differing
approaches to healthcare, one may reach different conclusions. The question about truthtelling focuses on delivery negative news72 and sometimes delivery negative news is hard
for the healthcare professional to give, rather than the patient to hear. Some would
describe this type of behavior as paternalist towards patients who have the right to direct
their own care.
In order to respect patient autonomy and in turn participate in informed consent,
healthcare professionals must disclose all relevant and adequate information for patients
to make a fully informed choice.73,74 Only in rare cases can a healthcare professional
claim therapeutic privilege, therapeutic use of placebos, or withholding information from
research subjects.75 In these situations, all of which are research based, revealing
information may affect the outcome of the research and it generally communicated up
front during the informed consent process. By considering principles of beneficence and
nonmaleficence, there may be times where not telling the truth is justifiable. There are
some who argue that there are times where it is more beneficial to the patient to not
disclose every piece of truth regarding the diagnosis and prognosis. This is generally
discussed when serious or even fatal prognosis are discussed.76,77 There is the fear, that
by communicated negative information, patient may not have any hope for their future
and in turn refuse any and all treatment. Instead, by withholding information, patients
have a better outlook and potentially a better chance for recovery.
In the ethics of care approach to healthcare is the emphasis on the patienthealthcare professional relationship.78 Originally developed as a feminist approach,
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ethics of care holds to the belief in caring for others and emphasizes the importance of
interdependency and empathy.79
Ethics of care recognizes the vulnerability and dependency that healthcare creates
between patient and healthcare professional.80 Because of this relationship, the patient is
trust the healthcare professional to act in a caring way and the healthcare professional
must act with compassion. Because of that compassion, there are times when not telling
the truth may be acceptable. The key is getting to know the values and preferences of the
patient including whether or not they would feel comfortable with withholding
information.81 There is concern thought that not telling the truth can damage the patienthealthcare professional relationship82 and so not telling the truth should never be the
standard, but rather the exception.
2.

Promoting or Destroying Hope
In many cases, physicians do not feel comfortable taking hope away from patients

and by telling the truth, they run the risk of that happening.83 They may feel that they are
destroying hope that patients have for the future. It may be too difficult to deal with the
emotional reactions from patients and by either editing the truth or withholding
information, it is easier to address patient needs and treatment. In telling the truth, hope
is destroyed and so are the therapeutic effects that are associated with it.84 However, to
justify not telling the truth or withholding information every time, give little credit to the
patient to have perspective and intelligence to their situation. Patients may even lose
hope if they discover the healthcare professional had treated them differently and justified
withholding information. And along with the loss of hope goes trust as well.85
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By focusing on promoting hope in patients, healthcare professionals are acting in
a way that focuses on patient-centered care now more than ever. The perpetual focus on
veracity demonstrates that truth-telling is no longer a suggestion or an opinion, but an
important principle to consider with equal weight as autonomy or justice. 86 Many
professional codes of ethics include truth-telling as an important part of being an ethical
professional. In the case of fertility preservation, healthcare is offering this as a way to
hope for a specific future of attempting to have children. The risks of aging or side
effects of disease can be overwhelming to a patient, but unlike delivery fatal news,
patients have an option on how to address the risk being presented to them. Healthcare
professionals are the gateway to understanding fertility preservation and knowing the risk
of infertility should encourage them to share about the options for fertility preservation.
Patients can rest their mind that even though they have a risk of infertility, they did all
they could to preserve fertility in a difficult time in their lives.
C.

Decision Making
As discussed in the previous chapter, fertility preservation is actually two separate

decisions- one is to preserve fertility and the other is to attempt to get pregnant. There
are also two distinct tracks that these decisions can do.87 In the first track are the adults
that make decisions for themselves which may or may not include a partner.88 At the
time of preservation, the patient (and their partner) decide to do fertility preservation and
what method makes the most sense for their situation. During the second decision of the
first track, they work together to determine when is best to use their preserved material
and attempt to get pregnant. In the second track, parents make decisions with the assent
from an adolescent or a child.89 90,91 For minors, the first decision to preserve fertility lies
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with the parents acting with best interest, but the second decision to attempt a successful
pregnancy is the decision when the minor becomes a legalized adult.92 It creates an
unusual dynamic by forcing the child or adolescent to make a decision in the futureeither in favor or against getting pregnant. There is a third decision that needs to be made
in both tracks, discussed prior to decision one and resolved before decision two can move
forward- what to do if the patient were to pass away before a pregnancy can be
attempted. Questions suddenly provoke answers for who owns the preserved material
that was preserved and should anything be done with it.93
There are a few difference scenarios of who owns the preserved material and what
that means for the family and friends of the patients that are still alive. Below is a list of
potential options for the cryopreserved material that a patient can do. Ultimately, patients
are hopeful for a successful pregnancy that leads to having a child.
1. Patient uses cryopreserved material to attempt to get pregnant. May
need donor gametes for sperm or oocytes to create embryo (either
before fertility preservation or after defrost of material).
2. Patient uses cryopreserved embryos to attempt to get pregnant in
conjunction with partner.
3. Patient uses cryopreserved embryos to attempt to get pregnant without
the support of the partner.
4. Patient decides that the cryopreserved material be donated either to
someone else to attempt to get pregnant or to research.
5. Patient is discards all cryopreserved material and does not attempt to
get pregnant.
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The decision making regarding the use of the cryopreserved material is also depended on
the prognosis based on the conclusion of treatment or at the appropriate age and the
quality of the cryopreserved material. Patients who are able to have a supportive partner
willing to be involved in the process makes for the easier option, but that is not always
realistic. In some cases, partners may change their minds and no longer want to be
involved in the process of attempting to get pregnant. Unfortunately, in those cases, there
can be a custody battle for the right to use the already existing embryos.
From 2010- 2015 there was a case over the rights to embryos from a couple that
had broken up.94 The couple had created the embryos with the hope to have a child one
day after the woman completed her cancer treatments. The woman, Karla Dunston
argued that this was her only chance for a child after infertility due to cancer, and the exboyfriend, Jacob Szafranski was preventing her from using the embryos. Dunston’s goal
was to attempt to get pregnant and raise the child alone. The man argued that he no
longer had interest in having children with the woman and by allowing her to use the
embryos he was being forced into fatherhood and child support for which he wanted no
part of. Szafranski’s goal was to throw out the embryos so that no child would result.
The informed consent document from the cryopreservation bank signed by both parties
noted that in the case of death for one of them, the embryos would be donated and the
embryos could not be used without the consent of both parties. The informed consent
document did not qualify as a contract.95 Since there was an only oral contract, the courts
had to consider the interests of both parties. This was the Dunston’s only chance to have
a biological child which was ruled to our weigh the Szafranski’s concern for privacy.
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The courts ruled in favor of the Dunston and the judgment was affirmed on appeal in
June 2015.96
In the cases of death of a patient, access to the cryopreserved material is more
complicated. The goal in these cases is often to hope for a child that has the genetic
material of the deceased loved one. The justification is often because this is fulfilling the
deceased hope to become a parent. Below are a list of the options.
1. Patient dies and designates their partner has the right to access the
cryopreserved material in a way they deem appropriate. This could
include disposing of the material, or attempting to get pregnant.
2. Patient dies and parents or other family members have the right to
access the cryopreserved material in a way they deem appropriate.
This could include disposing of the material, or attempting to get
pregnant. The use of a sperm or oocyte donor may be needed.
3. Patient dies and designates a friend has the right to access the
cryopreserved material in a way they deem appropriate. This could
include disposing of the material, or attempting to get pregnant. The
use of a sperm or oocyte donor may be needed.
4. Patient dies and designates that the cryopreserved material be donated
either to someone else to attempt to get pregnant or to research.
5. Patient dies and designates that none of the cryopreserved material can
be used to attempt a pregnant by anyone.
In these cases, it is extremely complicated when a patient dies and their designation is not
discussed with partners, family, or friends ahead of time. There has been controversy
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over the use of the cryopreserved material after the patient passes away. This is
especially true since there have been instances where a mom applied for benefits on
behalf of a child born from her deceased husband’s sperm. These requests are often
taken on a case by case basis depending on the laws in the state.97 While attempting to
get pregnant with the deceased partners cryopreserved material is rare it does happen.
Decision making is generally transferred to whomever is designated on the form or to
whomever is next of kin. This becomes complicated if the partner was not legally
married to the deceased at time of death. Autonomy says that patients have the right to
make decisions for themselves and by handing over the cryopreserved material to the
designated person, this respects the patient’s autonomy. However, beneficence and
nonmaleficence question what is the benefit or harm for this situation. Is it acceptable to
bring a child into this world already having a deceased parent?
For parents or other family members using a deceased patient’s cryopreserved
material can be even more convoluted. Most discussions about consent from the parents
and assent from the patient are focused on the initial decision to preserve fertility and not
on the decision if the patient dies.98 The case involves patients who were minors at the
time of cryopreservation, they may not have designated a person to take over custody if
they die. One has to question as to the purpose of parents or family members attempting
to have a child from the cryopreserved material.99 Are they trying to fulfill the hope of
the deceased patient to become a parent? Or maybe their fulfilling the hope of their own
to be a grandparent, aunt, uncle, or cousin? It becomes challenging when trying to
explain to the child how they came about and who the biological parents are.
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IV.

Advantages to Fostering Hope

Ethical principles and concepts foster hope in fertility preservation. By doing so,
it give patients a sense of control over their own care, provides optimism which can effect
outcomes, and build into the survivorship approach to disease. The advantages of
fostering hope can create a better bond between the patient and the healthcare
professional. Even though the patient is making the decisions, by fostering hope, patients
feel as if they are part of the team seeking to address the healthcare needs. If a healthcare
professional rejects the patient’s wishes and crushes their hope, the relationship may
remain irretrievable broken. When fostering hope, there should always be a goal of
supporting the patient’s right to direct care, maintaining an optimistic view of the
situation, and focusing on survivorship.
A.

Right to Direct Care

The principle of autonomy says patients have the right to direct their own healthcare. 100
By encouraging patients to establish their own goals and priorities, it gives patients a
sense of control and ownership to their treatment. By fostering hope in the discussion of
fertility preservation, patients can exert their autonomous wishes, but be managed by the
trust-worthiness of an honest physician. It demonstrates respect for the patient
throughout the entire process.101 Healthcare professionals may disagree with the patient,
and there are free to do so, but need to communicate with the patient about the
disagreement. The patient-healthcare professional relationship can only function with
respect, trust, and honesty that has mutual understanding and good communication.102
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1.

Meaning of Directing One’s Own Care
To direct one’s own care, means to take charge in making decisions for one’s own

life. It gives authority to the patient, provided they are capable and competent. To have
the right to direct one’s own care is based in autonomy. This means that final say goes to
the patient and the healthcare professional needs to support that decision (provided it is a
reasonable request).103 As discussed before, this can be a positive or a negative right.
The positive right is to seek out treatment, while the negative right is the refusal of
treatment. In the case of hope in fertility preservation, directing one’s own care means
allowing the patient to determine what is best. Patient has to determine if having a child
in the future is something that the patient may desire. The hope is that in the end, the
patient can attempt to have a child. Patients may also choose not to pursue fertility
preservation because they do not hope for children. Their focus may be solely on
overcoming and illness and wants to have the most aggressive treatment available.
2.

Establishing Goals and Priorities
When patients choose to exercise their right to direct their own care, establishing

goals and priorities can make the process more manageable. This must be done once the
patient knows what options are available as standard of care or research.104 For those
who are delaying having children, there should be a consideration as to the why and how
this choice has been made. Fertility decreases as age increases, and spontaneous
pregnancy can be difficult. For those who are facing an illness like cancer or lupus, there
should be consideration for what is important moving forward. This is an evaluation in
the importance of quality of life for the patient.
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Quality of life for the patient is also a matter of making a judgment call. A patient’s
values, preferences or beliefs about what constitutes as a better quality of life over
another is personal and provided it does not harm someone else, should be open for
discussion with the healthcare professional. Today, medical technology is made
available around the world. There are machines and procedures for everything
imaginable. The idea originally behind most, if not all, is to prevent death, but with the
creation of reproductive technology, life can be created. Fertility preservation ultimate
success is the live birth of a healthy baby. Since hope is defined as the ability to imagine
a future outcome that is realistic and possible, quality of life is part of that imagination
process. Patients may believe that the quality of their life will be diminished if they are
unable to have a child in the future.105 A patient determines what is important and
imagines how he or she wants to life live.
Healthcare professionals have a responsibility to ensure that the goals and
priorities are realistic. There are patients who may hope for a child, but knows that based
on their current prognosis, that their quality of life is not suitable for that child. This still
reflects the patient’s right to direct their own care, specifically refusing to preserve
fertility. Others may want to delay treatment in order to have to do in vitro fertilization
right away. In those cases, patients may not understand the severe risk of postponing
treatments.106 In some cases, a pregnancy can actually feed a cancer because it contains
estrogen loving cells.
3.

Hope in the Process
Once a patient chooses to pursue fertility preservation, their hope shifts from one

part of the process to another. Hope goes from being general- hoping to survive or
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hoping to have a child in the future to something more specific. They hope that the
medication works, the retrieval of oocytes or sperm is easy, and the freezing process goes
smoothly. Once, the cryopreservation process is complete, hope shifts from the worry
about undergoing fertility preservation to the treatment of disease. After the treatment is
complete hope shifts again to hoping that are not infertile or to hoping that the disease
does not return. Healthcare need to foster hope in each and every stage of the process.
There are trends that show fostering hope may help with a better outlook on life and in a
patient’s evaluation for their own quality of life.107
B.

Optimism
Optimism is a positive response to a situation either negative or positive. For

instance, someone may apply for a job, but get turned down. While one would assume, a
pessimistic response, the person may response optimistically because they did not want
the job in the first place. Optimism in the face of hard circumstances has demonstrated a
positive outcome in healthcare. Many have attempted to study and quantify optimism in
the face of challenging diagnosis and prognosis.108,109,110,111 Hope and optimism are not
the same although the terms have been used interchangeable. Hope is a belief in a future
outcome that is both possible and realistic. Hope looks forward but is affected by
outward variable. Optimism looks both forward and back based on inward criteria.112
1.

Optimism as a Response
When someone responds positively to a give situation, the response is called

optimism. Determining whether someone is positive or optimistic can be subjective.
Studies have tried to qualify optimism in light of healthcare. The look at factors of
psychology, emotions, confidence, projection of goals, feelings satisfaction, stress, anger,
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hurt, mistrust, distress, and hope.113 These types of studies look for correlation between
satisfaction of the physician or nurse and optimism, the interpersonal perception and
optimism or even the emotional distress level and optimism.
2.

Links to Positivity
There are some who believe that being optimistic more closely relate to having

positive disposition114 as opposed to a response from a positive outcome. This means
that the person is naturally optimistic or positive as part of who they are instead of it
being conscience choice. This positive or optimistic disposition may help patients who
are trying to cope with the current healthcare crisis. In fertility preservation, an optimist
outlook may not mean that more oocytes are harvest when it comes times for ovarian
hyperstimulation, but it may mean that the patient is better able to cope if there is only a
few oocytes collected. While hope for a child may diminish in knowing there are fewer
oocytes than expected, the optimistic patient knows that all it takes is one oocyte to get
pregnant. In the study done by Lancastle and Boivin, research showed “dispositional
optimism was significantly related to several aspects of reproductive health, which
together indicated a more favorable biological response to fertility treatment.”115 One of
the interesting finds from the study showed that those were optimistic tended to act in
ways, lack of smoking or increases sexual intercourse that promoted better health and
increased reproductive success.116
3.

Risks with Optimism
For those who are optimist, there are some risks that can come about as well. For

instance, those who are demonstrating optimist solely as a response to something
positive, may have hope for a positive outcome. However, if a negative event happens,
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there is the risk of losing hope in the future. Changing in emotional states are difficult to
predict. For healthcare professionals who are looking to improve hope or optimism,
caution should be taken in the methods being used. As discussed before, withholding
information will initially may increase hope or optimism in the current situation, it does
not guarantee long term success. If a patient were to discover they were being
manipulated and lied to, all trust could be broken and emotional or psychological harm
may come to the patient.117
C.

Survivorship
Survivorship is a strategy when dealing with cancer in ways to find support,

information, and community in order to deal with diagnosis, live with cancer, and thrive
after cancer. This terminology is growing in popularity due to the increased survival
rates. With nearly 14 million people living with cancer as of 2016, cancer affects even
more people than that number.118 Survivorship is meant to be a strategy of support for
the patient. Some studies have approach the cancer discussion not just regarding the
diagnosis and treatment decisions, but with an approach that guides the patient into
addressing long-term survival including present and future goals.119,120,121 Advancements
in medicine allow patients to think beyond the immediate diagnosis and hope for a
realistic and possible future. Once the long-term goals are established steps, such as
fertility preservation, are taken to ensure that everything possible is done prior to
treatment to protect those long-term goals in the future. There is no guarantee of these
goals, but patients cling to the notion of hope that they are realistic and possible in the
future.
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There are various challenges that cancer survivors face like secondary primary
malignancies, cardiotoxicity, infertility, amputation, psychiatric affects, education and
social function, and financial issues.122 Within each one of these issues are smaller issues
which are unique depending on the type of cancer and demographics of the patient. For
instance, one of the biggest challenges for the young adult demographic is fertility unlike
survivors in the fifties. Family, friends, and any support system that the survivor has in
place as well as the healthcare professionals are all affected and can gain more in site by
accessing survivorship programs. It is important to show the continued support to the
cancer survivor. Dealing with the issues after remission can be just as challenging as
fight the disease itself. Organizations like the American Society for Clinical Oncology or
the Center for Disease Control and Prevention, or the National Cancer Institute all
provide resources to all those affected by cancer. Survivorship is about looking forward
and with hope, cancer survivors can do that realistically and with possibility.
1.

Patient
According to the CDC, a cancer survivor is a “person who has been diagnosed

with cancer, from the time of diagnosis throughout his or her life.”123 This means from
the moment of diagnosis, patients are called cancer survivors. While this may seem a bit
premature, by labeling someone a survivor, it provides optimism going into a very
intense healthcare battle. Some have described adjusting to cancer as adjusting to a new
normal. Cancer has a way of completely changing someone’s life. In just looking at the
fertility issues along, cancer survivors are forced to deal with questions about parenthood,
pregnancy, infertility, sterility, research protocols- all before even starting the actual
treatment of cancer. Many young adults (or even adolescents) want to have children.
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While it may not have been a verbal confirmation, when imaging the future, having a
family is part of that picture. Being told that not only is cancer in your body, but in
trying to treat cancer, a cancer survivor may no longer be fertile, can be devastating to the
life that was imagined. With the advances in medicine, fertility preservation has bridge
the gap between wanting children and attempting to have children after cancer.
Survivorship can provide resources to access oncofertility programs and resources to
support groups for dealing with infertility. It can even provide questions and suggestions
of ideas of what you ask the healthcare professional during the appointment.
2.

Caregivers
Family and friends of cancer survivors are known as caregivers. They can be

formal caregivers who are trained to provide health care or they can be informal
caregivers who provide care out of love and respect for the cancer survivor.124
Caregivers may provide aid in the hospital, at home, daily or periodically. They see to
the physical, emotional, and mental well-being of cancer survivors. For cancer survivors
dealing with fertility issues, they may be healthcare experts who know the medical
information or they could be a support system that drives and attends doctor’s
appointments.
3.

Healthcare Professionals
There are also healthcare professionals that are involved in survivorship. The

idea is a way to better coordinate healthcare for the cancer survivor. Healthcare
professionals who deal with cancer survivors, need to maintain education on the
increasing changes in survivorship and how best to approach their patients. This means
having access to resources and good clinical data. Cancer survivors are at great risk for
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many issues including unhealthy lifestyle behaviors, underlying genetic issues,
underlying risk factors that contributed to the initial cancer diagnosis, and even
developing a secondary cancer.125 Healthcare professional needs to be aware of the signs
and symptoms for these. It is important for the healthcare professional to be aware of the
signs of mental health changes as well. Cancer is a disease that can completely change a
person’s perspective and so it is important to be aware of changes.
4.

Impact of Survivorship on Fertility Preservation
Survivorship plays a bigger role once the cancer treatment is complete. Fertility

preservation is done before treatment. While these two things may seem at odds
regarding their timing, there is still important things that survivorship covers, especially
once the cancer survivor is ready to attempt to get pregnant. As discussed before, fertility
preservation is two separate decisions. The first is the decision to cryopreservation
material, and the second is attempting to get pregnant. Survivorship can help to address
the first decision at initial diagnosis and the second decision when in remission. For
women, chemotherapy can send women into early menopause which can complicate the
attempt to get spontaneously pregnant after remission.126 The ideal situation is for a
cancer survivor to seek a reproductive specialist as early as possible.
5.

Impact of Survivorship on Hope
Survivorship is a manifestation of the hope that cancer survivor has. It is a way

for the cancer survivor to live life, with support. Survivorship provides cancer survivors
with realistic and possible options. As cancer survivors, caregivers, and healthcare
professionals work together, they form a cancer survivorship plan. It is a strategy on how
to approach life. It can include what concerns that are greatest for the patient, and what
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signs and symptoms the caregiver needs to be most concerned with. Creating a
survivorship plan is the process of verbally identifying and physically writing down what
the patient hope is possible in the future. It voices concerns in a manageable, even
optimist way.
V.

Disadvantages to Hope in Fertility Preservation

While there are advantages to fostering hope in fertility preservation, there are
also disadvantages. These disadvantages can affect how patients approach healthcare,
how they interact with their healthcare professionals, how they think about their disease
and treatment, and how they reason through their options for fertility preservation. There
is only one chance to make a decision regarding fertility preservation. Patients either
choose to preserve fertility before they age or before they start treatment for disease. If
they do not preserve fertility, they may lose the opportunity. Since time is critical,
healthcare professionals and patients need to do their due diligence in order to make a
decision regarding fertility preservation. When fostering hope in fertility preservation
that patients are at risk for disadvantages like inaccurately projecting the future of
research, including false expectations and the inability to manage the involvement of
partners and/or parents. The future of research is hard to predict. It is difficult enough to
predict the risks and benefits of treatment and the severity of side effects. Fertility
preservation has standard of care procedures that are effective for adults, but there is
always room for better methods. Trying to pinpoint when something will become
standard of care can be complicated. False expectations can lead patients to be
disappointed. Most patients are not well versed in the purpose of research. They may
expect research to provide a cure or improvement. There is also the risk of the return of
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disease. Cancer provides a risk or recurrence and that may affect the fertility
preservation. It may mean being unable to use the cryopreserved material because there
is the risk the cells contain cancer or having to delay attempting to get pregnant because
treatment needs to take place. There is also a concern that patients will put too much
hope in futile treatments. When patients fail to be realistic in their expectations, they
may struggle to comprehend why treatments are futile.
A.

Projection of Research
Science, health care, and research is constantly changing, adjusting, and

improving. It takes time to conduct research which in turn improves health care.
Unfortunately, the ideas and imaginations in science work faster than the actual research
study. It is difficult to predict where science will be in the distant future. However, that
is also part of the greatness of science. At any given time, a new break through is
possible. It can completely change the landscape of science and medicine. As discussed
earlier, different aspects of hope which includes imagination and uncertainty.127 Those
are foundational to the concepts of science and medicine. While those conducting
research work meticulously to get everything precise and consistent, imagination and
solid scientific work is what drives research.
Uncertainty as to how and why things do what they do is part of the nature of
researchers. They seek and hope to discover something new, improve the status quo.
Patients put their hope into science and research for a treatment or therapy to address
their diagnosis. Hope is fostered in fertility preservation because, at its core, the options
in fertility preservation are not a guarantee for a child. Not everyone is eligible for the
standard protocol of oocyte, embryo, or sperm cryopreservation.128,129 Instead, patients
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participate in these research protocols hoping that when the time comes, they can
overcome their infertility because of the research they participated in and knowledge
gleaned from other studies conducted. Unfortunately, time and science do not always
line up. So while hope is important to foster, it must remained realistic and possible,
otherwise patient can lose sight of the current state of medicine.130
One example of the unpredictable nature of fertility preservation is the process of
moving oocyte cryopreservation from research to standard of care. As discussed earlier,
sperm cryopreservation was as early as the 1950s. By the 1980s, embryo
cryopreservation was around. However, it was not until 2013, that oocyte
cryopreservation became standard of care.
1.

Predicting the Future of Research
So the question becomes how accurate is the prediction when it comes to

research? Can science, health care, and research know exactly what the standard of care
will be available in five years? Maybe, the standard of care could be related to studies
that have been in process for years. Can researchers know what the major diseases will
be in ten years? It is always possible to make educated guesses that comes true, but more
than likely, it will not be accurate. It is possible that healthcare professional know
exactly what time of treatments will be most effective in twenty years? The answer is not
surprising. No one knows. Whether it is five, ten, or twenty years, there are too many
variables that affect the success of research. It depends on the current science, the
financial support, enrolling participants, getting government approval, creativity of the
researcher, and potential risks that are discovered. It depends on the location of the
patient, access to teaching hospitals and research institutions, and the knowledge of the
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healthcare professional. It depends on the changes in disease and priorities of the
researchers.
All healthcare professionals are expected to keep current on their expertise. They
need to continue their education and improve their skill sets. This means reading
journals, attending conferences, and meeting with others in their field. This is not just a
task of enjoyment, but one that is required in order to stay licensed and insured.
Healthcare professionals are trusted by patients to be truthful and honest about the best
way to treat a disease. For fertility preservation, patients trust that their reproductive
specialist recommends what is best based on the patient’s medical history, diagnosis,
prognosis, treatment, and other factors like age. They assume that healthcare
professionals are not recommending outdated or irrelevant cryopreservation techniques.
If the healthcare professional would violate that trust, healthcare professional is putting
his or her entire career in jeopardy.
2.

Imagination of the Patient
Another issue in predicting research is the imagination of a patient. Earlier,

imagination as one of the most important components of hope was discussed.
Imagination and uncertainty allow the individual to look forward beyond the time of
illness or disease. It allows for the creation of a future.131 It builds into the desires,
wants, goals and values of that individual as well. As said earlier, imagination is a
powerful motivator in fostering hope. Imagination pushes the boundaries of what is
possible.132 However, patients do not always imagine based on risk-benefit assessment,
statistics, professional experience, or research data. They imagine based on personal
experience of the past and goals for the future. Patients are not solely embedded in the

199

world of medicine. They may not understand the difference between research and
standard of care, and they may never care to understand. In their imagination any
medical treatment that is being offered is good enough. Anything that provides
improvement is worth a chance.
Capp writes that hope and its connection to the imagination allows for a wider
perspective than the present situation.133 However, in the case of medicine this wider
perspective can be troubling. Not all information available is good or helpful. While the
internet is a powerful tool that is able to bring information into the homes of millions of
people that previously would have never had access to it, it is also a place that has false
and misleading information. There is no standard of what can be posted on the internet
and very fake information can look and sound very legitimate. Healthcare professionals
have their hands full trying to address every imaginative and discovered treatment that
comes into their office. The best thing that healthcare professionals can do it education
people on where to go for good scientific information. Providing resource
recommendations can help turn the disadvantage of imagination into an advantage.
3.

Example: Delay in Oocyte Cryopreservation
One example is the delay in oocyte cryopreservation to change from research to

oocyte cryopreservation. In 2013, the American Society for Reproductive Medicine
(ASRM) published their guidelines on oocyte cryopreservation based on the evaluation of
the numerous studies that were conducted over the last few decades. The ASRM noted
that mature oocyte cryopreservation success rates (meaning oocyte survival, fertilization
success, and pregnancy success) was very low until 2011.134 Many of the techniques that
were used to cryopreserve sperm and embryos were not successful or effective on
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oocytes. By thinking outside of the normal cryopreservation protocols, researchers were
able to find success through new methods. The development of vitrification aided the
success in oocyte cryopreservation. It has been shown to be effective for women who are
facing both age-related decline in fertility and those facing infertility due to cancer
treatments.135,136 This technology allowed numerous studies to be conducted to prove the
safety and efficacy of mature oocyte cryopreservation.
The approval of oocyte cryopreservation as standard of care did not remove all
the concerns about the process. There is the question of the financial cost. Since this is
no longer research, women have to pay for the procedure and storage fees. Research is
no longer going to fund basic oocyte cryopreservation. Instead research is going to
investigate new ways to cryopreserve oocytes.137 These new research protocols, while
possibly making great strides, now have to consider it if is worth it for patients to enroll
in these research studies, when mature oocyte cryopreservation is available. For
example, there are studies which are investigating the difference in cryopreserving
immature or mature oocytes. The goal is that by cryopreserving immature oocytes, they
can be matured at a later date when ready to be fertilized. By retrieving immature
oocytes, hyperstimulation of ovaries would no longer be necessary. This would remove
almost two weeks of hormones, blood tests, and ultrasounds. It could allow women to
only delay treatment as long as it would take to schedule the retrieval procedure.
B.

False Expectations
Another disadvantage of fostering hope in fertility preservation is false

expectations by patients and families. There are many who do not understand the
purpose of research and how participation in research is not the same as treatment to cure.
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In addition, patients may not understand the time delay in both preserving fertility and
attempting to get pregnant. It is not an overnight process by any means. While
preserving fertility is done as soon as possible because the patient needs to start
treatment, attempting to get pregnant after treatment has a greater delay. There are many
serious medical issues to consider before attempting to get pregnant.
1.

Understanding the Purpose of Research
Research in medicine is crucial to the development of science. Research seeks to

gain information in order to add to the body of knowledge with the hope in helping
patients either in the present or future. Research has grown into an industry of its own
over the years. Some go into the practice of medicine today to only conduct research for
their entire careers. Because of the prominent level that research has reached, concern
over the operation of research and the need for regulation followed. Most of these
regulations were developed in response to some form of abuse or harm. Today within the
field of bioethics, research ethics has developed into its own discipline.138 Research is
heavily regulated by the Institutional Review Board at the given institution as an
impartial evaluator on everything from the science, to the protocol, to the language,
recruiting methods, to compensation to government regulation. The FDA and NIH have
their own sets of regulations that must be met in order to maximize benefit and minimize
risk. Research involving human subjects get an extra level of concern to avoid additional
harms. Because of such high concern over research, there are many publications about
the considerations that need to be taken in research. Below is a few of the considerations.
Evidence-based medicine has derived out of the concept of research. In order to practice
and give the best medical recommendations, it is vital that there is evidence to back up
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medical claims. This stems out of the data that is collected by research either during a
protocol or in a review of the current standard protocols. Research participation is
heavily monitored to ensure safety of the participants. This includes discussions
regarding voluntariness, informed consent, and capacity. There are also additional issues
to consider in research that include regulations in that specific country where the research
is being conducted.
a.

Evidence-based medicine
In clinical medicine, clinicians are expected to use the best evidence available for

patient care. This concept of evidence-based medicine is a rigorous way to examine all
of the available research for a given set of parameters in order to ensure the best possible
outcome for the patient. Evidence-based medicine is constantly evolving and changing,
but the most important part should remain the same - it is patient-centered.139 Research
protocols that are done effectively add to this body of knowledge and the practice of
evidence-based medicine. Unfortunately, since medicine is an ever changing field,
evidence-based medicine is constantly in a state of flux. Therefore, evidence-based
medicine may determine one option is the best practice today, but tomorrow another
study may prove another option better. It is important to keep pushing forward with
evidence-based medicine in order to best serve the patient. One of the important parts of
evidence-based medicine is that there are personal considerations to make that include
patient’s values, goals, beliefs, hopes in addition to the tradition concepts of benefits,
risks, and financial considerations.140
One of the issues with evidence-based medicine today is how to incorporate that
model into the move towards personalized medicine. Evidence-based medicine is based
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on large populations, evaluation of statistics, the search for trends and repetition of
results. Personalized medicine will mean a smaller pool of participants, which affects the
ability to evaluate the statistics and search for trends. It may take years before repetition
of results forms any good evidence-based conclusions. It may be important to start
looking for new and innovative ways to evaluation medical research in a way that both
adds to the body of knowledge and builds into need to help patients.
b.

Research participation
When a subject enrolls in research, there a few important things to consider. First

is the concept of voluntariness. Participants must join the protocol willingly and free
from exploitation, coercion, or manipulation. This must be carefully monitored not just
by the researcher, but also by the Institutional Review Board. Second, is informed
consent. Participants need to be given all available information in order to make an
educated decision. Third is the concept of capacity. Patients need to be able to
comprehend the benefits and risks of research. They need to understand the difference
between standard protocols and research protocols. It is important for participants to
grasp that while research provides hope, it does not necessarily provide a cure.
In order to better protect those who are having to consider fertility preservation, it
is important that they meet with an expert in this area. Getting recommendations from
the oncologist or specialist is not enough. The patient needs to meet with a reproductive
specialist. However, the current rates for this are discouraging. Ten years ago in 2006, it
was reported that less than 50% of patients are referred to a reproductive specialist by
their oncologist.141 In general, the main purpose of research is to produce knowledge that
is available for anyone that can aid patients.142 However between the two concepts of not
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referring patients to specialists and simply being a means the end of general knowledge,
somehow patients can get lost. They end up being labeled as vulnerable in the research
world. Children especially can fill this category because the lack decision-making
capacity. It is important the oncologist refer their patients to specialists for a closer
examination of fertility preservation research protocols, because there is the possibility of
gaining enough knowledge the help that current patient, but also, protect them from being
exploited or harmed. Patients should still meet required criteria to enroll in study, but
also approach the research protocol with capacity, voluntariness, and fairness to ensure
protection.143 According to the 'Common Rule' in the US, vulnerable groups include
children and pregnant women. While in fertility preservation children definitely meet
this description, the adult patients are not vulnerable because of the fertility status. They
can be identified as vulnerable because there is the risk of economic disadvantage or
participation without personal benefit, or who cannot protect their own interest.144
2.

Future Cancer Concerns
There is also the concern of the impact of the disease either for a relapse or risk of

transmission. Cancer patients always have a concern about the possibility of relapse.
There is no formula for predicting relapse of a disease. However, studies continually do
not show any cause effect relationship between pregnancy and cancer relapse.145
There is a concern that in the fertility preservation process, the cells that are being
cryopreserved may contain cancer.146,147 The fear is that after a patient has entered
remission and in cases such as the transplantation of ovarian or testicular tissue, there is
also the chance for reintroduction of cancer cells in the body. Some physicians may be
more or less uncomfortable with the transplantation depending on the healthiness of the
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cryopreserved cells and the length of time the patient has been in remission from the
disease.
Another concern is the risk of transmission to future children. There is such a big
push today for the knowledge of genetic diseases. Cancers such as breast, nonpolyposis
colorectal, and ovarian amongst others are autosomal dominant, causing further concern.
While hereditary cancers are only about 5% of all cancers, when the risk of transmission
deals with a specific patient and their future child, the concern is suddenly a very real
issue for that patient.148,149,150 Techniques such as preimplantation genetic diagnosis
(PGD) can be used to screen embryos for these genetically inherited cancers, but do not
guarantee that the child will never get cancer in their lifetime. PGD testing always has a
series of ethical issues that are discussed. This can included, but are not limited to the
morality of screening embryos for specific traits, moral status of the embryos, and the
autonomous right of the parents to choose. Additional concerns of birth defects for the
future children have proven to be unfounded.151 Studies show that the rate of birth defects
is the same for parents who have had cancer and those who have not.152,153 Most
importantly, it is important to have moral support in making these difficult
decisions.154,155 Getting this support allows the patient to talk through their options and
concerns while getting input as to their mindset and thinking processes.
Patients with cancer have a right to be concerned about the cancer returning.
While the rates and data are available for those who disease reoccurs, there is not perfect
predictor as to which patient faces this. The more time passes, the better the chances of
no recurrence. The greatest chance of recurrence is in the first 1-2 years, but after five
years the recurrence drops 4% with every year.156 There is no guarantee that a disease
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will or will not recur. However, one cannot live in fear of that recurrence. The hopes
that fertility preservation fosters can aid in overcoming that fear and looking at the
possible positive outcomes.
Future cancer concerns also balance the delicate relationship between the
personal autonomy of the patient and the professional autonomy of the physician. Most
commonly the recommendation is to delay pregnancy for one to two years to avoid
recurrence.157 There is the risk that the patient will simply ignore the physician and go
to another seeking someone who is willing to perform the fertility treatment they are
asking for. Physicians need to be aware of this possibility and do their research into the
background and history of a patient prior to conducting any treatment.
3.

Futility in Treatment/Research
The philosophical notion of futility plays an interesting dynamic when it comes to

providing care. The idea of futility is based upon the idea of uselessness. Futility can be
discussed at any point in life, but it most discussions tend to focus on the end of life.
While this definition may seem too simple, according to Eric Chwang, this is the most
effective term to describe a notion that many fail to address effectively.158 There is the
idea that if a treatment in medicine is futile it is useless, that is to say it does not have the
intended function. For example, a patient can stop responding to chemotherapy to treat
cancer. In this case, chemotherapy is a futile or useless treatment. In this example, the
patient may still have high levels of pain and that symptom still needs to be addressed. In
order to determine if something is futile, though, there must be an analysis of the balance
of autonomy, beneficence, harm, and distributive justice. This balance recognizes that
though the patient or family has the right to make their own decisions, this is only when
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the decision is determined to benefit the patient. Based upon distributive justice, it is a
waste of medical resources to provide a futile treatment to a patient.159 The futile
treatment could in turn bring a greater harm to the patient. The strength of the autonomy
of the patient is questioned because of the notion of futility of a treatment.
So for patients facing futility in their treatments, there is the question of what to
do regarding the material that was cryopreserved. If the patient is facing end of life
issues, trying to attempt to get pregnant or finding a surrogate to carry the pregnancy is
generally not at the top of the list for importance. However with false expectations, there
is a concern that patients may not understand the reality of futility. Again, healthcare
professionals have a difficult responsibility to address this issue.
C.

Involvement of Other People
Parents and partners that are involved in the decision making process of fertility

preservation of the patient bring their own biases and hope for the future into the
discussion. These biases introduce additional issues, they cannot be eliminated. Most
survivorship discussions emphasize that support for patients in the form of family.160,161
Partners may have their own expectations for having children, and these expectations
may clash with the patients' expectations. Parents of children and adolescent patients
also have their own expectations regarding grandchildren and that may cloud their ability
to make the best decisions for the patient.162 Because of these biases, it creates an
additional consideration to manage hope in fertility preservation.
1.

Multiple Stakeholders

In the case of fertility preservation, there are many participants in the discussion and
many feel that they are stakeholders in the case at hand. They can include the patient,
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parents, spouse or partner, physician, and/ or researcher. There can also be conflicting
views as to what should be done between the stakeholders.163 These opinions and views
come back to the fundamental concept of decision-making process. While each
stakeholder may believe that they have a valid view point, the patient should have the
final decision-making power. It goes back to the ethical principle of autonomy. Each
stakeholder does play an important part.
Patient: The patient holds the most important role. It is their diagnosis that
brings about the entire discussion. If the patient is an adult, then assuming
they have decision-making capacity (which is always presumed) then they
have the autonomous right to make decision about fertility preservation
and treatment.
Parents: Parents play a part in this as family members. If the patient is a
minor, then the parent have the legal right to give consent, while the
patient give assent. In adult patients, parents are sometimes included for
moral support.
Spouse/ Partner: A spouse or partner also plays a supportive role for the
patient. This could also mean providing either sperm or eggs to aid in the
fertility preservation process. This means that they would have to give
consent and have decision-making authority over their own involvement.
Physician: The physician is the person who is the gateway to all the
medical expertise available. They are to lay out all of the options and
provide recommendations for treatment and referrals to other specialists.
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Researcher: The researcher is trying to enroll patients into their study.
They accept or reject a patient based on an IRB approved protocol. They
can also be a source for medical information.
Each of these participants play a unique role in the diagnosis. However, it all centers on
the patient. Respecting autonomy and the decision-making capacity of the patient should
be of utmost priority of everyone involved. There may also be barriers effective
communication because all of the stakeholders come from a different mindset and may
not understand the others' point of view.164 It is important to continue discussions even
when it becomes difficult.
2.

Forms of Influence
Those who are involved with the patient may have undue influence over that

patient. The patient is already in tough spot if they are considering fertility preservation.
Many times when patients are making decisions that need to talk it through and receive
input from those that care about them. Partners and parents are most often the two types
of support system for those who are considering fertility preservation. Partners not only
can contribute a verbal opinion, but can contribute a gamete to create an embryo for
cryopreservation. Because minors do not have the right to make decisions for
themselves, parents are the ones who are making the final decision and consent for the
procedure. The issue with dealing with partners or parents is the risk of undue influence
over the patient and it could result in the patient making a decision they neither wanted
nor hoped to be a part of.
There are different types of forms of influence. Beauchamp and Childress
identify the following three: persuasion, manipulation, and coercion.165 No matter what it
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is called any undue influence over a patient is inappropriate and unethical. As discussed
earlier, patients have the right to determine their own care. While most of the
conversation regarding respecting autonomy tends to focus on the healthcare
professional. This is also true for the partner and parents of the patient. Ultimately, the
decision belongs to the patient (or at least the assent of the minor patient). Partners and
parents can provide opinions and recommendations. They can even participate in the
imagination of the future. They can encourage the patient to consider all their options.
They can speak about their experiences and concerns. However, no one should ever
force a patient to do fertility preservation and no one should ever force a patient to refuse
fertility preservation. This decision must be left to the patient. If a patient is not making
their own decisions that can directly affect how and why the hope in something. Instead
of focusing on a future outcome that is realistic and possible, the patient may actually
dread the future outcome because it was not necessarily what the patient truly wanted to
do.
3.

Paternalism
Paternalism becomes a major concern in bioethics literature when there is a call

to protect or help a group especially one that is labeled vulnerable. Michael Kottow
addresses paternalism by stating that it “is only acceptable in those cases when an
authorized agent makes decisions in the name and to the benefit of disautonomous
beings."166 An authorized agent would be a surrogate that has been officially
recognized whether it was appointed by the individual or by the courts.
Paternalism is divided into three major categories – hard paternalism, soft
paternalism and maternalism.167 Hard paternalism is direct coercion. This gives not
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consideration to the individual autonomy. It is difficult if not impossible to justify hard
paternalism in any case when the individual has full capacity and autonomy. For
example, forcing an adult to undergo fertility preservation is a form of hard
paternalism. The agent may see the end result as the individual is able to have a child.
However, it is not justifiable to the procedure; this is not just paternalism but assault.
Soft paternalism is providing unwanted information and avoiding other information in
order to achieve a desired outcome. This is a manipulation of the individual. An
example would be telling a person that they can only use one chemotherapy drug for his
cancer and it will cause permanent sterility so he must cryopreserve his sperm
immediately. Maternalism controls the individual with a guilty conscious. Telling a
woman that she is a selfish because she does not want to have children and to undergo
fertility preservation is to be less selfish is an example of maternalism. Though these
examples are obvious, it is not always as easy to identify or agree upon as a society.
The issues here are those considering fertility preservation are not
disautonomous. These individuals most often have full capacity and full autonomous
rights.168 Paternalism undermines patient autonomy,169 and ignores the elements of
informed consent. Those who are vulnerable need to be protected, but what needs to be
protected is their autonomy. Protecting the vulnerable does not mean stepping in to
make decisions for then, but rather reinforcing equality and preventing harm or danger
to come upon them. Paternalism is often seen as an active process; agents take action
in order to do what they believe is best. However in protecting the vulnerable it is
usually about not inflicting harm or removing the harm or exploitation.
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VI.

Conclusion

By better understanding the ethical principles and concepts at play, fertility
preservation can better be managed through the employment of the discussion of hope.
Autonomy, beneficence, nonmaleficence, and justice all build into the discussion of hope
in fertility preservation. It gives patients the authority to make their choices known. It
allows them to imagine many options and weigh the benefits and risks. Ethical practices
such as informed consent, truth-telling, and decision making when done well, reinforce
the patient’s hope in fertility preservation.
However, it is important to consider what the advantages and disadvantages of
hope in fertility preservation mean. Advantages like right to direct care, optimism, and
survivorship build not only into the patient’s current circumstance, but also prepares the
patients for any future issue that come along. Disadvantages however make fostering
hope in fertility preservation more difficult. Healthcare professionals may have to
address the disadvantages because it could affect the entire plan for how to address
disease or age-related fertility decline.
By considering all these points, it is still important to foster hope in fertility
preservation. It encourages the patient to think about their future, one that is based in
reality and possibility.

1

Jennifer Beste. "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting
Duties." Bioethics (Blackwell Publishing Ltd.) 19, no. 3 (2005): 221.
2
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
221.
3
Karey Harwood. "Egg Freezing: A Breakthrough for Reproductive Autonomy." Bioethics 23, no. 1
(2009): 39-46.
4
Practice Committees of American Society for Reproductive Medicine and Society for Assisted
Reproductive Technology. "Mature oocyte cryopreservation: a guideline." Fertility and Sterility
99, no. 1 (2013): 37-43.

213

5

Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
221.
6
United States Conference of Catholic Bishops. "Directive 38." In Ethical and Religious Directives for
Catholic Health Care Services, (Washington, D.C.: United States Conference of Catholic Bishops,
2007), 22.
7
Gregory Dolin, et al. "Medical Hope, Legal Pitfalls: Potential Legal Issues in the Emerging Field of
Oncofertility." Santa Clara Law Review 49, no. 3 (2009): 688-389.
8
Kathleen M. Galvin and Marla L. Clayman. "Whose future is it? Ethical family decision making about
daughters’ treatment in the oncofertility context." Cancer treatment and research 156 (2010): 431.
9
Gwendolyn P. Quinn, et al. "Preserving the Right to the Future Child: An Ethical Case Anaylsis." The
American Journal of Bioethics 12, no. 6 (June 2012): 39.
10
Tom L. Beauchamp and James F. Childress. Principles of Biomedical Ethics. Sixth Edition. (New York:
Oxford University Press, 2009.): 138.
11
Michael Weintraub, et al. "Should Ovarian Cryopreservation be Offered to Girls with Cancer." Pediatric
Blood Cancer 48 (2007): 7.
12
Joel Feinberg. "The Child's Right to an Open Future." In Whose Child? Children's Rights, Parental
Authority, and State Power, edited by William Aiken and Hugh LaFollette. Totowa, (NJ: Rowman
& Littlefield, 1980).
13
Claudia Mills. "The child's right to an open future?" Journal of Social Philosophy 34, no. 4 (2003): 499.
14
Mills, "The child's right to an open future?," 505-506.
15
Mills, "The child's right to an open future?," 507-508.
16
Weintraub, et al., "Should Ovarian Cryopreservation be Offered to Girls with Cancer," 7.
17
Galvin and Clayman, "Whose future is it? Ethical family decision making about daughters’ treatment in
the oncofertility context," 437-438.
18
Gwendolyn P. Quinn, et al. "Preserving the Right to the Future Child: An Ethical Case Anaylsis." The
American Journal of Bioethics 12, no. 6 (June 2012): 38-39.
19
Gwendolyn P. Quinn, et al. "Preserving the Right to the Future Child: An Ethical Case Anaylsis." The
American Journal of Bioethics 12, no. 6 (June 2012): 39.
20
Stegman, "Unique ethical and legal implications of fertility preservation research in the pediatric
population," 1037-1039.
21
Antonella Surbone. "Truth-telling, Risk, and Hope." Annals of New York Academy of Sciences 809, no. 1
(1997): 72-79.
22
M. Hickey, et al. "Breast Cancer in Young Women and Its Impact on Reproductive Function." Human
Reproduction Update 15, no. 3 (2009): 324.
23
Tom L. Beauchamp, "The Belmont Report." In The Oxford Textbook of Clinical Research Ethics, edited
by Ezekiel J. Emanuel, et al. (New York: Oxord University Press, 2008): 150.
24
Beauchamp and Childress, Principles of Biomedical Ethics, 150-151.
25
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
217.
26
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
222.
27
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
223-224.
28
Pasquale Patrizio and Arthur L. Caplan. "Ethical issues surrounding fertility preservation in cancer
patients." Clinical obstetrics and gynecology 53, no. 4 (2010): 720.
29
Beauchamp and Childress, Principles of Biomedical Ethics 150-151.
30
Gwendolyn P. Quinn, et al. "Who decides? Decision making and fertility preservation in teens with
cancer: a review of the literature." Journal of Adolescent Health 49, no. 4 (2011): 338.
31
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
215.
32
Pasquale Patrizio and Arthur L. Caplan. "Ethical issues surrounding fertility preservation in cancer
patients." Clinical obstetrics and gynecology 53, no. 4 (2010): 720.
33
Jennia Michaeli, et al. "Fertility Preservation in Girls." Edited by Einat Shalom-Paz. Obstetrics and
Gynecology International, (2012): 6.
34
Beauchamp and Childress, Principles of Biomedical Ethics, 241.

214

35

Beauchamp and Childress, Principles of Biomedical Ethics, 248.
Beauchamp and Childress, Principles of Biomedical Ethics, 250.
37
Beauchamp and Childress, Principles of Biomedical Ethics, 253.
38
Beauchamp and Childress, Principles of Biomedical Ethics, 255.
39
Beauchamp and Childress, Principles of Biomedical Ethics, 267.
40
John Rawls. A Theory of Justice. Revised Edition. (Cambridge, MA: Harvard University Press, 2003): 3.
41
Rawls, A Theory of Justice, 11.
42
Rawls, A Theory of Justice, 52-53.
43
Rawls, A Theory of Justice, 11.
44
John Stewart Mill. "John Stewart Mill, 'On the Connexion between Justice and Utility' from
Utilitariamism." In Justice, edited by Jonathan Westphal. (Indianapolis: Hackett Publishing
Company, 1996): 159.
45
Mill, "John Stewart Mill, 'On the Connexion between Justice and Utility' from Utilitariamism," 159.
46
Mill, "John Stewart Mill, 'On the Connexion between Justice and Utility' from Utilitariamism," 160.
47
Mill, "John Stewart Mill, 'On the Connexion between Justice and Utility' from Utilitariamism," 160.
48
Mill, "John Stewart Mill, 'On the Connexion between Justice and Utility' from Utilitariamism," 160.
49
Ruth Chadwick, Henk ten Have, and Eric M. Meslin, eds. The SAGE Handbook of Health Care Ethics.
(Los Angeles: SAGE Publications, 2011).
50
Albert R. Jonsen, Mark Siegler, William J. Winslade, Mark Siegler, and William J. Winslade. Clinical
ethics: a practical approach to ethical decisions in clinical medicine. McGraw Hill, Medical Pub.
Division, 2006.
51
Ezekial J. Emauel, Christine Grady, Robert A. Crouch, Reidar K. Lie, Franklin G. Miller and David
Wendler. (Eds.) The Oxford Textbook of Clinical Research Ethics. New York: Oxford University
Press. 2008.
52
Vilhjalmur Arnason, Hongwen Li, and Yali Cong. “Informed Consent” In The SAGE Handbook of
Health Care Ethics. edited by Chadwick, Ruth, Henk ten Have, and Eric M. Meslin (Los Angeles:
SAGE Publications, 2011), 106.
53
Anne Drapkin Lyerly. "Marking the Fine Line: Ethics and the Regulation of Innovative Technologies in
Human Reproduction." Minnesota Journal of Law, Science, and Technology 11, no. 2 (2010): 704.
54
Arnason, Li, and Cong, “Informed Consent,” 112.
55
Linda Farber Post, Jeffrey Blustein, and Nancy Neveloff Dubler. Handbook for Health Care Ethics
Committees. (Baltimore: Johns Hopkins University Press, 2007), 43.
56
Beauchamp and Childress, Principles of Biomedical Ethics, 119.
57
W.J. Dondorp and G.M.W.R. De Wert. "Fertility Preservation for Healthy Women: Ethical Aspects."
Human Reproduction 24, no. 8 (2009): 1779-1785.
58
Pasquale Patrizio. "Ethical Discussions in Approaching Fertility Preservation." In Fertility Preservation:
Emerging Technologies and Clinical Applications, edited by E. Seli and A. Agarwal, (Springer,
2012): 19-25.
59
Pasquale Patrizio, Samantha Butts, and Arthur Caplan. "Article Ovarian Tissue Preservation and Future
Fertility: Emerging Technologies and Ethical Considerations." Journal of the National Cancer
Institute. Monographs 34 (Dec 2004): 107.
60
Michaeli, et al., "Fertility Preservation in Girls." 6.
61
Arnason, Li, and Cong, “Informed Consent,” 107.
62
Arnason, Li, and Cong, “Informed Consent,” 109.
63
Jeffrey Nisker, Francoise Baylis, and Carolyn McLeod. "Choice in Fertility Preservation in Girls and
Adolescent Women with Cancer." Cancer Supplement 107, no. 7 (October 2006): 1687.
64
Beauchamp and Childress, Principles of Biomedical Ethics, 133-134.
65
Michaeli, et al., "Fertility Preservation in Girls," 6.
66
Dondrop and Wert, "Fertility Preservation for Healthy Women: Ethical Aspects," 1784.
67
Dondrop and Wert, "Fertility Preservation for Healthy Women: Ethical Aspects," 1783.
68
Pernilla Pergert and Kim Lutzen. "Balancing Truth-telling in the Preservation of Hope: A Relational
Ethics Approach." Nursing Ethics 19, no. 1 (2012): 23.
69
Elaine Glass, and Douglas Cluxton. "Truth-telling: ethical issues in clinical practice." Journal of Hospice
& Palliative Nursing 6, no. 4 (2004): 232-242.
70
Glass and Cluxton, "Truth-telling: Ethical issues in clinical practice," 239-240.
36

215

71

Ann Begley, and Bronagh Blackwood. "Truth‐telling versus hope: A dilemma in practice." International
Journal of Nursing Practice 6, no. 1 (2000): 30-31.
72
Pavlos Sarafis, et al. "Disclosing the Truth: A Dilemma between Instilling Hope and Respecting Patient
Autonomy in Everyday Clinical Practice." Global Journal of Health Science 6, no. 2 (2014): 128137.
73
Beauchamp and Childress, Principles of Biomedical Ethics, 121-124.
74
Glass and Cluxton, "Truth-telling: ethical issues in clinical practice," 234.
75
Beauchamp and Childress, Principles of Biomedical Ethics, 124-125.
76
Pergert and Lutzen, "Balancing Truth-telling in the Preservation of Hope," 22.
77
Glass and Cluxton, "Truth-telling: ethical issues in clinical practice," 234, 237.
78
Glass and Cluxton, "Truth-telling: ethical issues in clinical practice," 223.
79
Beauchamp and Childress, Principles of Biomedical Ethics, 36-37.
80
Ruud ter Meulen. “Ethics of Care” In The SAGE Handbook of Health Care Ethics. edited by Chadwick,
Ruth, Henk ten Have, and Eric M. Meslin (Los Angeles: SAGE Publications, 2011), 42.
81
Glass and Cluxton, "Truth-telling: ethical issues in clinical practice," 225.
82
Sarafis, et al., "Disclosing the Truth," 129.
83
Sarafis, et al., "Disclosing the Truth," 131.
84
Begley and Blackwood. "Truth‐telling versus hope: A dilemma in practice," 27.
85
William Ruddick. "Hope and deception." Bioethics 13, no. 3-4 (1999): 346.
86
Begley and Blackwood. "Truth‐telling versus hope: A dilemma in practice," 30.
87
R. V. Larcher Grundy, et al. "Fertility Preservation for Children Treatment for Cancer (2): Ethics of
Consent for Gametes Storage and Experimentation." Arch Dis Child, (2001): 360-362.
88
Michelle Peate, et al. "It's now or never: fertility-related knowledge, decision-making preferences, and
treatment intentions in young women with breast cancer—an Australian fertility decision aid
collaborative group study." Journal of Clinical Oncology 29, no. 13 (2011): 1670-1677.
89
Galvin and Clayman, "Whose future is it? Ethical family decision making about daughters’ treatment in
the oncofertility context," 429-445.
90
Veronica Lambert, and Michele Glacken. "Engaging with children in research: Theoretical and practical
implications of negotiating informed consent/assent." Nursing Ethics 18, no. 6 (2011): 781-801.
91
Barbara J. Stegman "Unique ethical and legal implications of fertility preservation research in the
pediatric population." Fertility and Sterility 93, no. 4 (March 2010): 1037-1039.
92
Grundy, et al. "Fertility Preservation for Children Treatment for Cancer (2)," 360-362.
93
Susan L. Crockin. "Legal issues related to parenthood after cancer." Journal of the National Cancer
Institute. Monographs 34 (2005): 111-113.
94
Angie Leventis Lourgos and Bonnie Miller Rubin. "Court gives frozen embryos to Chicago woman over
ex-boyfriend's objection." Chicago Tribune, Jun 12, 2015.
95
Ray Strom. "Embryos: Who do They Belong to?" Chicago Lawyer Magazine, Sept 2014.
96
Jacob Szafranski v. Karla Dunston. IL App (1st) 122975-B (Appellate Court, Circuit Court of Cook
County, Jun 12, 2015).
97
Tamar Lewin "The Nation: Taking After Father, A Frozen Sperm Riddle." The New York Times, Jan 13,
2002.
98
Lambert and Glacken, "Engaging with children in research," 781.
99
Galvin and Clayman, "Whose future is it? Ethical family decision making about daughters’ treatment in
the oncofertility context," 437.
100
Beauchamp and Childress, Principles of Biomedical Ethics, 103.
101
Stein Husebo. "Communication, Autonomy, and Hope." Annals of the New York Academy of Sciences
809, no. 1 (1997): 445.
102
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
221.
103
Husebo, "Communication, Autonomy, and Hope." 440-459.
104
Husebo, "Communication, Autonomy, and Hope." 441.
105
Joseph M. Letourneau, et al. "Pretreatment fertility counseling and fertility preservation improve quality
of life in reproductive age women with cancer." Cancer 118, no. 6 (2012): 1710.
106
American Cancer Society. Fertility and Women with Cancer. (Atlanta: American Cancer Society, 2013),
17.

216

107

Letourneau, et al., "Pretreatment fertility counseling and fertility preservation improve quality of life in
reproductive age women with cancer." 1715.
108
Stephen M. Auerbach, et al. "Optimism, satisfaction with needs met, interpersonal perceptions of the
healthcare team, and emotional distress in patients' family members during critical care
hospitalization." American Journal of Critical Care 14, no. 3 (2005): 202-210.
109
Michael F. Scheier and Charles S. Carver. "Optimism, coping, and health: assessment and implications
of generalized outcome expectancies." Health psychology 4, no. 3 (1985): 219.
110
Simon E. Blackwell, et al. "Optimism and mental imagery: A possible cognitive marker to promote
well-being?." Psychiatry research 206, no. 1 (2013): 56-61.
111
Deborah A. Colby and Kim Shifren. "Optimism, mental health, and quality of life: a study among breast
cancer patients." Psychology, health & medicine 18, no. 1 (2013): 10-20.
112
Anthony Scioli, et al. "A prospective study of hope, optimism, and health." Psychological reports 81,
no. 3 (1997): 723-733.
113
Auerbach, et al., "Optimism, satisfaction with needs met, interpersonal perceptions of the healthcare
team, and emotional distress in patients' family members during critical care hospitalization," 202210.
114
Deborah Lancastle and Jacky Boivin. "Dispositional optimism, trait anxiety, and coping: unique or
shared effects on biological response to fertility treatment?" Health Psychology 24, no. 2 (2005):
171.
115
Lancastle and Boivin. "Dispositional optimism, trait anxiety, and coping: unique or shared effects on
biological response to fertility treatment?" 176.
116
Lancastle and Boivin. "Dispositional optimism, trait anxiety, and coping: unique or shared effects on
biological response to fertility treatment?" 176.
117
Beste, "Instilling Hope and Respecting Patient Autonomy: Reconciling Apparently Conflicting Duties,"
215-222.
118
Division of Cancer Prevention and Control. Cancer Survivorship: Basic Information for Cancer
Survivors. Centers for Disease Control and Prevention. 2016.
http://www.cdc.gov/cancer/survivorship/basic_info/survivors/index.htm (accessed Sept 25, 2016).
119
Hatem Soliman and Samuel V. Agresta. "Current Issues in Adolescent and Young Adult Cancer
Survivorship." Cancer Control 15, no. 1 (January 2008): 55-62.
120
Lois B. Travis, et al. "Testicular Cancer Survivorship: Research Strategies and Recommendations."
Journal of National Cancer Institute 102, no. 15 (August 2010): 1114–30.
121
Lisa A. Schwartz, et al. "Self-Reported Health Problems of Young Adults in Clinical Settings: Survivors
of Childhood Cancer and Healthy Controls." Journal of American Board of Family Medicine 23,
no. 3 (May-June 2010): 306–14.
122
Soliman and Agresta, "Current Issues in Adolescent and Young Adult Cancer Survivorship," 55-62.
123
Division of Cancer Prevention and Control. Cancer Survivorship: Basic Information for Cancer
Survivors. Centers for Disease Control and Prevention. 2016.
http://www.cdc.gov/cancer/survivorship/basic_info/survivors/index.htm (accessed Sept 25, 2016).
124
Division of Cancer Prevention and Control. Cancer Survivorship: Who Are Caregivers, and How Do
They Support Cancer Survivors? Centers for Disease Control and Prevention. 2016.
https://www.cdc.gov/cancer/survivorship/caregivers/ (accessed Sept 26, 2016).
125
Division of Cancer Prevention and Control. Cancer Survivorship: Basic Information for Health Care
Professionals and Researcher. Centers for Disease Control and Prevention. 2016.
http://www.cdc.gov/cancer/survivorship/basic_info/health-care-pros/index.htm (accessed Sept 26,
2016).
126
American Cancer Society. Cancer Treatment & Survivorship: Facts and Figures 2016-2017. (Atlanta:
American Cancer Society, 2016): 4.
127
Christy Simpson. "When Hope Makes Us Vulnerable: A Discussion of Patient-Healthcare Provider
Interactions in the Context of Hope." Bioethics 18, no. 5 (2004): 434.
128
Sabine Irtan, et al. "Ovarian transposition in prepubescent and adolescent girls with cancer." The Lancet
Oncology 14, no. 13 (2013): e601-e608.
129
Tuua Ruutiainen, et al. "Expanding Access to Testicular Tissue Cryopreservation: An Analysis by
Ananlogy." The American Journal of Bioethics 13, no. 3 (2013): 28-35.
130
Soliman and Agresta, "Current Issues in Adolescent and Young Adult Cancer Survivorship," 55-62.

217

131

Simpson, "When Hope Makes Us Vulnerable: A Discussion of Patient-Healthcare Provider Interactions
in the Context of Hope,"434.
132
William F. Lynch,. Images of Hope: Imagination as Healer of the Hopeless. (Notre Dame: University of
Notre Dame Press, 1974): 35.
133
Donald Capps. "Imagining Hope: William F. Lynch’s Psychology of Hope." Pastoral Psychology 65,
no. 2 (2016): 151.
134
Practice Committees of American Society for Reproductive Medicine and Society for Assisted
Reproductive Technology, "Mature oocyte cryopreservation: a guideline," 37-43.
135
Juan A. Garcia-Velasco, et al. ""Five years' experience using oocyte vitrification to preserve fertility for
medical and nonmedical indications." Fertility and Sterility 99, no. 7 (2013): 1996-1997.
136
Ana Cobo, et al. "Is vitrification of oocytes useful for fertility preservation for age-related fertility
decline and in cancer patients?" Fertility and Sterility 99, no. 6 (2013): 1485-1495.
137
Joseph A. Lee, et al. "Optimizing human oocyte cryopreservation for fertility preservation patients:
should we mature then freeze or freeze then mature?" Fertility and Sterility 99, no. 5 (2013):13561362.
138
Paul Ndebele. "Research Ethics." In Handbook of Health Care Ethics: Core and Emerging Issues,
edited by Ruth Chadwick, ten Have Henk and Eric M. Meslin. (London: SAGE Publications Ltd,
2011.): 306.
139
John Concato. "Is It Time for Evidence-Based Medicine." JAMA 307, no. 15 (April 2012): 1642.
140
Victor M. Montori, and Gordon H. Guyatt. "Progress in Evidence-Based Medicine." JAMA 300, no. 15
(October 2008): 1815.
141
Michelle L. Matthews, et al. "Cancer, Fertility Preservation, and Future Pregnancy: A Comprehensive
Review." Obstetrics and Gynecology International 2012 (2012): 2.
142
Ndebele, "Research Ethics," 244.
143
Ndebele, "Research Ethics," 245.
144
Ndebele, "Research Ethics," 245-6.
145
American Cancer Society, Fertility and Women with Cancer, 17.
146
American Cancer Society, Fertility and Women with Cancer, 17-19.
147
American Cancer Society, Fertility and Men with Cancer. (Atlanta: American Cancer Society, 2013), 1517.
148
Matthews, et al., "Cancer, Fertility Preservation, and Future Pregnancy: A Comprehensive Review." 7.
149
American Cancer Society, Fertility and Women with Cancer, 18.
150
American Cancer Society, Fertility and Men with Cancer, 16.
151
Melissa Davis. "Fertility Considerations for Female Adolescent and Young Adult Patients Following
Cancer Therapy: A Guide for Counseling Patients and Their Families." Clinical Journal of
Oncology Nursing 10, no. 2 (April 2006): 217
152
American Cancer Society, Fertility and Women with Cancer, 18.
153
American Cancer Society, Fertility and Men with Cancer, 16.
154
American Cancer Society, Fertility and Women with Cancer, 20.
155
American Cancer Society, Fertility and Men with Cancer, 18.
156
Hickey, et al., "Breast Cancer in Young Women and Its Impact on Reproductive Function." 326.
157
Hickey, et al., "Breast Cancer in Young Women and Its Impact on Reproductive Function." 331.
158
Eric Chwang. “Futility clarified.” Journal of Law, Medicine & Ethics Fall (2009): 489.
159
Roy Joseph. “Hospital Policy on Medical Futility – Does it help in conflict resolution and ensuring good
end-of-life care?” Annals Academy of Medicine. 40, no. 1 (2011): 20.
160
Suzanne Mellon and Laurel L. Northouse. "Family survivorship and quality of life following a cancer
diagnosis." Research in Nursing & Health 24, no. 6 (2001): 446-459.
161
Neeraj K. Arora, et al. "Perceived helpfulness and impact of social support provided by family, friends,
and health care providers to women newly diagnosed with breast cancer." Psych-Oncology 16, no.
5 (2007): 474-486.
162
Galvin and Clayman, "Whose future is it? Ethical family decision making about daughters’ treatment in
the oncofertility context," 429-455.
163
Quinn, et al., "Who decides? Decision making and fertility preservation in teens with cancer: a review of
the literature," 344.

218

164

Gwendolyn P. Quinn and Susan T. Vadaparampil. "Fertility Preservation and Adolescent/ Young Adult
Cancer Patients: Physician Communication Challenges." Journal of Adolescent Health 44 (2009):
395.
165
Beauchamp and Childress, Principles of Biomedical Ethics, 133-134.
166
Michael H. Kottow. "The vulnerable and the susceptible." Bioethics 17 (2003):460.
167
Soren Holm, "Obesity interventions and ethics." Obesity Review 8, no. s1 (2007): 207.
168
Kottow, "The vulnerable and the susceptible." 460.
169
Derek Sellman, “Towards an Understanding of Nursing as a Response to Human Vulnerability.”
Nursing Philosophy. 6 (2005): 8-9.

219

Chapter Six: Programs and Recommendations for Fertility Preservation
I.

Introduction

Chapter Six will discuss elements for readdressing the current approach to fertility
preservation discussions. There are current programs and guidelines used for fertility
preservation, but most are aimed at the science of fertility preservation, and only a few
consider the decision making process or the influence that hope has over these decisions.
These programs vary from registries to consortiums, to professional organizations, to forprofit companies. The chapter highlights examples of the different groups, but it is in no
way meant to be an exhaustive list. Recommendations will be made in order to
encouraging the advantages and discouraging the disadvantages in fostering hope in
fertility preservation (Chapter Five).
Oncofertility programs were created to be an information resource for patients
and healthcare professionals who are struggling to understand and make a decision
regarding fertility preservation. They provide information directly from the healthcare
professionals and testimonials from patients who have experienced what this patient is
about to undergo as they consider fertility preservation.
Registries are a way to collect data about cancer patients. It can track the
patient’s information including age, gender, race, disease, health, treatment, and other
variables before, during, and after treatment looking for trends and new information.
Registries are meant to be long-term studies that consider factors over a period of time. It
can help in the understanding of cancer to investigate rates, risks, and additional issues
that were previously unknown or unsure of.
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Consortiums allow healthcare professionals to exchange information and
collaborate on new information. It provides up and coming research for science, ethics,
law, psychology, oncology, and other areas while keeping the patient’s personal narrative
at the forefront of the case. Healthcare professionals can better equip themselves by
working with a consortium to education themselves on fertility preservation. It can better
prepare a healthcare professional to discuss fertility preservation with a patient and/or
know where to refer them to.
For-profit companies seek to provide a needed service for those considering
fertility preservation. Many companies offer exclusive meetings or internet consultations
for patients at their convenience. They are trying to go to the patients instead of making
the patients comes to them. It takes time and effort by a few individuals to start a
business that will actually turn a profit.
Advocacy groups like the American Cancer Society and Fertile Action seek to
help patients as they deal with cancer. They raise money and provide necessary
resources in order to help patients with the difficulties of oncofertility. Fertile Action
seeks to provide financial aid because of the costly nature fertility preservation, while the
American Cancer Society provides information, support groups, and encouragement
before, during, and after cancer. The American Cancer Society seeks to highlight the
importance of survivorship as a way for patients to adjust to their lives during and after
cancer. It can even connect patients with others to provide a bond and a kinship. Those
who have had similar experiences can share their personal narratives.
SaveMyFertility.org is unique in that is an advocacy group, but is geared towards helping
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healthcare professional communicate well towards patients. This is done by providing
toolkits to use during the conversation.
Professional organizations provide insight into the healthcare information for
healthcare professionals. American Society for Reproductive Medicine and American
Society for Clinical Oncology both seek to better education and provide resources for
healthcare professionals that are members. These organizations can create guidelines and
publish official statements on current issues of the moment.
Together all the groups, seek to address fertility preservation. Some track data,
while others provide resources. The problem is that with so many options, it can be
confusing and overwhelming not just for the patients, but for the healthcare professional
too. It is important to remember the goal in all of this- to foster hope in fertility
preservation. This means trying to improve the advantages of hope that were identified
in Chapter Five- directing one’s own care, optimism, and survivorship. This can be done
by recognizing and addressing issues of vulnerability, managing communication, and
including ethics consults in the process of decision making. This means being aware of
issues relating to harm, inability to protect one’s own interest, exploitation, and
susceptibility. Vulnerability can affect a patient’s ability to direct one’s own care in a
way that is free from coercion or undue influence. It means being truthful with patients
and seeking to communicate clearly and effectively. Truth and trust work together to
create an effective patient-healthcare professional relationship. It means including ethics
consultation in the process of decision for fertility preservation. This can be done by
various means, but what it does is provide a mechanism to address ethical issues that may
arise.
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II.

Evaluation of Fertility Preservation Programs

Colorado Oncofertility Program1 and the Oncofertility Consortium®2 are just two
examples of fertility preservation programs aimed to provide information and support for
patients. The provide literature that is easy to understand and relevant to the current state
fertility preservation. There is a slight difference in fertility preservation and
oncofertility. Fertility preservation is the bigger category that describes cryopreserving
material for any reasons in order to prevent fertility in the future. Oncofertility is a type
of fertility preservation that deals only with those diagnosed with cancer. Since this is the
most common reason for fertility preservation, there is no surprise that the programs and
groups focus on oncofertility specifically. It is important to consider the purpose,
methods, and information that the program is supply to the patient. There are positive
and negative aspects to each approach. It is important to look for commonality and
explicit differences in these approaches in order to best understand the currently methods
and to make recommendations on how to improve or change. The critical nature of
looking for ethical and legal behavior is vital in order to protect patients as they pursue
fertility preservation. If a physician refers the patient to the program, he or she must
ensure that it is a good source of information. Otherwise, the healthcare professional is
putting the patient into a possibly risky situation. It is necessary to be critical of these
groups to ensure they are acting ethically and legally responsible. There are groups that
may struggle with the conflict of helping the patient while trying to make money. Since
the procedures and storage of cryopreserved materials are so expensive, there is reason to
be concern.
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A. Registries and Programs
There are many different groups that seek to address the issue of fertility
preservation. Most are concerned with disseminating information to the masses.
Oncofertility programs and centers are usually based at a university or healthcare facility
and are established as a group in to order to direct research funds and grants directly to
oncofertility program. Consortiums are mainly focused on providing education for those
in healthcare. It can be an effective resource if used properly. There are times, when the
information can be overwhelming and it may not be possible to find what someone is
searching for, but consortiums aim to do more good than harm. Some websites are an
offshoot of something else, like in the case of myoncofertility.org. This site was
designed to be used by patients, parents, and partners for those considering oncofertility.
By including success stories and testimonials, patients can better connect to the process
and decision making that is coming.
1.

Colorado Oncofertility Program
The Colorado Oncofertility Program (COP) seeks to provide the most accurate

and timely information regarding fertility preservation for their patients. This was done
through the creation of a registry program. The intentions of programs similar to this are
to empower patients without compromising ethical concepts like confidentiality and
promoting quality insurance.3 The goal is to provide accurate and timely information but
that can only be done when information is shared and known. If information is keep
secret until it is published or until an organization deems it standard of care, progress will
take much longer. If patients are well informed it empowers them to make informed
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decisions about their treatment and care. In addition, it can set them up for an effective
survivorship plans in the future.
By understanding the quality of life for survivors, the program seeks to
understand the side effects from cancer treatments for the long-term.4 Long-term
understanding can help to investigate rates, risks, trends, and additional issues that were
previously unknown. Quality of life is key to addressing and planning for survivorship.
As discussed before, survivorship is a way for survivors, caregivers, and healthcare
professionals to learn about their roles and to support each other in adjusting and thriving
in the new normal. Cancer is serious diagnosis and those who survive will be affected for
the rest of their life. It is hard to predict what kind of outcome a patient will have, but the
more that is studied and known, the better predictions for trends can be made.
Colorado Oncofertility Program stands out from the others by the “direct
integration of clinical care and research.”5 As part of the Advance Reproductive
Medicine at University of Colorado, it offers a wide variety of services having to do with
fertility. It works to help patients achieve their goals, reduce the cost of healthcare,
provide experts in fertility, invest in cutting edge technology, and be resource for anyone
struggling with fertility issues.6 Services include more than fertility preservation. It
includes infertility diagnosis and treatment, fertility treatments, male fertility treatments,
in vitro fertilization, donors and surrogacy, LGBT family planning, support groups,
menopause treatment, polycystic ovary syndrome treatment, intracytoplasmic sperm
injection, and fertility weight loss.7 All of these services can be combined in various
ways to help a patient best address their fertility needs. In time, this may need to be
updated based on changes in success rates of their procedures.
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For those considering oocyte cryopreservation (labeled egg freezing), the program
makes a distinction between medical reasons and social reasons. In both cases, oocyte
cryopreservation is done in order to attempt to get pregnant at a later time. Despite
oocyte cryopreservation being a standard of care technique, the program still
recommends embryo cryopreservation when possible. This is due to the much better
rates of success for embryo cryopreservation than egg freezing.
As part of the Reproductive Medicine Network, there is a great resource of
sharing research information concerning infertility and anything related to it.8 By being
associated with this organization, the healthcare professional can be better equipped to
consider research option when standard of care is not available. In addition, it provides
access to REDCap projects, which connects healthcare professional in a controlled access
to share new information in order to provide the best care for patients.9
The Colorado Oncofertility Program fertility preservation resources focus mainly
on women and cancer. As discussed earlier, there are other diseases like lupus that use
chemotherapy for treatment which puts patients at risk for fertility preservation also. The
information on the site provides a minimal introduction and healthcare professionals have
a responsibility to fill in the gaps with the necessary information. However, it does
recognize the need for special consideration when facing issues of infertility due to
treatment for disease. The oncofertility team includes two psychologists as a way to
recognize that many struggle with the decisions regarding fertility preservation.
2.

Oncofertility Consortium®
The Oncofertility Consortium® based out of Northwestern University is a

nationwide program at over 50 sites in order to study oncofertility and collaborate on
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research and data. The goal is to provide opportunity for collaboration among those
studying oncofertility. Being such a new area of research, there is constant change to the
science, ethical, and legal issues, and administrative responsibilities. This increase in
information must be digested by the healthcare professional in order to ensure they are
competent in their knowledge and skills and able to answer questions or make the
necessary referrals to those who have the knowledge and skills. It is not just about
conducting studies that are focused on ways to preserve fertility, but also on why
infertility happens due to cancer treatments, addressing communication barriers, and
addressing legal and ethical issues that arise during fertility preservation.10
With a large database of information, patients, healthcare professionals,
educators, and researchers can search through the hundreds of documents on anything
from institutional review board documents to new articles that are in main stream media
to website for advocacy groups and organization. It provides guides on current research
techniques, up to date information on the success or failure of the research, and what
things that healthcare facilities need to consider before conducting a study. It allows
users to narrow the search based on the audience, gender, age, reason for fertility
preservation, and even language.
One of the Oncofertility Consortium's® projects is the FIRST Registry. FIRST is
an acronym that stands for Fertility Information Research Study. As part of a study
funded by the National Institutes of Health, the study is registering young survivors to
critically look at how cancer affects them and their ability to survive and thrive.11 Being
an observational study, this research is only meant to collect information and look for
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trends, commonality, and differences. It provides no clinical or therapeutic benefit, but
tracks the life of a survivor.
The consortium presents itself to emphasize the importance of collaboration in
research. It allows for growth, new information and understanding as healthcare
professional, researchers, and patients seek out additional information. Projects focus on
anything from the science of ovarian tissue cryopreservation to research of ethical and
legal issues regarding fertility preservation. The site provides names of researchers,
purposes and progress of projects. The goal of connecting and collaborating on research
is clearly the main objective.
One study seeks to debate the ethical and legal issues that are dealing with the
ovarian tissue that was cryopreserved for prepubescent children. As discussed earlier,
there are significant ethical and legal questions regarding the nature of this research.
Issues such as decision making including both the patient and parents have a tremendous
importance in determining the ethical nature of the studies that are focused on the longterm use of cryopreserved material.12
Patients may be overwhelmed at this site. It appears to be more focused on
supporting the healthcare professional and researchers. Healthcare professionals can find
this site helpful as they try to navigate the science of fertility preservation. There is so
much information to read and evaluate, sites like this one can better help healthcare
professional navigate the information. However, once one digs into the site, there is a
referral to a patient focused site called myoncofertility.org. This patient-centered site is
to educate and answer questions patients may have as the start to navigate oncofertility.
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3.

My Oncofertility
Designed to be patient friendly, there are numerous question and answers

available to patients, families, partners, and others that are involved in the process of
oncofertility. The site is designed to be interactive including the opportunity to submit
questions and watch videos of experts talk about the information about oncofertility.
Patients can consider questions like “What is oncofertility?” and “What is normal male
fertility and how is it affected by cancer treatment.?”13 By starting at the most basic
information, patients are able to slowly increase their understanding as the can be quickly
overwhelmed by the information presented.
By working through the question and answers, parents are able to have a better
understanding for the discussion of fertility preservation when it concerns their child.
Beyond explaining the options for adolescents being the same as adults, it also explains
why there are only research protocols available for prepubescent children.14 Parents are
facing not only the illness of a child, but a real risk that the child may end up infertile. It
seeks to answer questions in a way that is not overwhelming, but informative and helpful.
One particularly interesting question is “What is Oncofertility research revealing?” As
most parents are unaware, this is an extremely loaded question. It discusses the
importance of research regarding laparoscopic surgery to remove the entire ovary prior to
cancer treatment. The purpose is to cryopreserve the ovary and use it at a later date.
Immature follicle cryopreservation allows for immature follicles take from thawed
ovarian tissue could potentially be matured and used identical to a mature oocyte to be
fertilized and turned into an embryo. However, this type of research is currently not
being done in humans, only animals.15 Other studies focus on new cryopreservation
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methods, long term effects of chemotherapy and tracking those who have done
oncofertility.
For partners, the site is designed to explain the role the patient and the partner
play in oncofertility. Similar to the question and answers in the other sections, the
information provided it clear, concise, and focused on explaining complicated
information in an easy manner. It also provides resources on how to be and show support
to the patient. Cancer does not just affect the individual patient, but anyone that is around
them.
There are twenty videos of dedicated to the topic of decision making by cancer
survivors, partners, and parents. These videos address question about issues of how does
insurance affect non-married couples, or why someone chose to delay treatment in order
to do sperm cryopreservation. Topics of gamete donation, in vitro fertilization,
intrauterine insemination, ovarian suppression, timing fertility preservation with cancer
treatments, testicular shielding, legal concerns, the effect of not having a partner, and
decisions regarding specific drugs for treatment are all covered in the video topics.16
These videos allow those dealing with oncofertility to gain insight and
information from those who have been in the exact same shoes. It allows the patient,
partners, and parents to not feel so isolated in their pursuit of fertility preservation.
Decision making regarding fertility preservation is a serious discussion and many
struggle with understanding all the information and balancing the risks, benefits, and
harm that accompany the various decisions. By being a comprehensive resource for
those considering and going through fertility preservation, it provides a need source of
comfort and strength.
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4.

International Programs
In Australia and New Zealand, there is also a high level of interest regarding

oncofertility and fertility preservation. The National Perinatal Epidemiology and
Statistical Unit at the University of New South Wales has its own web-based registry
developed in 2013 called The Australian and New Zealand Fertility Preservation Registry
(ANZFPR). The goal of this project was to create evidence on the research for fertility
preservation and to determine outcomes of assisted reproductive technology. By
focusing on specific types of cancer, different methods of cryopreservation, both short
and long term consequences to cryopreservation, success and failure of pregnancy, and
many other areas, the registry seeks to look for medically indicated methodologies in
order to provide safe and effective medical recommendations and treatments for fertility
preservation.17
This program does not have much information available for those looking to
either participant or gain additional information or progress update. As of 2014, the
project is listed as complete, but no additional information is given.18
FUTuRE Fertility is an Australian based registry program for oncofertility.
FUTuRE stands for Fertility Understanding Through Registry and Evaluation. In
associate with The Kids Cancer Center at Sydney Children’s Hospital, The Bright
Alliance Cancer Centre at the Prince of Wales Hospital, The Royal Hospital for Women
and the University of New South Wales, all are contributing data and research to this
registry. The purpose is to evaluate the use of fertility preservation and the risks that are
associated with it in the long term.19
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The website to completely dedicated to the registry including information
regarding ethical issues such as privacy and confidentiality, ownership of data, registry
publication, consumer involvement, registry governance and custodian.20 The data is
aggregated by age, gender, socioeconomic status, and cancer type in treatment. This is
then compared to the use of fertility preservation, the continue health status of
participants in the registry, family planning outcomes, and interpretation of data.21 This
data is annually published. In addition there are studies focusing on the health economics
and psychological health outcomes that are associated with fertility.
Because of these studies, an Oncofertility Consortium® was started in 2015,
launching in 2016. Its goal is to create interdisciplinary collaboration to address
oncofertility needs. It will continue its work on the registry and the current research
studies, but it will also begin to expand to include general reproductive health,
hematology, economics, epidemiology, translation of information, and policy research.
These areas all can contribute to the knowledge regarding fertility preservation and
specifically oncofertility. It is only through continued research, can information be
gleaned and used to create new research and eventually standard of care for any
demographic that is available. This goal is a long way off, but it is important to establish
bench marks that can drive energy and enthusiasm forward. Without those, research can
become stale and no longer indentified as needed due to lack of interest.
Lastly, FUTuRE Fertility provides valuable resources for patients facing cancer
and the decision of oncofertility. There are categorized by ages including: adults,
adolescents and young adults, and pediatrics. This is important, because recognizing the
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differences in the science of fertility preservation is valuable to those making decisions.
It also refers people to reliable funding sites, advocacy groups, and fertility societies.
5.

Companies Seeking Patients
Some companies are set to make a profit in the world of fertility preservation.

Having this type of company is not inherently unethical or illegal. However, there is
great concern for those who are being deceptive or withholding information. Companies
that list all treatments as being equal are not fully informing the patient of the differences
between standard of care and research.
a.

Fertilitypreservation.org
Fertilitypreservation.org is a company that provides infertility and fertility

preservation services directly to the consumer. Dr. Kutluk “Lucas” Oktay is the
physician and his support staff includes a financial coordinator, certified ultrasound
technician, academic affairs and public relationship person. It does not include any type
of additional medical experts in reproductive technology. Services include egg freezing,
elective oocyte cryopreservation, ovarian tissue freezing and transplantation, fertility
preservation in children, in vitro maturation, random start ovarian stimulation, infertility
treatments after chemotherapy, pregnancy after cancer, and post-mortem emergency
fertility preservation.22 While this is a comprehensive list, one should be concerned if a
single physician is offering all of these services, both standard of care and research as the
same.
This type of company concerns many people. By claiming a domain name that is
fertility preservation and having that domain name (fertilitypreservation.org) match the
name of the company, there is concern over the exploitation and vulnerability of patients.
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When a patient types fertility preservation into search engines, this is one of the top
search results. With a physician establishing this company and lending his credentials to
this company worries some that there is little to no oversight. Services like ovarian tissue
and testicular tissue cryopreservation and transplantation are not clearly identified as
research protocols, which can be misleading to the patients. Instead, they are listed right
alongside sperm cryopreservation which has been around since the 1950s. There is not a
clear delineation between standard of care and research. Additionally, there is concern
for the ethics and legal issues that accompany this type of business. There is no
university or healthcare facility that is associated with the company. There is no
discussion as to the process for institutional review board approval or anyone who can
double check Dr. Oktay’s work. Patients that are vulnerable may get confused on the
information provided on this site. It appears official and well researched, but the trouble
is the lack of explanation for research protocols. It make one think is this company
offering services for a fee that are not considered safe, effective, or standard of care.
b.

ReproTech Limited
ReproTech Limited is a long-term storage bank for cryopreserved materials.

Patients, families, parents and partners can contact one of the four ReproTech Limited
locations to store embryos, oocytes, sperm, ovarian tissue or testicular tissue. All of these
options have a charge associated with them as so long as the person pays the fee, the
material continues to be cryopreserved. They are very clear that they are not involved
with gamete donation or assisted reproductive technology services. They only store
reproductive material. They are advertise affordable and cost effective prices and refers
to programs that can provide additional funding.23
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The storage fees are based on the various time frames a person may need. This
can include quarterly, one year, two, three, five, or ten years of storage. Those
cryopreserved materials which are believed to be potentially infectious are stored
separately are charged a higher fee. Embryos are also charged at a different rate
compared to gametes. In addition, there are typical administration fees and shipping fees
if needed.24
As a part of the Fertility Preservation Network, it provides resources places that
sperm oocyte, embryo, ovarian tissue and testicular tissue can be cryopreserved and
conveniently shipped to ReproTech Limited. It breaks the information down by method
of cryopreservation and then by state. These referrals to clinics are mostly healthcare
facilities and teaching hospitals and universities. Most provide multiple services for
cryopreservation and some also include access to advocacy groups like LiveStrong. 25
There are no recommendations to oncofertility programs or registries.
c.

Other companies
Companies such as EggBanks26 and Eggsurance27 are both for-profit companies

that focus solely on oocyte cryopreservation. Their focus is primarily on those who are
pursing fertility preservation in order to prevent age related fertility decline. These
women are often seeking methods, which they know are costly, in order to prevent eggs
from declining in quality. Usually associated with a single physician, there is the same
concern about how they are regulated and whether or not they take advantage of
vulnerable people. These companies offer private consultation and party consultations.
By doing that, it creates an atmosphere of relaxation and provides a fun and interesting
way to both advertise the cryopreservation and consider the offer. Companies like
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EggBanks and Eggsurance are providing service that is requested by the
consumer/patient. There is still the necessity of informed consent and the assurance that
the patient understood the information presented, the capacity to appreciate the nature of
the procedures, and the voluntary nature to consent to the procedure. These companies
should only be allowed to use standard of care options because it is important for safety
and efficacy in moving forward with oocyte cryopreservation.
B.

Commonalities
There are commonalities in these programs, registries, consortiums, and

companies. These groups are seeking to provide access to fertility preservation with the
intended goal of helping a patient have a child. Having a child is not a guarantee and
even in the best cases, rates vary patient to patient. There are inherent risks and benefits
to pursing fertility preservation and attempting to get pregnant as discussed before. There
is a concern though that the patients reading the information from these various
programs, registries, consortiums, and companies may get the wrong information or
understanding because the information provided can be very dense, confusing or
inaccurate. This is not to discount the intelligence of those reading the information. It is
just the nature of the information and the risk of miscommunication.
Oncofertility programs are mainly designed to aid patients in seeking out
resources in order to do fertility preservation. Patients can go to these sources and read
about fertility and infertility, the risks of infertility due to cancer treatment, and the
concern about effectiveness of methods. Program likes the ones at University of
Cincinnati Oncofertility Services, University of Connecticut Center for Advanced
Reproductive Services, or Penn Fertility Preservation Program all aim to provide
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information and services that are beneficial to a patient who is ready to undergo cancer
treatment. These types of programs are great for healthcare professionals to refer their
patients to in order for the patient to receive the best care and the best information.
Patients are relying on the healthcare professional to know who to go to with questions
and who to recommend for treatment.
Registries allow patients who choose fertility preservation to be monitored and
tracked for a long time. Patients can enroll and these registries take demographics,
diagnosis and treatment information, and survivorship in an automated way in order to
examine data and look for useful trends and statistic. The down side is that patients may
never learn of the long-term information that was gleaned from their personal
information. There are ethical questions as to whether a patient has the right to access
their own health information. In most cases, the research protocol explains that patients
do not have the right to their own information and it would be impossible to supply
individuals with meaningful data. Depending on the results, there is also a concern that if
results are negative, is there is an obligation on the part of the registry to provide that
information. If a registry found conclusive evidence that a certain type of chemotherapy
drug cause infertility in females 98% of the time, does the registry have an obligation to
inform past and current participants in the registry of the danger? There is no consensus
as to the answer.
Consortiums aim to collaborate and connect healthcare professionals. This is
designed to provide up to date information about research studies and discussions that are
currently being considered. Consortiums have the goal of education and teaching in mind
as the structure their group. Healthcare professionals can use this as a way to connect
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with other research and as a way to increase their skill and knowledge about fertility
preservation and oncofertility. Consortiums function best when there is thought and
planning into how the search for information is sorted and obtained. Consortiums like
the Oncofertility Consortium® created a database of resources that allows the person to
narrow their search to the topic at hand.
For-profit companies are the most difficult. There are also problem with some of
these. Those with companies offering fertility preservation and oncofertility services
have a conflict of interest. They are seeking to make money from the vulnerability of
someone facing the risks of infertility. These sites are not regulated or collaborate
outside of their company. It runs the risk of containing false information and setting up
false expectations, and remaining isolated from the current information available.
There is also a concern on how these groups deal with the issue of hope for these
patients. As discussed prior, patients pursue fertility preservation based on hope in order
to attempt to have a child in the future. This hope is based on the possible and realistic
nature of the health care information available. In the cases of the oncofertility programs,
registries, and consortiums, the goals seems to be the importance of providing
information. It seeks to give the best knowledge out there into the hands of those facing
the need for fertility preservation. These groups try to maintain being fair and balance in
terms of discussing the possibilities in the future with regarding to have a realistic view
of the future. Companies that are focused on making money may struggle to adequately
address hope. This is because hope is a reason the business exist. If there was no hope,
there would be no need for the business because infertility would not be as big of an issue
as it has become.
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These companies are hard to just shut down due to legal protections for
companies and the way medical claims are advertised. Patients that are seeking methods
for short cuts, cheap options, unproven methods, and unclear claims will always be
available as long as there is the internet. That is not to say that companies like
ReproTech Limited or Fertilitypreservation.org are unethical or attempting to create for
short cuts, cheap options, use unproven methods, and advertise unclear claims. One can
only go by the information provide on the website. There may be a more thorough
informed consent process once the patient meets with a healthcare professional.
III.

Advocacy Groups and Professional Organizations

Special interest and advocacy groups such as the American Society for
Reproductive Medicine,28,29 American Society for Clinical Oncology,30 and American
Cancer Society31,32 provide their own approaches and recommendations for how to
handle fertility preservation. Fertile Action is a not-for-profit focusing on relieving the
cost of fertility preservation. They provide recommendations for both the patients and
the healthcare professionals. These groups provide expertise for the science, but must
also take into consideration the expectations and hope that is established because of that
science. Additionally, they comment of issues that are currently facing our world, but
providing expert opinions from committee members. While each organization has a
slightly different focus, they all address fertility preservation, fertility and cancer,
oncofertility, age-related fertility decline, and information about research.
A.

American Society for Reproductive Medicine
The American Society for Reproductive Medicine is a “multidisciplinary

organization dedicated to the advancement of the science and practice of reproductive
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medicine.”33 It seeks to provide information about reproductive medicine to those that
need or want it. This is done through research, education, and advocacy of patients and
healthcare professionals and providers. Members can join the organization for a fee and
join groups and committees to discuss various reproductive medicine topics. Some
committees respond to an event in the media or results from a research project. Either
way, this organization is one of the authorities for reproductive medicine including
fertility preservation. There are events and conferences that members and non-members
can attend. The website provides many resources and basic definitions and opinions on
various topics.
The ASRM allows non-members access some introductory information as well as
the latest news, research and resources.34 For instance, the Department of Defense
Secretary Ash Carter announced in a partnership with the ASRM and the Society for
Reproductive Technology, started a two year pilot project in January 2016, to provide
fertility preservation for active duty service members.35 This means that any active duty
service member can cryopreserve oocytes, sperm or embryos prior to going overseas to
service in military duty. This opportunity is very important to active duty service
members because war is dangerous and there is no predicting what could happen to active
duty service member. So by preserving fertility, a military family may be able to attempt
to have children someday upon the return of the military member. In 2013, the American
Society for Reproductive Medicine announce that it was no longer considering oocyte
cryopreservation experimental. This meant that there was a shift from research to
standard of care.36 According to the American Society for Reproductive Medicine's
"Mature Oocyte Cryopreservation: A Guideline" over 981 studies were conducted.
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Common understandings from these studies show that length of cryopreservation had no
statistical impact on the live birth rates, while maternal age at time of cryopreservation
played a major role.
ReproductiveFacts.org is a companion site to the ASRM site. It is geared toward
patients to better communicate information directly to them. While similar documents
are available, there is easier language on the reproductivefactors.org. The most common
topic on the site is infertility including a guide to infertility and state laws regarding
insurance coverage.37 It also provides information on how to find a healthcare provider,
additional risks factors for infertility, and other reproductive medicine issues.
B.

Fertile Action
Fertile Action is charity focusing on cancer and its effect on fertility. Seeking to

educate, support, and advocate, the organization works with patients to reduce their cost
of fertility preservation. The goal is to reduce it by as much as 50%38 because the cost of
fertility preservation, due to medical reasons, is expensive and rarely covered by
insurance. Either patients have to take on the burden of the cost or they apply for
assistance in other ways.
Started by Alice Crisci, in 2008, she experienced the real life situation of cancer at
31 years old. Her personal narrative of struggle to pay for fertility preservation struck a
chord and she was able to take her knowledge and experience and pass it along to others.
Through the contribution of private donation, patients are given the opportunity to apply
for scholarships.39 It programs information on fertility risks from cancer treatments, 40
fertility preservation,41 parenthood after cancer, and other resources.
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Part of the organization is aimed at helping patients navigate the cost of fertility
preservation through accessing insurance. As discussed before, there are issue of justice
when it comes to the cost and insurance issues surrounding fertility preservation. Action
Fertile focuses on the right to appeal initially because it recognizes that most claims will
be denied and there are time limits for appeals. The goal is to apply the issues as related
to cancer and not fertility.42 The reasoning is the more information that is linked to
cancer, the more likely it is to be covered. Even with the passage of the Affordable Care
Act, fertility services even beyond fertility preservation are not likely to be covered.
Beyond helping the individual, there is also the opportunity to help build
oncofertility programs. The goals is to aid in the process of creation to implementation.
The Fertile Action organization aims to help in the following ways:


Establish an Oncofertility Program



Write short-term and long-term strategic plans



Conduct patient insurance advocacy and/or train billers to handle
cancer patients and their insurance needs in a specific manner



Promote your Oncofertility Program in the local community



Bridge key relationships between oncology providers and your REI’s



Organize and host Oncofertility receptions



Schedule in-services and grand rounds on behalf of your REI’s



Market your program through social media, print materials and online
content



Conduct localized research on referral sources, health insurance
benefits and legislative initiatives
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Implement operational toolkits



Create PPT templates for educational presentations to clinicians.43

The problem with these types of organizations is the lack of funding or expertise to
continue to maintain the information provided. The site has few pages that are blank and
provide little or no information for the patient.44,45 It continues to be an issue because
many women search “fertility preservation” on the internet and sites like this one with
good intentions, but little information, are often at the top of the search results. While the
board includes many physicians and advocates, it does not include bioethicist,
psychologist, social workers, nurses, or other healthcare professionals that can provide
additional perspectives. It also appears to be an isolated organization, meaning it is not
involved or connected with others to pool resources or discuss changes in the current
information.
C.

American Cancer Society
The American Cancer Society is a nationwide organization that is “dedicated to

eliminating cancer as a major health problem.”46 By working with local offices
nationwide, the goal is to save lives, reduce suffering, and promote research, education,
advocacy, and service.47 This organization provides information all about cancer from
the different types to various cancer topics to sharing encouraging stories of hope for
those who have been affected by cancer. It provides information on both standard of care
and research options to treat cancer. It encourages people to stay healthy which can
include stop smoking, a healthy weight, eating right, and getting regular preventative
checkups. It provides tool to evaluate health and cancer prevention.
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One of the most important pieces of information provided by the American
Cancer Society is the information regarding support and treatment. While the site
provides lots of resources to read about types of treatment, success stories of treatment,
risks of treatment, there is also information about getting support while dealing with
cancer. It provides resources for caregivers and support programs. Survivorship
programs are encouraged as a way to adjust to the new normal of living with and after
cancer.
The American Cancer Society know that fertility preservation is a major topic for
those who are facing cancer. The American Cancer Society provides two documents in
order to help address the multiple issues of fertility preservation. Fertility and Women
with Cancer is a document that provides comprehensive recommendations with how to
deal with fertility preservation.48 It provides recommended treatments, question to ask
ahead of time, the various fertility options, as well as suggestion to avoid pregnancy
during treatment. One of the standout things from the documents it that all options for
fertility are listed, not just the once concerning fertility preservation and biological
children. Other options including adoption, surrogacy, and donor gametes are listed as
just as reliable of options as in vitro fertilization or artificial insemination. In a separate
section, it discussion the issues as they relate to both prepubescent and adolescent girls.
This document is not meant to just as a list of fertility preservation options, but to engage
the cancer patient into considering all option that are about fertility and cancer. The
second document, is similar in that is focuses on the same issues, but addresses fertility
preservation and infertility as it relates to men.
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D.

American Society for Clinical Oncology
The American Society for Clinical Oncology is an organization dedicated to

“conquering cancer through research, education, and promotion of the highest quality
patient care.”49 There are over 40,000 oncology professionals members found in 120
countries worldwide. It has many committees and groups that discussion and respond to
the current issues of the day including making public statements on issues. It trains and
teaches healthcare professionals to keep their knowledge and skills sharp.
It has practices and guidelines that all members must follow which can include
quality improvement, practice management, billing, coding, and reporting, as well as
resources for patients. The American Society for Clinical Oncology is active in research,
publishing studies, and providing opportunities to collaboration and work together. It
keeps track of data to create reports and studies that allow better understanding of certain
issues.
The American Society of Clinical Oncology Clinical Practice Guidelines was
updated as of 2013. It highly recommends that all healthcare providers should address
the issues of infertility before undergoing cancer treatment. There should be discussion
at the time of diagnosis and the treatment plan meeting in order to provide access to
fertility preservation as soon as possible. Because there are great standard of care
options, fertility preservation should be pursued as soon as possible in order to allow the
patient the most time and opportunity to see it through. Fertility preservation discussions
should take place with cancer anticipating treatment meetings. All healthcare
professionals are expected to know the specifics or know how to refer the patient
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elsewhere. There are seven key recommendations as provided by the American Society
for Clinical Oncology in order to best address fertility preservation.


Discuss fertility preservation with all patients of reproductive age (and
with parents or guardians of children and adolescents) if infertility is a
potential risk of therapy



Refer patients who express an interest in fertility preservation (and
patients who are ambivalent) to reproductive specialists



Address fertility preservation as early as possible, before treatment
starts



Document fertility preservation discussions in the medical record



Answer basic questions about whether fertility preservation may have
an impact on successful cancer treatment



Refer patients to psychosocial providers if they experience distress
about potential infertility



Encourage patients to participate in registries and clinical studies.50

It recognizes the three types of standard of care- sperm, embryo, and oocyte
cryopreservation as well as many research methods including ovarian tissue and testicular
tissue cryopreservation and transplantation. It does warn that the guidelines are not to
replace any type of clinical judgment by a trained healthcare professional. As of 2013,
there was no new changes that was warranted by the literature review. Just like the
American Cancer Society, there is special mention of fertility preservation and dealing
with children and adolescents. Parents are to make decisions based on best interests. For
now those who have not gone through puberty cannot participate in any standard of care
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options. Additionally, no cases of live births after ovarian tissue transplantation in
prepubescent children has been reported. Any attempt at this should be carefully
supervised under the watchful eye of an institutional review board.51 The communication
between the patient and the healthcare professional needs to be thorough and complete.
This includes discussions on individual risk of infertility, options for fertility
preservation, timing regarding fertility preservation, cost of fertility preservation, risks of
pregnancy and children after cancer, and the possibility of referring the patient to a
reproductive specialists.52 Every conversation with a newly diagnosed patient should
include that entire list of topics. It is important to know that patients have the right to be
informed of all their options. Healthcare professionals should not skip the discussion
because it is too hard or there is not enough time.
IV.

Fostering Advantages of Hope in Fertility Preservation

By identifying commonality in fertility preservation programs and advocacy
group guidelines, recommendations can be made on how to approach fertility
preservation while fostering authentic hope. These recommendations will be based on
trying to support the advantages to fostering hope in fertility preservation (Chapter Five).
This will be done through establishing the need to protect the vulnerable, managing the
communication between patient-healthcare professional, and requesting for outside
ethical consultation. Protecting the vulnerable is the ability to keep a patient free from
exploitation or being taken advantage of in circumstances where there is a risk for those.
Managing communication means trying to understand the person where they are at and
not expecting them to do all the work in the relationship. Without communication, there
is no opportunity for fertility preservation. Communication can between the healthcare
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professional and the patient, between two healthcare professionals, or even between the
patient and someone in his or her support system like a partner or a family member. An
ethics consultation may be best equipped to address both the need to protect the
vulnerable and the ability to manage communication. Ethics consultants can evaluate if
there is an ethical issue present that would prevent the patient from moving forward with
a decision. If those three things are done on a consistent and regular basis, then there is a
good chance that the advantages to hope and fertility preservation will be fostered. It will
allow the patient to have the freedom to direct his or her own care, the pursuit of
remaining optimistic even in times when there is bad news, and the reliance on
survivorship to help the patient adjust to the new normal. Together the system can foster
hope in fertility preservation.
A.

Protection of the Vulnerable
Fertility preservation may leave patients and families feeling vulnerable. They

struggle to make sense of their diagnosis, the understanding of the material, and the
overwhelming feeling that nothing is going right and there are no other options.
Protection of the vulnerable is part of the responsibility of healthcare and research.
Seeking fertility preservation does not necessarily make an individual vulnerable simply
because of the future possibility of infertility, but healthcare professionals have a
responsibility not to take advantage of these patients either, but rather leave them feeling
protected and secure. Hope can leave a patient open to vulnerability and if they are truly
vulnerable, there may be little the patient can do to protect him or herself. By protecting
the vulnerable, trust, honesty and open communication can be established.53 This allows
for the fostering of hope in the decisions that the patient makes and prevents false hope.
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In order to better protect those who have to consider fertility preservation, it is important
that they meet with an expert in this area. Seeking out the appropriate healthcare
professional can aid in the decision making process. The patient needs to meet with a
reproductive specialist that is up to date on not only the standard of care, but also the
research protocols. However, the current rates for this are discouraging. In 2006, it was
reported that less than 50% of patients are referred to a reproductive specialist by their
oncologist.54 Since children and adolescents make up some of the fertility preservation
population and because they lack decision-making capacity, they need to be protected
from being exploited or harmed. Parents should only act in the best interest of the child,
leaving any and all personal feelings aside. All patients should still meet required criteria
to enroll in a research protocol, and enroll with capacity, voluntariness, and fairness to
ensure protection.55
1.

Vulnerability
Vulnerability is a difficult concept to pinpoint in a sentence or thought, and

even more difficult to justify applying the notion or the principle. It has many different
terms and aspects that cannot be over looked. “There is no single approach to the
definition of vulnerability,” according to Alexander Morawa.56 Vulnerability also has
implications that must be addressed when applied to specific conditions. When
protecting the vulnerable, it must be addressed in terms of harm, inability to protect
one’s own interest, exploitation and susceptibility.
a.

Harm
According to English Oxford Dictionary, vulnerability is susceptibility to

physical or emotional attack or harm.57 So many times in bioethics literature the most
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basic definition of vulnerability is in terms of harm. So the question becomes what is
harm and how does it relate to vulnerability. No rational person enjoys seeing harm to
come others especially when they are in a worse off state. Vulnerable populations are
often categorized as expose to harmful circumstances.58
Harm though can be too vague of a definition. It may not convey the
seriousness or the authenticity of the situation. Florencia Luna wrote that “[g]eneral
labels suggest general answers.”59 Harm cannot possibility address vulnerability in its
entirety. For example, if children are at risk for harm such as a poor education, then the
general answer would be to change the education. This does not provide adequate
answers or any solution to the problem. Is the poor education from the school system,
the specific instructor, or maybe the student’s refusal to learn? By labeling something
as harmful, it does not signify an agent of where the harm comes from. It only states
that harms exist. Luna goes on to argue that its implications create false ideas about
protection.60 It again gives no clear solution or means of protection.
Vulnerability usually relates to the possibility of being harmed. But what does
the possibility of being harmed mean? Doris Schroeder and Eugenijus Gefenas argue
that harm is part of being human.61 Everyone is subject to harm at some point in their
life no matter their circumstances. The potential for harm is not enough of a definition
to label or create vulnerability. “Vulnerability concerns integrity as a basic principle
for respect for and protection of human and non-human life.”62 According to Peter
Kemp and Jacob Dahl Rendtorff, there are four important basic ethical principles –
autonomy, dignity, integrity, and vulnerability.63 Vulnerability, being last, incorporates
the previous three well. In order to understand vulnerability one must acknowledge an
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individual’s autonomy, and the dignity and integrity of that person to create respect for
the vulnerable.64 Integrity provides respect not just for the individual as a person, but
also as a human being with a life and a story.
By using the element of harm in the definition of vulnerability, one does bring
in the external elements of vulnerability to the surface.65 This external element of
vulnerability can be reduced to danger. Vulnerable populations are in a state of current
or possible danger. This element explains again a broad definition, but gives more
dimension to the idea of harm. This eternal element also gives small direction as to
where the corresponding action should be. If there is danger, one must address where
the source of the danger is to be found. For example Schroeder and Gefenas use the
disease of malaria. The external harm or danger is from the mosquitoes. The action to
remove the external harm or danger would be to eradicate the mosquitoes.66 This
cannot be the only element of vulnerability. Schroeder and Gefenas go on to explain
the intrinsic element which is the inability to protect one’s own interest.
For fertility preservation, the concern for harm is one that includes the risks of
the procedure to preserve fertility. Patients who choose to undergo fertility
preservation, choose to do so knowing there is a risk to hyperstimulation of ovaries or
accessing sperm. In some cases, the risk of harm is extremely low, but that is not
always true. Patients are to decide what level of risk they are willing to face, but
healthcare professionals also have a responsibility to ensure that no unreasonable level
of harm comes to the patient.
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b.

Inability to protect interests
Vulnerability also must include the idea that there is the inability to protect

one’s own interest.67 This means that there is the inability to recognize or exercise
specific steps to keeps one either safe or free from harm or danger. This inability is
summarized as a lack of power of control. It can take many forms. In terms of
economics, this could mean that an individual lacks the money to provide for
themselves even at a day to day level. This could be education, where an individual
does not have the means to either seek out a good education or the education provided
to them is lacking. This could be in terms of intelligence and how to address the
inability to reason or think logically. Protecting one’s own interest is a basic
assumption that is taken for advantage of by the individual. The problem here is that
those who can protect their own interest often fail to understand what it is like to not be
able to protect one’s own interest.
The Council for International Organization for Medical Science defines
vulnerability as, “ the incapacity to protect one’s own interests owing such impediments
as lack of capability to give informed consent, lack of alternative means of obtaining
medical care…”68 This is usually in the context of international research. However, it
is important to include this aspect of vulnerability in the basic understanding as well.
Protecting one’s own interest is a matter of the internal component of
vulnerability.69 It is the aspect that indicates the level of control the individual or
group has when or if they are labeled vulnerable. The example of malaria can be taken
further in this definition. As explained previously, a population can be vulnerable to
mosquitoes giving them malaria. That harm or external vulnerability is the need to
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eradicate the mosquitoes. The internal component here is that the individuals are
vulnerable to malaria because they are unable to protect themselves from the
mosquitoes.70 The population cannot protect their own health in this case. By
acknowledging the vulnerability, one can help this population. The solution would be
to provide nets. By providing the nets for those who cannot protect themselves, one
can help the vulnerable, but the vulnerable have to choose to use the nets.
By using both the external and the internal components of vulnerability one can
see the importance of this principle. For example, children are vulnerable to chicken
pox. As first glance this is too broad of a statement. Are all children vulnerable to
chicken pox at all times? The answer is obviously no because chicken pox is not
constantly surrounding the child. From the external component, chicken pox does
cause harm to an individual. They cause itching, burning, and result in red bumps all
over the skin. Unless there is the internal component, one could argue that using the
term vulnerable is a misuse of the word. All children have the potential of catching
chicken pox sometime during their lifetime. These children become vulnerable once
they are exposed to the virus. Either they are near another individual with chicken pox
or shingles. The child here is unable to protect one’s own interest because chicken pox
is an air born disease. The most contagious time for someone with chicken pox if up to
two weeks before the red spots appear. In order to protect children from the
vulnerability, two things can happen. First from an external perspective, remove the
carrier of chicken pox. If someone knows they have chicken pox or have been exposed
to chicken pox, they should not go out into public. Second from an internal
perspective, the child could be vaccinated with the chicken pox vaccine to curb the
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disease and give the child immunity. This then reduces the vulnerability of the child
from chicken pox.
For fertility preservation, cost and access to fertility preservation can be a major
issue that leaves a patient unable to protect one’s own interest. They may not be able to
pay for the cost or drive to a specialist to perform the procedure. Healthcare should try
to intervene when it can. In some cases, the cost can be reduced by scholarship or
grants. As time and skills become more streamline, costs may decrease. If companies
followed the example set by Facebook and Apple to provide coverage for infertility
treatments that would also go a long way to protect the vulnerable.
c.

Exploitation
Exploitation is another element to vulnerability. English Oxford Dictionary

defines exploitation as “the fact of making use of a situation to gain unfair advantage
for oneself.”71 Exploitation is using someone in a situation that is less than ideal. The
phrase “unfair advantage” adds another dimension to this definition. Most would agree
that taking advantage of someone is not socially acceptable; however, there is a certain
small scale at which taking advantage of someone is tolerated (though this may be not
morally right). Adding the piece of unfair changes things. It brings in the question of
this advantage being morally wrong and it also treats the individual or group as a means
to an end rather than the end itself.
Exploitation is wrong from a moral standpoint.72 Labeling an action wrong
does not mean that it is exploitation.73 Exploitation adds intent to the mix, although this
is not necessarily a requirement. Intent to harm or take advantage of someone is not
acceptable. The problem is that those who are vulnerable may not be able to identify
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the harm or escape the harm. The exploitation does not take into consideration the
individuals or groups that are being exploited. Rather it is the utilization of people,
circumstances and opportunities in order to gain something else.74
Exploitation sees the individual or groups as a means to an end. It does not look
at the impact on the individuals or groups. The action focuses on the benefit of the
agent and has no regard for the interests of the individual or group.75 The individual or
group cannot be seen as a means; the must be treated as the end. In circumstances, it is
easy to see exploitation when it has obvious negative effects on the individual or group.
However, exploitation gets difficult to identify when it fails to have obvious negative
impact. Those who are deemed vulnerable must have some type of exploitation in their
path. The question here is do we deem someone vulnerable because of the future
possibility of exploitation or because exploitation has taken place.
Two examples for the possibility of the exploitation for the obese population are
seen in consumerism. First, fast food restaurants, companies the process with
hydrogenated oils, and grocery stores that sell unhealthy food as a cheap rate are all
using the obese population as a means to an end. These examples knowingly put out
products that are unhealthy because they know that people will purchase them. They
produce food that people will consume. They do not always take into consideration
that what is in their product is making people unhealthy and contributing to obesity.
Consumers, especially in a poor economy, buy what is cheap and available to them.
Fast food restaurants have menus with items for a dollar. Companies process food with
cheap and unhealthy ingredients to save their budget to make a bigger profit. Grocery
stores carry what sells, not what is necessarily the healthiest. Second, diet companies,
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fitness facilities, and at home gym products all target groups such as those trying to lose
weight, those trying to maintain weight or those trying to curb obesity. While being a
healthy weight is important and trying to curb obesity is very commendable, the
companies do not look at each individual as their end result. They are in the business to
make a profit. The advertisements for the companies make grand promises and display
unrealistic success stories. They know that such extreme examples are not normal and
acknowledge this in the fine print that results are not typical. Obese individuals that are
trying to lose weight want to be the success stories that are not typical. They see a
product promise more than they can deliver and are willing to pay to get healthy. So
what is to be done?
For fertility preservation, there is a risk of patients being exploited. They may
be desperate to have a child and desperate to do fertility preservation. There may be
too many barriers that are preventing the patient from accessing it though. Companies
like EggBanxx, Eggsurance, and Fertilitypreservation.org are seeking to provide a
service, but they are at risk for their conflict of interest to possibly exploit those who
are seeking fertility preservation. They see the patient as a consumer first, then as a
patient. The lack of access to fertility preservation, can create a desperate situation
where a patient may be willing to compromise safety or efficacy in order to access
fertility preservation.
d.

Susceptibility
A criticism that often goes with the vulnerability discussion is susceptibility.

Vulnerability and susceptibility are two distinct claims that are often either intertwined
to mistaken for each other. It is important understand these both separately and
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together. Michael Kottow has written extensively on the difference between
vulnerability and susceptibility. “By insisting on the distinction between vulnerability
and susceptibility, an ethical claim is brought forth that will require on one hand justice
and respect for universal human rights in order to protect the vulnerability, and on the
other institution of specific social actions to take care of the susceptible.”76
Kottow argues that vulnerability is a human condition.77 All are vulnerable.
This description of vulnerability creates an equality among all human beings. It is not
just that certain individuals or certain groups experience something, but rather all
human beings experience the need to be protected.78 There is always a condition or
circumstance that makes us fall into a category or group. At some point everyone will
need protection or help. Vulnerability “is an essential attribute of mankind to be
acknowledged.”79 It describes an attribute that makes everyone equal as a human
being. Vulnerability is not a situation to be protected from or gotten rid of, but rather a
way to create a universal condition and universal protection to everyone. In order to
increase the argument of vulnerability, one must also include other ethical principles to
gain respect and protection. It brings the idea of universal justice as well as dignity,
worth and autonomy.80 There is not eliminating vulnerability. Political justice seeks to
create a sense of equal protect, but by no means erases the human condition of
vulnerability. The human condition is vulnerable because of the need to respect human
life and the need to protect all humans from harm.
Susceptibility on the other hand is a “condition of being biologically weak or
disease which an increased predisposition toward additional harm.”81 This does above
and beyond the vulnerability of the human condition. Susceptibility is instead what has
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been previously described as the possibility of harm and inability to protect one’s own
interest. Here susceptibility is “a determined state of destitution and therefore can only
be reduced or neutralized by measures that are a) specifically designed against the
destitution in question and b) actively applied.”82 Unlike vulnerability, susceptibility is
the indication that suffering is taking place.83 This requires an awareness of that harm
or suffering. Susceptibility is action driven.
This contrasting notions of vulnerability and susceptibility are not as different as
Kottow argues. Vulnerability, though as Kottow argues, is a human condition and
susceptibility, is a condition predisposed to additional harm, and neither is exclusive of
each other. Susceptibility is instead of more specific aspect of vulnerability.
Susceptibility also implies a potential for additional harm. Being vulnerable, though
universal, is specific to the individual. Not all individuals are vulnerable to the same
universal injustice. Susceptibility is also broader because circumstances and situations
can become too congested with specifics and details and loses focus of the condition
that causes harm. While it is important to acknowledge the difference in the overall
definition of vulnerability and susceptibility, they are more alike at the practical level.
In fertility preservation, patients may be susceptible to make a rushed decision
in order to seek out treatment for their disease in a quick and timely manner Healthcare
professionals need to work hard to ensure that a patient is able to fully understand,
capable to appreciate the situation, and voluntarily consenting.
B.

Management of Communication
Management of communication goes back to the importance of truth-telling.

Being honest with patients can establish a relationship between those who are
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communicating. There is a strong connection between truth-telling and hope.84,85,86,87,88
When someone hopes is a specific goal or outcome, patients need to be informed of the
realistic and possible nature of that outcome. Patients need to believe in the words that
the healthcare professional is telling them so they can either change what they are
hoping for or continue to hope in the outcome. Truth-telling provides a stable and
effective foundation for the healthcare professional and patient relationship. It means
using layman’s terms and not scientific jargon that can overwhelm the patient. This can
be tiresome for the healthcare professional who is taught to speak with correct medical
terminology in order to engage with other healthcare professionals. The American
Society for Clinical Oncology (like many other groups) created fertility preservation
brochures to help communicate better with patients,89 while this may be helpful as a
jumping off point, healthcare professionals should never rely on a brochure to provide
all the necessary information or as a tool to allow follow up questions. Brochures are
someone else’s thoughts as to what information is relevant and necessary to make a
decision. However, brochures are designed to be general and broad. Healthcare
professionals need to be more specific in order to address the personal narrative of the
patient that is sitting in the office. Patients need to be treated as a partner in the
decision making process. After all, they are the primary decision maker and it is the
patient's name (or their parents' name) that goes on the informed consent document.
Clear, well-managed communication takes the routine information from a brochure or
website and brings it into the practical, real life application of fertility preservation to a
specific patient and applies their specific values and goals.90 It fosters hope in the
future of having children as a realistic and possible outcome.
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1.

Truth and Communication
Communication is closely tied to truth, honesty, and integrity. By being truthful,

communication can be accomplished between two individuals. Patients are assumed to
have autonomy. They have the right to determine their care and to request or refuse
treatment. Because there is an increased number of options available, patients need to be
informed about all of these options in order for the patient to make an educated
decision.91 In some cases, a healthcare professional may believe that it is appropriate to
leave out an option or withhold information. However, by doing this the healthcare
professional risks damaging.92 In cases where patients find out that the healthcare
professional lied, there is a risk for constant distrust of the healthcare professional by the
patient. They may continue to second guess every piece of information shared with them.
It could go as far as not following directions for treatment, which can affect the efficacy
and well-being of the patient.93 There is the question though as to what extent a patient
should be informed. There may be times when not informing the patient is to their
benefit because if keeps their worry at bay or prevent nervousness before a procedure. In
the majority of cases, the reason to withhold information is related to a terminal
diagnosis.94 Patients may not be accepting of hearing a terminal diagnosis and some
argue that in those cases it is okay to omit information. However, in the case of fertility
preservation. The information regarding fertility preservation is not about a terminal
diagnosis. The diagnosis of cancer may be terminal (but rarely is a terminal diagnosis of
cancer encouraged to undergo fertility preservation) and therefore it may be acceptable to
withhold information. But fertility preservation is not terminal. In fact, it may be seen as
the opposite of it. Fertility preservation is about the opportunity to cryopreserve material
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in order to attempt to have a child in the future. There is no justification for withholding
fertility preservation options, considering that none of them are terminal in any way.
2.

Save My Fertility®
Save My Fertility® is an online education toolkit created for aid patients and

healthcare professionals in communicating about fertility preservation. It is a resource for
healthcare professionals as they seek to communicate effectively with patients and their
families. The goals, determined by The Hormone Foundation® and the Oncofertility
Consortium®, is to increase the awareness of fertility preservation for cancer patients to
the public and healthcare professionals, and to educate about cancer treatments and its
effect on fertility.95 They created tools in order to prepare the healthcare professional to
speak with authority and expertise. SaveMyFertility.org provides provider pocket guides
as a handy resource. This resources can guide the healthcare professional as they
communicate with the patient either before or during the discussion. There are three
guides: Fertility Preservation for Children Diagnosed with Cancer,96 Fertility
Preservation for Men Diagnosed with Cancer,97 and Fertility Preservation for Women
Diagnosed with Cancer.98 Fertility Preservation for Children Diagnosed with Cancer
provides information about fertility preservation options and risks that include
discussions the issues of consent by the parents and assent by the minor patient. Fertility
Preservation for Men Diagnosed with Cancer and Fertility Preservation for Women
Diagnosed with Cancer contain similar information, but geared towards the appropriate
gender. All of the pocket guides provides resources for additional information and
questions. Also available as an app for smart devices, the pocket guides provide prompts
on how to start a discussion. It provides decision trees to work through as a group in
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order to see if fertility preservation and what options are best for you. There is a table
that contains a list of the possible cancer treatments and whether they are considered high
risk, intermediate risk, low risk, no risk, or unknown risk for infertility. There are also
facts sheets available the go through the definitions of all the terms in fertility
preservation, and poses questions and answers that patients (or parents need to
consider).99,100,101,102
3.

Communication and Hope
There are also be issues of culture and language barriers that affect the ability to

communicate.103 Healthcare facilities and university have resources available to address
those needs when they may arise. Again this cannot be enough of a reason to avoid
communication but rather a reasons to strive for it. Hope can be understood across
languages and cultures. Patients in any culture can understand the desire to have children
at a future date. Healthcare professionals need to work harder to ensure the information
and experts opinions are being effectively communicated and encourage patients to be
bold to ask questions. When information is appropriately disclosed, it can increase the
hopefulness in the patient.104 In order to communicate effectively to continuing fostering
hope there needs to some practical steps to ensure good communication. Making sure
that there is privacy, well managed time, and lack of interruptions for either party as well
as the willingness to allow the patient to include family or friends to the meeting. 105
Healthcare professionals should strive to speak at the literacy and comprehension level of
the patient. This can include having them repeat information and confirm
understanding.106
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As patients are striving to take in all the information provided, it can be a
daunting task. There is a reasons that medical school take four years, plus residency, and
psychologists often earn a PhD, and social workers put in hours towards clinical
experience. It would be impossible for a patient to learn all the material that the
healthcare professional has learned over the lifetime of his or her education and work.107
Healthcare professionals should also do their due diligence to listen well. A healthcare
professional’s job is not to just speak, but to listen to the patient. Patients may be hesitant
to voice questions or concerns, but good communication, encourages a patient to speak
up.
C.

Ethics Consultation Meetings
Fertility preservation programs need to consider bringing in outside consultation

to better manage the hope that is created in the discussions of fertility preservation. Some
programs bring in social worker or a psychologist. The recommendation here is to bring
in a clinical ethicist. The clinical ethicist can work with both the healthcare professional
and the patient to establish values and determine quality of life. This determination can
then inform the goals for treatment and fertility preservation that the patients feels best
fits their needs, goals, and quality of life. This can lead to a discussion concern decision
making and making sure the patient is participating in the informed consent process.
Healthcare professionals can sometimes be rushed in the process and it is important to
ensure understanding. Patients can be overwhelmed with diagnosis and prognosis of a
disease (like cancer) and may not be equipped to advocate on their own behalf in the
initial fertility preservation discussions. Bringing in an ethics consultation may provide
an objective, non-threatening voice where a patient can be heard and respected.108 An
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ethics consultation can help to eliminate conflict of interest concerns with researchers or
physicians, and allow the patient to identify values and goal, not just for the disease, but
also beyond into survivorship.
In the case of uterine transplantations (discussed back in Chapter Two), a clinical
ethicist was included on both the Swedish team109 and the Cleveland Clinic team.110 The
interdisciplinary team saw the need to bring in an ethicist to help address moral and
ethical issues. Ethics consultations can be used to address both clinical and
organizational ethical issues that may arise in the development of protocols or to help
patients in their own personal narratives.
In moving forward, it is worth reviewing both the CASES and ISSUES model as
modeled by the Veteran Administration National Center for Health Care Ethics. For
many providing the recommendation of bringing in an ethics consult is meaningless.
They do not necessarily know what that is or how it functions. The VA lays out an easy
to follow model for both clinical ethics (CASE) and organization ethics (ISSUES) both of
which may be necessary in order to address ethical issues in fertility preservation. The
goal in all of this is to foster the hope that has been established in its connection to
fertility preservation. These provide step by step instructions that can be easily taught to
whomever is going to conduct an ethics consultation.
1.

CASES: Clinical Ethics
CASES is a model by which one can conduct clinical ethics consultations. A lot

of what goes on in the CASES model is reading and thinking. The actual write up is a
final thorough summarization and recommendation, not a detailed report of every single
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piece of information and thought. The CASES model provides a tangible process to
move forward with for ethics consultations for clinical cases.
Clarify the Consultation Request. This step is to determine the type of consult
request and gain basic information regarding the request- including expectations and
ethical questions. It is important to establish why the request was called, and if it is
appropriate for ethics to be involved. It is also important to identify if this is a current
active case or not.111
Assemble the Relevant Information. Step two is all about gaining the important
and necessary information. This includes relevant medical facts, patient values, and
anything else that is important to the consult. It may also include talking with others who
have expertise that can help in the consult - including healthcare professionals, the patient
or the family. Once the information is collected it is important to identify what is
relevant and to summarize the information.112
Synthesize the Information. Step three is all about determining what to do with
the information. It is important to recognize what kind of consult is necessary - meaning
individual, team or full committee. This step also goes into the ethical analysis of the
situation and as well as identifying the appropriate decision maker.113
Explain the Synthesis. Step four is all about communication and documentation.
This means talking with the person who requested the consult and possibly patient as
well. It covers discussion of the recommendations and documenting everything in the
records. It also provides additional resources if necessary.114
Support the Consultation Process. Step five is a reflective look at the
consultation. It allows feedback for the consult, and follow up with the participants. It
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may also go further to adjust the consultation process if there is a problem or concern.
Additionally, there may be a need to address a system issues that resulted in the consult
in the first place.115
In fertility preservation clinical ethical issue that may arise are the determination
of capacity for a mature minor, issues of analyzing for benefits, risks, and harm, undue
influence from a partner, parents, or family, parents conflict of interest in consent on
behalf of their child, or issues of access regarding access or resource allocation.
2.

ISSUES: Organizational Ethics
In order to best use ISSUES, it is important to identify a gap between the current

practices and the best practices.116 While each step has a set description and goal, the
pieces often overlap and are a continuation of the previous step to a certain extent. One
step follows the next because the flow of the ISSUES in this specific order is well
thought out. This is a way to analyze the organizational ethics at the hospital. Often this
is the results of knowledge gained in step five of CASES.
Identify an Issue. This step seeks to as it clearly states, identify ethics issues.
According to the VA, this step clearly must be a proactive step. It cannot expect issues to
suddenly arise and need tending. It requires an ethicist to review the current systems and
processes, review previous ethics cases, review outside literature, and compare other
systems and processes. It takes work to identify an issues, characterize each one and
create a priority of what issue to tackle first.117
Study the Issue. When studying the issues, this mean an in depth review of the
current practice within the facility and an in depth review of the best practice for that
facility. The final piece to this step is creating and perfecting the goals for improvement
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to bridge the gap between the current practice and the best practice. The VA even
suggests creating a flow chart or diagram to better understand the process or system that
is being studied.118
Select a Strategy. When selecting a strategy, it is important to have completed a
thorough research and study of the issues. By studying the issue, one is able to identify
the major causes of the quality gap in that issues. The strategy must then reflect the way
to bet address the gap and seek a solution to narrow it. It may be important to try more
than one strategy because the major causes may be extremely diverse and require
individual attention. An important piece is to think creatively and allow questions and
adjustments to be made as strategies are developed.119
Undertake a Plan. Undertaking a plan involves knowing how to carry it out,
knowing how to evaluate it, and then actually executing it. It is important to know who
does what and when. Everyone must be in the know, in order to work effectively.
Knowing how to evaluate the strategy is important not only after the strategy is complete,
but also during the strategy as well. It allows time for review and gives the opportunity
to address unforeseen weaknesses as well as address known problems that were a
possibility. It keeps the strategy from being a waste of time and resources.120
Evaluate and Adjust. This is the actual evaluation and adjustment of the strategy
as the plan is being undertaken. So while the previous step made a plant to evaluate and
adjust, this step does that part of the plan. It ensures that goals are being met, participants
are doing their jobs and being informed of the strategy changes, and ultimately is
narrowing the gap between the current practice and the best practice. Once the entire
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plan is complete, it is also important to do a complete and thorough evaluation of the
strategy as a whole.121
Sustain and Spread. This step seeks to ensure that the best practice is maintained.
The use of the new strategy should leave the practice with a permanent improvement. It
always requires additional monitoring to make sure that is continues to be the best
practice. It may also be important to additionally spread the strategy to others whether it
is within the same facility or other systems entirely.122
Organizational issues may include conflict of commitment for a healthcare
professional between the patient and employer, financial conflict of interest if the
healthcare professional owes stock in a cryopreservation bank that she or he refers
patients to, or repeat offenses of withholding information in order to speed up the family
meeting.
Both of these models have their flaws, but by attempting to do each step, it can
help to better understand and address the ethical issue. Patients may not fully
comprehend the presence of ethics at a meeting, but the ethicist needs to explain that the
goal is to address whatever issue is at hand, while simultaneously fostering hope for the
patient.
V.

Conclusion

By examining the current approaches, programs, and advocacy groups, one can
better understand the complexities of fostering hope in fertility preservation. The
connection between hope and fertility preservation is present whether one acknowledges
it or not and therefore healthcare has to manage it better. In order to protect patients,
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ethics can play a much larger role in communication with patients regarding fertility
preservation.
Groups like oncofertility programs, registries, consortiums, for-profit companies,
advocacy groups, and professional organizations are all seeking to provide patients and
healthcare professionals with the necessary information and resources to aid in decision
making regarding fertility preservation in the cases of disease, especially cancer. The
problem with some of these groups, is the lack of accurate information, misleading in
methods of fertility preservation, or focusing on long term instead of helping the current
patient. Still these groups provide information that patients and healthcare professionals
may not get anywhere else. However, providing good information does not justify
unethical behavior.
Oncofertility programs are to provide fertility preservation information for
patients and healthcare professionals who are trying to understand and make decisions
regarding fertility preservation. They provide information directly from the healthcare
professionals and testimonials from patients who have experienced to better connect and
explain fertility preservation. The problems is that the focus is solely on cancer patients
so patients with other disease may struggle to find information and resources to preserve
fertility. It does not provide any support after the cancer. The decision to attempt to get
pregnant is just as difficult as the first decision. There needs to be resources on how to
approach the second decision as well.
Registries are a way to collect data about cancer patients. It can track a patient for
many demographic information before, during, and after treatment looking for trends and
new information. Registries are meant to be long-term studies that consider factors over
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long periods of time. The problem is issues of privacy, notification and ownership.
There are some who believe that the ownership of the data belongs to the organizations,
but the organization may have a responsibility to notify patients if negative or dangerous
information is discovered.
Oncofertility Consortium® allows healthcare professionals to exchange
information and collaborate on new information. It provides cutting edge research for
science, ethics, law, psychology, oncology, and other arenas while keeping the patient’s
personal narrative at the forefront of the case. This is one of the best resource
opportunities for healthcare professionals. However, that does not mean healthcare
professionals will use it or spend time improving their knowledge and skills.
For-profit companies are providing a service for those considering fertility
preservation. Many companies offer exclusive parties or international consultations for
patients at their convenience. There is an ongoing issue of conflict of interest by the
owners who are usually physicians. They are making money off of people who are in a
very vulnerable state and this could be considered exploitation.
Advocacy groups like the American Cancer Society and Fertile Action help
patients as they deal with cancer and the specific needs that arrive thereafter. Patients
tend to use these types of sites as a resource most often. Healthcare professionals need to
be well educated so they can address any proposed treatments from the patient. It may
mean that the healthcare professionals have to do research and get back to patient.
Professional Organizations provide insight into the healthcare information for
healthcare professionals. American Society for Reproductive Medicine and American
Society for Clinical Oncology both seek to better education and provide resources for
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healthcare professionals that are members. These organizations can create guidelines and
publish official statements on current issues of the moment. These organizations are the
standard for healthcare professionals to get their information from.
In all of these cases, the vulnerability of the patient is important to consider and
watch. If a patient is vulnerable there needs to be extra consideration regarding harm and
a risk of exploitation. Groups like the for-profit businesses may not be seeking out
vulnerable patients, but the need to be careful that their conflict of interest does not cause
undue influence over the patient.
Managing good communication means that healthcare professionals need to do
their homework, find good resources to encourage communication, and work to establish
and maintain trust. Once trust is broken, there is very little than can be done to repair it.
Ethics consultations can be brought in to help address the ethical issues that may
arise in the process of decision making for fertility preservation. The VA’s methods of
CASES and ISSUES provide structure and follow through to ensure that ethical issues
are identified, addressed and reviewed to prevent recurrence.
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Chapter Seven: Conclusion
I.

Introduction

Fertility preservation places hope in a future outcome for patients that are realistic
and possible. We must work hard to foster that hope. This can be done by having open
and honest communication, working hard to identify ethical issues, and seeking to protect
those who may be vulnerable. While patients do not want to be at risk of infertility,
sometimes it is impossible to avoid when patients are diagnosed with cancer and of other
diseases life lupus or rheumatoid arthritis. Infertility is unpredictable and varies person to
person. The advancements in healthcare including innovative treatments, allows patients
to not just survive disease for a short time, but to live long, healthy lives as other healthy
people do. Survivorship is put in place to help guide the patients into adjusting with their
new normal and moving forward in life. In order to seek a better outcome, aggressive
treatments are done, but they also bring side effects including the risk for infertility
among other concerns. Fertility preservation is the precaution, but it does not guarantee a
patient will not be infertility not will it guarantee them a healthy child. It is a
preventative procedure that may not be necessary in the future, but it is better to have it
and not need it than to need it and not have it.
By having access to aggressive treatments, hope is fostered not only to beat
serious diseases like cancer; but also the potential for a future pregnancy through the
cryopreservation of gametes and tissues. Options such as sperm and embryo
cryopreservation have been around for a while, and methods like oocyte cryopreservation
is only newly standard of care. By providing these possible cryopreservation options,
hope is fostered beyond fertility preservation and into healthcare in general. Patients will
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be more likely to return to their physician and seek any treatment that is needed in the
future. When patients experience successful treatments, patients may have a greater
expectation for healthcare to work wonders in the future. Healthcare professional need to
do a successful job of keeping patients maintaining realistic and possible hope. It is
important that patients are not looking for a medical miracle in the far off distant future,
but understand the current state of medicine and research. Projecting wants and desires
that are not based in reality can be damaging not only to the patient, but also to the
healthcare professional. Patients need to maintain a realistic and authentic view of their
current circumstances; otherwise, they are bordering on a false hope that could lead to
disappointment and despair.
In trying to maintain this realistic view, the considerations for fertility
preservation are numerous. Clinical ethicists should be present to ensure patients' rights
are being respected, and to critically examine the hope that patients have towards fertility
preservation prior to any procedures. By understanding the basic science of fertility
preservation, examining the basic definition of hope, considering all the different factors
that fertility preservation brings about including a short discussion on research and its
impact on healthcare, one can see how hope and fertility preservation are connected. By
discussing the ethical concepts of autonomy, beneficence, nonmaleficence, truth-telling,
informed consent, and decision making, it better demonstrated the connection between
hope and fertility preservation. It demonstrated that by addressing the ethical
considerations prior to any procedures, authentic hope can be fostered in fertility
preservation.
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II.

Chapter Summaries

A critical look at fertility preservation helped to better understand fertility
preservation and its connection to hope. The history and science of reproductive
technology leading to fertility preservation was discussed, specifically how ethics has
sought to address the many difficult changes in medicine. The concept of hope
specifically pulled from philosophy and theology, but also was discussed specifically in
relation to healthcare and research and as such can was discussed with fertility
preservation. The ethical role of hope was examined in its relation to fertility
preservation, in order to discuss why hope is different in this context as opposed to other
areas of healthcare. The ethical analysis of the reliance on hope in fertility preservation
was discussed about specific ethical concepts that were considered in relation to hope and
developed a critical ethical analysis of the advantages and disadvantages of the reliance
on hope in fertility preservation. Finally, by considering the current practice of hope
there was a better understanding that more need to be done on the basis of additional
ethical analysis.
Chapter Two focused on fertility preservation. The history and science of fertility
preservation was analyzed, specifically the historical advancements of science and its
contribution to medicine. By understanding the various methods of reproductive
technology, one is able to better understand and see the growth in healthcare.
Whether preventing pregnancy or combating infertility, reproductive technology has
progressed quickly. Medical research has proven that it continues to find innovative
ways to push the expectations and the applications of technologies. Even though the
technology has progressed, law and ethics often is playing catch up.
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1,2,3

Bioethics has struggled to address the complications that come with the

advancement of science in a timely manner.4,5,6 The expansion of innovative
cryopreservation has widen the ethical discussion to include new research protocols some
of which are so new there have only been a handful of live births attributed to that
method.7 While fertility preservation is recommended for those who are at risk for
infertility, either due to delaying pregnancy/ parenthood8,9 or side effects of medical
treatments like chemotherapy, there is no fool proof way to predict the risks of infertility.
10,11,12,13,14,15,16

Fertility preservation for delaying parenthood does not guarantee a

successful attempt at pregnancy any more than infertility due to a diagnosis. Differences
in demographics like gender, age, and socioeconomics of the patient population limits the
methods that patients have access to before the first conversation with a healthcare
professional. It puts patients at an unfair disadvantage that may never be equaled out.
The bioethical issues of decision making, procreative liberty, invasiveness of procedures
including risk, affordability of cryopreservation, and even disparities for referral patterns
in addition to other bioethical issues of moral status of embryos, viability, value of life,
federal funding, and cost and insurance coverage are all affected by issues of access. The
healthcare professional needs to be approach all reproductive technology with the
purpose of establishing trust to discuss what best fits the specific patient. 17,18,19,20
Understanding the standard of care and experimental options are just as important as
understanding the possible demographic issues that a patient may be facing as they move
forward with their highly personal decision.
Chapter Three sought to analyze the concept of hope specifically pulling from
philosophy and theology both describing the nature and characteristics.21 In addition, it
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detailed the specifics of hope in relation to healthcare and research. 22 Philosophers
Bloch, Marcel, and Kant and theologians Aquinas, Moltmann, and Lynch did not agree
on a singular definition of hope. But recognizing trends and commonality in their
individual description can lead to creating a working definition. It is important to
consider the effect of the personal narrative (biographical understanding) in any decision
making and how that differs from the abstract concept of hope. Context is vital to being
able to flesh out the concept of hope in a way that is useful and practical. By finding key
descriptions from the existential discussion, such as realistic possibility and the future,
one can better dictate how hope is used within a personal narrative like fertility
preservation. One of the biggest concerns regarding hope is ensuring authenticity and
preventing false hope.23

As discussed false hope is really an inappropriate term to

describe hopelessness, disappointment, and despair, but yet the term false hope continues
to persist. Authentic hope has been connected to trustworthiness and honesty.24 False
hope sets up an individual for disappointment so hope must be based in reality. 25 Within
healthcare, hope is part of the patient-healthcare professional relationship and can
demonstrate respect for autonomy and the prevention of exploitation of the
vulnerable.26,27 Without understanding how the individual is using the word hope, it is
difficult to manage and to foster such a concept. The conclusion of the discussion on
hope led to the working definition that hope is the belief in a future that has a realistic and
possible outcome.
Chapter Four examined the ethical role of hope in its relation to fertility
preservation. It discussed why hope was different in this context as opposed to other
areas of healthcare. Though discussed in the abstract to start, both hope and fertility
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preservation are part of a personal narrative for patients. By creating a personal
narration, one better understand the impact that hope has on fertility preservation. There
are two keys players involved when it comes to understanding the possibility of fertility
preservation: the healthcare professional and patient/families. It is important to consider
how hope is communicated in fertility preservation and what role hope plays in the
interactions between patients and healthcare professionals in the decision making
process. Healthcare professionals have to do their due diligence to ensure that they are
aware of the roles and responsibilities, they understand their expertise and the expertise
of others, and they maintain their competence for their field. For patients, they are facing
two separate decisions: the initial cryopreservation and the attempt to get pregnant in the
future.28 There is a responsibility of both the healthcare professional to thoroughly
explain the truth and the realistic expectations of fertility preservation and the patient to
maintain hope in a realistic, possible way in attempting to get pregnant. 29 There are
specific aspects to the future including genetic offspring, grandparenthood, and research
protocols that are a part of discussion for the future of patients. Since hope and fertility
preservation both involve the discussion of realistic possibility and the future, it is tough
to adequately maintain realistic hope and yet the goal is to continue to foster it.
Chapter Five presented an ethical analysis of the reliance on hope in fertility
preservation. It discussed what specific ethical concepts were considered in relation to
hope. Ethical principles such as autonomy, beneficence, nonmaleficence, and justice are
extensively discussed in ethical considerations of fertility preservation. Hope allows
patients to look to the future, and because of the principle of autonomy seek out
healthcare to attempt a successful pregnancy after fertility preservation and after given
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the all clear from their disease.30 Beneficence and nonmaleficence are not just part of the
short term decision, but also a part of the long-term future.31,32,33 The balance of benefits,
risks, and harm are hard to analyze, but must be done so the patient can make a informed
decision. Standard of care and research protocols for fertility preservation should be
made more readily available to promote justice.34 Issues of access will continue to
plague the system until there is a new way to make the procedures cheaper and reduce the
cost for insurance. Informed consent, truth-telling and decision making directly connects
to how hope is fostered in fertility preservation. Because fertility preservation affects
many different demographics and offer different methods to each, informed consent must
include understanding, capacity, and voluntariness. Truth-telling can potentially promote
or destroy hope depending on the information given or withheld.35,36 By fostering hope
in fertility preservation, patients have sense of control to direct their own care, provides
optimism which effects outcomes, and builds into the survivorship approach to disease.
Patients can exert their autonomy, and work with a trust-worthy healthcare professional
throughout the entire process.37,38 By fostering hope there is also a risk for
disadvantages. This can include inaccurate expectations and projection of the future of
science in a way that may not be truthful, and trying to manage the involvement of the
patient’s support team. By better understanding the ethical principles and concepts at
play, hope is better managed and even can be fostered.
Chapter Six provided elements for improving the current practice on the basis of
the ethical assessment developed in the previous chapter. There are several programs and
advocacy groups that address fertility preservation, but most are aimed at providing
information, not addressing the processing of decisions or the role that hope has in the
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decisions of fertility preservation. These programs and guidelines should encourage the
advantages and discourage the disadvantages in fostering hope in fertility preservation,
but there is a risk that it may negatively the patient. These groups provide expertise for
the healthcare, but must also take into consideration the expectations and hope that is
identified in the process of decision making. By identifying commonality in fertility
preservation programs, registries, consortiums, for-profit companies, professional
organizations, and advocacy group guidelines, recommendations can be made on how to
approach fertility preservation while fostering authentic hope. Seeking fertility
preservation does not necessarily make an individual vulnerable because of the future
possibility of infertility. However, there is a risk of vulnerability because the patient is in
a state that puts them at a disadvantage and encourages the need to reach out for help. By
trying to protect the vulnerable, trust, honesty, and open communication can be
established in these circumstances.39 Clear, well-managed communication takes the
routine information from a brochure or website into the practical, real life application of
fertility preservation to a specific patient and applies their specific values and goals.40
Bringing in an ethics consultation may provide an objective, non-threatening voice where
a patient can be heard and respected while it provides an added layer to ensure
understanding. It can address any outstanding clinical or ethical issues that may results
as part of the healthcare professional- patient relationship and the decision making
process. Many oncofertility programs and guidelines focus on creating a
multidisciplinary team.41,42 Including ethics in that team is important because someone
needs to be the expert in ethical issues that arise.. An ethics consultation can help to
eliminate conflict of interest, issues of capacity, issues of vulnerability and exploitation
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which are concerns among healthcare professionals, and allows the patient to identify
values and goal that will follow the patient into the survivorship phase. The connection
between hope and fertility preservation is present whether one acknowledges it or not and
every action affects the hope. In order to protect patients, ethics can play a much larger
role in fostering hope in fertility preservation with patient.
III.

Conclusion

The hope that fertility preservation fosters is based on the possibility to have
children and on the realistic future of science in addition to the authentic relationship
between the patient and healthcare professional involved. Fertility preservation covers a
wide range of demographics creating a unique personal narrative for each person.
Healthcare professionals need to refer patients to reproductive specialists in order to
provide the best medical information, which will allow for truth-telling and to manage the
hope that fertility preservation may foster. Key discussions need to take place to address
the common bioethical scenarios that a patient will face if and when they undergo fertility
preservation. Fertility preservation will continue to foster hope as long as patients are at
risk for infertility either by disease or delay in parenthood and even if current research
protocols become standard of care, new research studies will be created. By fostering
hope, patients are able to see beyond their circumstances and into the future for a realistic
positive outcome.
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